Processing 00000000.tx.1: Two waves of memory B-cell generation in the primary immune response Ayako Inamine1,2, Yoshimasa Takahashi1, Nobue Baba1, Kensuke Miyake3, Takeshi Tokuhisa4, Toshitada Takemori1 and Ryo Abe2,5 1 Department of Immunology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan 2 Division of Immunobiology, Research Institute for Biological Science and 5 Genome and Drug Research Center, Tokyo University of Science, 2669 Yamazaki, Noda, Chiba 278-0022, Japan 3 Division of Infectious Genetics, Institute of Medical Science, University of Tokyo, Tokyo 108-0071, Japan 4 Department of Developmental Genetics (H2) Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan Correspondence to: T. 

Phrase: "Two waves of memory B-cell generation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0678544:waves [Natural Phenomenon or Process]
   714 E C1421479:WAVE [Gene or Genome]

Phrase: "in the primary immune response Ayako Inamine1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0301875:Primary immune response [Organism Function]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Yoshimasa Takahashi1,"

Phrase: "Nobue Baba1,"

Phrase: "Kensuke Miyake3,"

Phrase: "Takeshi Tokuhisa4,"

Phrase: "Toshitada Takemori1"

Phrase: "and"

Phrase: "Ryo Abe2,"

Phrase: "5 1 Department of Immunology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "National Institute of Infectious Diseases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "1-23-1 Toyama,"

Phrase: "Shinjuku-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 162-8640,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan 2 Division of Immunobiology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1293097:Division [Therapeutic or Preventive Procedure]
   760   C2919030:Division [Organization]
   760   C2919031:Division [Activity]

Phrase: "Research Institute for Biological Science"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0035172:Research Institute [Organization]
   760   C0021622:institute [Organization]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "5 Genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017428:Genome [Gene or Genome]
   861   C2338314:Genome [Conceptual Entity]

Phrase: "and"

Phrase: "Drug Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "Tokyo University of Science,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040371:Tokyo [Geographic Area]
   770   C0041740:University [Manufactured Object,Organization]

Phrase: "2669 Yamazaki,"

Phrase: "Noda,"

Phrase: "Chiba 278-0022,"

Phrase: "Japan 3 Division of Infectious Genetics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1293097:Division [Therapeutic or Preventive Procedure]
   753   C2919030:Division [Organization]
   753   C2919031:Division [Activity]

Phrase: "Institute of Medical Science,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Tokyo 108-0071,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan 4 Department of Developmental Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0587466:Genetics department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "(H2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919509:H2 [Gene or Genome]
  1000   C1419394:H2 [Gene or Genome]

Phrase: ")"

Phrase: "Graduate School of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "Chiba University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Chiba 260-8670,"

Phrase: "Japan Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.2: Takemori; 

Phrase: "Takemori"

Phrase: ";"
Processing 00000000.tx.3: E-mail: ttoshi{at}nih.go.jp  Abstract Top Abstract Introduction Methods Results Discussion References  Memory B cells can be generated independently of germinal center (GC) formation and affinity maturation in Bcl-6-deficient mice, but the contribution of the GC-independent pathway for memory B-cell generation in normal mice remains unknown. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ttoshi{at}nih."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027468:NIH [Health Care Related Organization]

Phrase: "go.jp  Abstract Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "generated independently of germinal center (GC) formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1817919:germinal center formation [Organism Function]
   790   C0282491:Germinal Center [Tissue]
   753   C0205099:Center [Spatial Concept]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
   753   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "affinity maturation in Bcl-6-deficient mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0678723:Maturation [Organism Function]
   748   C0870861:maturation [Phenomenon or Process]
   748   C1254042:Maturation [Physiologic Function]

Phrase: "but"

Phrase: "the contribution of the GC-independent pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]

Phrase: "for memory B-cell generation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0682638:Memory B Cell [Cell]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]
   708   C0312737:Memory cell [Cell]

Phrase: "in normal mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "remains"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.4: To examine this, we administrated anti-inducible co-stimulator (ICOS) mAbs into mice at the onset of GC formation in the primary response. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "this,"

Phrase: "we"

Phrase: "administrated"

Phrase: "anti-inducible co-stimulator (ICOS) mAbs into mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "in the primary response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]
Processing 00000000.tx.5: This manipulation affected the generation of GC B cells in the spleen, but neither IgG1 memory B cell nor production of IgG1 long-term antibody was affected. 

Phrase: "This manipulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185111:Manipulation, NOS [Therapeutic or Preventive Procedure]
  1000   C0947647:Manipulation [Therapeutic or Preventive Procedure]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the generation of GC B cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "in the spleen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "neither IgG1 memory B cell"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0682638:Memory B Cell [Cell]
   875   C0312737:Memory cell [Cell]
   861   C0004561:B-cell [Cell]
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "nor"

Phrase: "production of IgG1 long-term antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0003261:Antibody Production [Biologic Function]
   753   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.6: In ICOS-manipulated mice, GC B cells accumulated somatic mutations in the IgVH genes and underwent affinity maturation; 

Phrase: "In ICOS-manipulated mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "accumulated"

Phrase: "somatic mutations in the IgVH genes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   767   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   753   C2986476:Somatic [Qualitative Concept]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "underwent"

Phrase: "affinity maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: ";"
Processing 00000000.tx.7: however, memory B cells scarcely accumulated mutations and reconstituted the secondary response by low affinity, supporting the notion that low-affinity memory B cells are generated in a GC-independent manner. 

Phrase: "however,"

Phrase: "memory B cells scarcely accumulated mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0026882:Mutations [Genetic Function]
   766 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "reconstituted"

Phrase: "the secondary response by low affinity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that low-affinity memory B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   933   C3554579:Low memory B cells [Finding]
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "generated in a GC-independent manner."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0282491:Germinal Center [Tissue]
   748   C0085862:Independent [Idea or Concept]
   748   C0205099:Center [Spatial Concept]
   748   C1299583:Independent [Finding]
   748   C3146294:Generated [Activity]
Processing 00000000.tx.8: Thus, it appears that memory B cells are established by two different pathways, associated with or without GC reaction and affinity maturation. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "established by two different pathways,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205448:Two [Quantitative Concept]
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C1704259:Pathways [Molecular Function]
   760   C1705242:Different [Qualitative Concept]
   760   C1705987:Pathways [Conceptual Entity]

Phrase: "associated with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C0750490:Associate [Idea or Concept]
   799 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or without GC reaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0282491:Germinal Center [Tissue]
   797   C2755839:reaction center [Cell Component]
   760   C0205099:Center [Spatial Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "affinity maturation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]
Processing 00000000.tx.9: The generation and long-term persistence of low-affinity IgG1 memory B cells and antibodies in ICOS-manipulated mice support the idea that low-affinity memory B cells may give rise to long-term antibody-forming cells. 

Phrase: "The generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "and"

Phrase: "long-term persistence of low-affinity IgG1 memory B cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0546816:Persistence [Mental Process]
   722   C1882350:Persistent Memory [Manufactured Object]

Phrase: "and"

Phrase: "antibodies in ICOS-manipulated mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that low-affinity memory B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   933   C3554579:Low memory B cells [Finding]
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to long-term antibody-forming cells."
Processing 00000000.tx.10: Keywords: affinity maturation, blocking antibody, germinal center, ICOS, somatic mutations  Introduction Top Abstract Introduction Methods Results Discussion References  The white pulp cord of the spleen is histologically divided into the B-cell follicle and T-cell area [the periarteriolar lymphocytic sheath (PALS)], where chemokines B Lymphocyte chemoattractant (BLC) and secondary lymphoid chemokine (SLC)/EBV-induced molecule 1 ligand chemokine (ELC) are synthesized by stromal cells, respectively (1). 

Phrase: "Keywords"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708608:Keyword [Intellectual Product]

Phrase: ":"

Phrase: "affinity maturation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "blocking antibody,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0282682:Blocking antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0233660:Blocking [Mental or Behavioral Dysfunction]
   861   C0332206:Blocking [Functional Concept]
   827 E C0028778:Block [Pathologic Function]
   827 E C1533157:Block [Substance]
   827 E C1706084:Block [Geographic Area]
   827 E C2828370:Block [Quantitative Concept]

Phrase: "germinal center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Center [Tissue]
   861   C0205099:Center [Spatial Concept]

Phrase: "ICOS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0175727:Stimulator [Medical Device]
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "somatic mutations  Introduction Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The white pulp cord of the spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1550235:Cord [Body Part, Organ, or Organ Component]
   748   C1552938:cord [Quantitative Concept]
   748   C1706500:Cord [Manufactured Object]

Phrase: "is"

Phrase: "histologically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205462:Histologically [Functional Concept]

Phrase: "divided into the B-cell follicle"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0004561:B-cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0018120:Follicle [Body Part, Organ, or Organ Component]
   753   C0332849:Divided [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1571705:Follicle [Body Part, Organ, or Organ Component]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "T-cell area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   734   C0039194:T-cell [Cell]

Phrase: "["

Phrase: "the periarteriolar lymphocytic sheath (PALS)"

Phrase: "],"

Phrase: "where chemokines B Lymphocyte chemoattractant (BLC)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0963811:B Lymphocyte Chemoattractant [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1366572:B-LYMPHOCYTE CHEMOATTRACTANT [Gene or Genome]
   840   C0004561:B lymphocyte [Cell]
   804   C0008013:chemoattractant [Biologically Active Substance]
   804   C0024264:Lymphocyte [Cell]

Phrase: "and"

Phrase: "secondary lymphoid chemokine (SLC)/EBV-induced molecule 1 ligand chemokine"

Phrase: "(ELC"

Phrase: ")"

Phrase: "are"

Phrase: "synthesized by stromal cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0162597:Stromal Cells [Cell]
   783 E C0596291:cells stroma [Cell Component]
   770   C0007634:Cells [Cell]
   770   C1883254:Synthesized [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "respectively"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: BLC is a chemoattractant to B cells via CXCR5 (25), whereas SLC and ELC are chemoattractants to T cells through CCR7 (68). 

Phrase: "BLC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0963811:B Lymphocyte Chemoattractant [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366572:B-LYMPHOCYTE CHEMOATTRACTANT [Gene or Genome]
   901   C0004561:B lymphocyte [Cell]
   827   C0008013:chemoattractant [Biologically Active Substance]
   827   C0024264:Lymphocyte [Cell]

Phrase: "is"

Phrase: "a chemoattractant to B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0963811:B-Cell Chemoattractant [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1366572:B-cell chemoattractant [Gene or Genome]
   760   C0008013:chemoattractant [Biologically Active Substance]

Phrase: "via CXCR5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332421:CXCR5 [Gene or Genome]
  1000   C1706891:CXCR5 [Gene or Genome]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "SLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "ELC"

Phrase: "are"

Phrase: "chemoattractants to T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0008013:Chemoattractants [Biologically Active Substance]

Phrase: "through CCR7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413191:CCR7 [Gene or Genome]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.12: Upon T-cell-dependent antigen exposure, B cells increase expression of CCR7 and increase responsiveness to the CCR7 ligands, resulting in a migration towards the T-cell area (6). 

Phrase: "Upon T-cell-dependent antigen exposure,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0274281:Exposure, NOS [Injury or Poisoning]
   804   C0332157:Exposure [Clinical Attribute]
   722   C0487637:T-cell Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "expression of CCR7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "increase responsiveness to the CCR7 ligands,"

Phrase: "resulting in a migration"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332294:Resulting in [Functional Concept]
   770   C0600210:Migration [Social Behavior]
   770   C0678226:resulting [Functional Concept]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "towards the T-cell area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   734   C0039194:T-cell [Cell]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.13: On the other hand, T cells are stimulated with antigens presented by dendritic cells in the inner PALS, followed by expression of CXCR5, which may, in turn, result in T-cell migration towards the B-cell area (9, 10). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "stimulated with antigens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "presented by dendritic cells"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   833   C0011306:Dendritic Cells [Cell]
   799 E C0003315:Dendritic cell [Cell]
   799 E C1511762:Dendritic Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0011305:Dendritic [Cell Component]
   770   C0439640:Dendritic [Qualitative Concept]
   770   C0449450:Presented [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0150312:Present [Quantitative Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in the inner PALS,"

Phrase: "followed by expression of CXCR5,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1332421:CXCR5 [Gene or Genome]
   760   C1706891:CXCR5 [Gene or Genome]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "which"

Phrase: "may"

Phrase: ","

Phrase: "in turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "result in T-cell migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "towards the B-cell area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   734   C0004561:B-cell [Cell]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.14: Such dynamics upon an antigenic challenge enable B cells and T cells to mutually activate at the boundary of the B-cell follicle and T-cell area (11) through interactions with co-stimulatory ligandreceptor pairs expressed on B and T cells, respectively, such as the CD40CD40 ligand (CD40CD154), B7.1 (CD80)/B7.2 (CD86)CD28 and inducible co-stimulator (ICOS)/activation-inducible lymphocyte immunomodulatory (AILIM)ICOS/AILIM ligands (1217). 

Phrase: "Such dynamics upon an antigenic challenge"

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "T cells to mutually"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0039194:T-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "activate at the boundary of the B-cell follicle"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0004561:B-cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0018120:Follicle [Body Part, Organ, or Organ Component]
   742   C1269647:Cell [Cell]
   742   C1515877:Activate [Functional Concept]
   742   C1571705:Follicle [Body Part, Organ, or Organ Component]
   742   C1704653:Cell [Medical Device]
   742   C1879547:Activate [Activity]
   742   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "T-cell area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   734   C0039194:T-cell [Cell]

Phrase: "(11"

Phrase: ")"

Phrase: "through interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "with co-stimulatory ligandreceptor pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709450:Pair [Qualitative Concept]

Phrase: "expressed on B"

Phrase: "and"

Phrase: "T cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "respectively,"

Phrase: "such as the CD40CD40 ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "(CD40CD154"

Phrase: ")"

Phrase: ","

Phrase: "B7.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366561:B7-1 [Gene or Genome]
  1000   C1705431:B7-1 [Gene or Genome]

Phrase: "(CD80"

Phrase: ")"

Phrase: "/B7.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413243:B7-2 [Gene or Genome]
  1000   C2698599:B7-2 [Gene or Genome]

Phrase: "(CD86"

Phrase: ")"

Phrase: "CD28"

Phrase: "and"

Phrase: "inducible co-stimulator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0175727:Stimulator [Medical Device]
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(ICOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0175727:Stimulator [Medical Device]
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "/activation-inducible lymphocyte immunomodulatory (AILIM)ICOS/AILIM ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0023688:Ligands [Chemical]

Phrase: "(1217"

Phrase: ")."
Processing 00000000.tx.15: After TB interaction at the boundary of the B-cell follicle and T-cell area, activated B cells increase expression of lymphotoxin , which in turn induces the maturation of follicular dendritic cells in the B-cell follicle (18). 

Phrase: "After TB interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "at the boundary"

Phrase: "of the B-cell follicle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   755 E C0439682:Follicular [Qualitative Concept]
   734   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "T-cell area,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   734   C0039194:T-cell [Cell]

Phrase: "activated B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "expression of lymphotoxin ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the maturation of follicular dendritic cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1516349:Cell Maturation [Cell Function]
   753   C0678723:Maturation [Organism Function]
   753   C0870861:maturation [Phenomenon or Process]
   753   C1254042:Maturation [Physiologic Function]

Phrase: "in the B-cell follicle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   755 E C0439682:Follicular [Qualitative Concept]
   734   C0004561:B-cell [Cell]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.16: Mature follicular dendritic cells then secrete BLC and attract activated B cells to form germinal centers (GCs) (19). 

Phrase: "Mature follicular dendritic cells then"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   884   C0242245:Dendritic Cells, Follicular [Cell]
   840   C0011306:Dendritic Cells [Cell]
   806 E C0003315:Dendritic cell [Cell]
   806 E C1511762:Dendritic Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0011305:Dendritic [Cell Component]
   804   C0439640:Dendritic [Qualitative Concept]
   804   C0439682:Follicular [Qualitative Concept]
   804   C1571705:Follicular [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "BLC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0963811:B Lymphocyte Chemoattractant [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366572:B-LYMPHOCYTE CHEMOATTRACTANT [Gene or Genome]
   901   C0004561:B lymphocyte [Cell]
   827   C0008013:chemoattractant [Biologically Active Substance]
   827   C0024264:Lymphocyte [Cell]

Phrase: "and"

Phrase: "attract"

Phrase: "activated B cells to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "germinal centers (GCs)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Centers [Tissue]
   861   C0205099:centers [Spatial Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.17: GC B cells express activation-induced cytidine deaminase and accumulate somatic mutations in their Ig genes, resulting in the generation of high-affinity variants (20). 

Phrase: "GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "activation-induced cytidine deaminase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1421876:ACTIVATION-INDUCED CYTIDINE DEAMINASE [Gene or Genome]
  1000   C3538973:Activation-Induced Cytidine Deaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010723:Cytidine Deaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1413247:CYTIDINE DEAMINASE [Gene or Genome]
   812   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "accumulate"

Phrase: "somatic mutations in their Ig genes,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   767   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   753   C2986476:Somatic [Qualitative Concept]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "resulting in the generation of high-affinity variants"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0332294:Resulting in [Functional Concept]
   744   C0079411:Generation [Temporal Concept]
   744   C0205250:High [Qualitative Concept]
   744   C0205419:variants [Qualitative Concept]
   744   C0678226:resulting [Functional Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1510827:Affinity [Natural Phenomenon or Process]
   744   C2700149:HIGH [Intellectual Product]
   744   C3146294:Generation [Activity]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.18: Although it has been widely believed that the precursors for memory B cells are generated in GCs, the accumulation of B cells without somatic mutations in the memory compartment of normal and GC-deficient mice suggests that memory B-cell development itself starts to operate at the early immune response, probably without a GC environment and the affinity maturation of B cell receptor (BCR) (21, 22). 

Phrase: "Although"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "widely"

Phrase: "believed"

Phrase: "that"

Phrase: "the precursors for memory B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0312738:Precursor B-Cells [Cell]
   767   C0018956:cells precursor [Cell]
   719   C1709634:Precursor [Idea or Concept]

Phrase: "are"

Phrase: "generated in GCs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0282491:Germinal Centers [Tissue]
   770   C0205099:centers [Spatial Concept]
   770   C3146294:Generated [Activity]

Phrase: "the accumulation of B cells"

Phrase: "without somatic mutations"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C2986476:Somatic [Qualitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
   768 E C0599444:soma [Cell Component]
   768 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   755 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "in the memory compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "of normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "GC-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that memory B-cell development"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C3155102:memory B cell development [Cell Function]
   923   C1511002:B-Cell Development [Cell Function]
   923   C3158362:B cell development [Cell Function]
   861   C0815089:cell development [Cell Function]
   812   C0243107:development [Physiologic Function]
   812   C0678723:Development [Organism Function]
   812   C1527148:Development [Functional Concept]
   756   C0682638:Memory B Cell [Cell]
   741 E C0458003:Developmental [Qualitative Concept]
   708   C0312737:Memory cell [Cell]

Phrase: "itself"

Phrase: "starts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "operate at the early immune response,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0301872:Immune response [Organ or Tissue Function]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1279919:Early [Temporal Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
   753   C3242339:operate [Functional Concept]

Phrase: "probably without a GC environment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0282491:Germinal Center [Tissue]
   753   C0014406:Environment [Spatial Concept]
   753   C0205099:Center [Spatial Concept]
   753   C0750492:Probably [Idea or Concept]

Phrase: "and"

Phrase: "the affinity maturation of B cell receptor (BCR)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C1817724:B cell affinity maturation [Biologic Function]
   774   C1516349:Cell Maturation [Cell Function]
   748   C0678723:Maturation [Organism Function]
   748   C0870861:maturation [Phenomenon or Process]
   748   C1254042:Maturation [Physiologic Function]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.19: Supporting this idea, it has been observed that memory phenotype B cells already appeared at day 7 post-immunization before the improvement of BCR affinity within GCs (23). 

Phrase: "Supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "this idea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that memory phenotype B cells already"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   875   C0312737:Memory cells [Cell]
   872   C0682638:Memory B Cell [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "appeared at day 7 post-immunization"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   753   C0042196:immunisation [Therapeutic or Preventive Procedure]
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   753   C0687676:Post [Temporal Concept]
   753   C1704687:Post [Manufactured Object]
   753   C3244291:immunization [Functional Concept]
   719   C0700364:APPEAR [Qualitative Concept]

Phrase: "before the improvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986411:Improvement [Conceptual Entity]

Phrase: "of BCR affinity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1510827:Affinity [Natural Phenomenon or Process]
   756   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "within GCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Centers [Tissue]
   861   C0205099:centers [Spatial Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.20: Moreover, transgenic B cells expressing low-affinity BCR can differentiate into memory B cells even without the improvement of BCR affinity (24). 

Phrase: "Moreover,"

Phrase: "transgenic B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "low-affinity BCR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   840   C0004561:B-cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "differentiate into memory B cells even"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   820   C0682638:b cells memory [Cell]
   790   C0004561:B-Cells [Cell]
   783   C0312737:Memory cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0025260:Memory [Mental Process]
   753   C0205615:differentiate [Qualitative Concept]
   753   C0700327:memory [Finding]
   753   C1706377:Memory [Manufactured Object]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "without the improvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986411:Improvement [Conceptual Entity]

Phrase: "of BCR affinity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1510827:Affinity [Natural Phenomenon or Process]
   756   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.21: Thus, it might be possible that low-affinity memory B cells can be generated through a GC-independent pathway in the early primary response as well as a GC-dependent pathway at a later stage for high-affinity memory B cells. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "might"

Phrase: "be"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that low-affinity memory B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   933   C3554579:Low memory B cells [Finding]
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "generated through a GC-independent pathway"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0282491:Germinal Center [Tissue]
   748   C0085862:Independent [Idea or Concept]
   748   C0205099:Center [Spatial Concept]
   748   C1299583:Independent [Finding]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
   748   C3146294:Generated [Activity]

Phrase: "in the early primary response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "as well as"

Phrase: "a GC-dependent pathway at a later"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]

Phrase: "stage for high-affinity memory B cells."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   804   C0682638:b cells memory [Cell]
   778   C0004561:B-Cells [Cell]
   774   C0312737:Memory cells [Cell]
   774   C0441781:Stage B [Intellectual Product]
   748   C0007634:Cells [Cell]
   748   C0025260:Memory [Mental Process]
   748   C0205250:High [Qualitative Concept]
   748   C0205390:Stage [Temporal Concept]
   748   C0700327:memory [Finding]
   748   C1299351:High [Qualitative Concept]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   748   C1706377:Memory [Manufactured Object]
   748   C2700149:HIGH [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.22: Memory B-cell development is completely dependent on helper signals from T cells, so the blockade of CD40CD154, CD80/CD86CD28 and ICOS/AILIMICOS/AILIM ligand (B7h/B7RP-1/GL50) interactions impairs GC formation and the memory B-cell response (2532). 

Phrase: "Memory B-cell development"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C3155102:memory B cell development [Cell Function]
   923   C1511002:B-Cell Development [Cell Function]
   923   C3158362:B cell development [Cell Function]
   861   C0815089:cell development [Cell Function]
   812   C0243107:development [Physiologic Function]
   812   C0678723:Development [Organism Function]
   812   C1527148:Development [Functional Concept]
   756   C0682638:Memory B Cell [Cell]
   741 E C0458003:Developmental [Qualitative Concept]
   708   C0312737:Memory cell [Cell]

Phrase: "is"

Phrase: "completely dependent on helper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "signals from T cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0039194:T-Cells [Cell]
   802   C0037083:cell signals [Cell Function]
   770   C0007634:Cells [Cell]
   770   C1710082:Signal [Phenomenon or Process]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "so"

Phrase: "the blockade of CD40CD154,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332206:Blockade [Functional Concept]
   770   C3540676:Blockade [Pharmacologic Substance]

Phrase: "CD80/CD86CD28"

Phrase: "and"

Phrase: "ICOS/AILIMICOS/AILIM ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0023688:Ligand [Chemical]

Phrase: "(B7h/B7RP-1/GL50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1424734:GL50 [Gene or Genome]

Phrase: ")"

Phrase: "interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "impairs"

Phrase: "GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "and"

Phrase: "the memory B-cell response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C0682638:Memory B Cell [Cell]
   708   C0312737:Memory cell [Cell]

Phrase: "(2532"

Phrase: ")."
Processing 00000000.tx.23: Injection of antibodies for CD154 and CD86 at the onset of GC formation has been used to block GC reaction and following memory B-cell development without inhibiting the foci of antibody-forming cells (AFCs) or an early serum antibody response (33). 

Phrase: "Injection of antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021485:injection [Therapeutic or Preventive Procedure]
   790   C1272883:Injection [Biomedical or Dental Material]
   790   C1533685:Injection [Therapeutic or Preventive Procedure]
   790   C1828121:Injection [Functional Concept]

Phrase: "for CD154"

Phrase: "and"

Phrase: "CD86 at the onset of GC formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C3158968:CD86 formation [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "GC reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0282491:Germinal Center [Tissue]

Phrase: "and"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "memory B-cell development without inhibiting"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C3155102:memory B cell development [Cell Function]
   833   C1511002:B-Cell Development [Cell Function]
   833   C3158362:B cell development [Cell Function]
   790   C0815089:cell development [Cell Function]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
   712   C1848980:Developmental arrest [Finding]

Phrase: "the foci of antibody-forming cells (AFCs)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0205234:Foci [Spatial Concept]
   719 E C1285542:focus [Functional Concept]

Phrase: "or"

Phrase: "an early serum antibody response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0003261:Antibody Response [Biologic Function]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.24: Thus, injection for blocking antibodies at the onset of GC formation allows us to elucidate the role of GC reaction in the following B-cell response. 

Phrase: "Thus,"

Phrase: "injection for blocking antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the role of GC reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the following B-cell response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
Processing 00000000.tx.25: ICOS/AILIMICOS/AILIM ligand interaction has been shown to be involved in the primary B-cell response by IgG antibody production, GC B-cell expansion and memory B-cell generation (34). 

Phrase: "ICOS/AILIMICOS/AILIM ligand interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the primary B-cell response"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0004561:B-cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0205225:Primary [Qualitative Concept]
   748   C0439631:Primary [Therapeutic or Preventive Procedure]
   748   C0871261:Response [Organism Attribute]
   748   C1269647:Cell [Cell]
   748   C1314939:Involved [Functional Concept]
   748   C1704632:Response [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1706817:Response [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]
   748   C2911692:Response [Mental Process]

Phrase: "by IgG antibody production,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0003261:Antibody Production [Biologic Function]
   827   C0033268:production [Occupational Activity]
   734   C2754943:IgG antibody [Cell Component]

Phrase: "GC B-cell expansion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0007595:cell expansion [Cell Function]

Phrase: "and"

Phrase: "memory B-cell generation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0682638:Memory B Cell [Cell]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]
   708   C0312737:Memory cell [Cell]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.26: In gene-targeted ICOS/AILIM- or ICOS/AILIM ligand-deficient mice (ICOS/ or ICOS-L/ mice), the IgG antibody response as well as the size and mean number of GCs in the spleen were impaired in the primary response to T-cell-dependent antigens (31, 32, 35), although the effect on affinity maturation was unknown. 

Phrase: "In gene-targeted ICOS/AILIM-"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   846   C0017255:Gene Activation [Genetic Function]
   813   C0024262:activation lymphocyte [Cell Function]
   804   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0017337:Gene [Gene or Genome]
   790   C0024264:Lymphocyte [Cell]
   790   C0150312:In [Quantitative Concept]
   790   C0175727:Stimulator [Medical Device]
   790   C0205263:Inducible [Functional Concept]
   790   C0332285:In [Spatial Concept]
   790   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1521840:Targeted [Functional Concept]
   790   C1879547:Activation [Activity]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "or"

Phrase: "ICOS/AILIM ligand-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "(ICOS/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0175727:Stimulator [Medical Device]
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "ICOS-L/ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "the IgG antibody response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0003261:Antibody Response [Biologic Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C2754943:IgG antibody [Cell Component]

Phrase: "as well as"

Phrase: "the size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "mean number of GCs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0454243:Number of centers [Quantitative Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0444504:Mean [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "in the spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "impaired in the primary response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205225:Primary [Qualitative Concept]
   760   C0221099:Impaired [Functional Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C0684336:Impaired [Pathologic Function]
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "to T-cell-dependent antigens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   906   C0487637:T-cell Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003320:Antigens [Immunologic Factor]
   706 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32,"

Phrase: "35"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the effect on affinity maturation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.27: The secondary IgG antibody response was reduced in ICOS/ mice compared with wild type (WT) mice (35), suggesting a reduction in the number of memory B cells or a defect in their functions. 

Phrase: "The secondary IgG antibody response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0003261:Antibody Response [Biologic Function]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "reduced in ICOS/ mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0175727:Stimulator [Medical Device]
   753   C0205263:Inducible [Functional Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "compared with wild type (WT) mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a reduction in the number of memory B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "a defect in their functions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.28: To investigate whether or not memory B-cell development occurs at the early immune response in the absence of a GC environment in normal mice, the mice were injected with anti-ICOS/AILIM mAb at day 5 post-immunization when GC formation begins. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "or"

Phrase: "not memory B-cell development"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   937   C3155102:memory B cell development [Cell Function]
   884   C1511002:B-Cell Development [Cell Function]
   884   C3158362:B cell development [Cell Function]
   840   C0815089:cell development [Cell Function]
   804   C0243107:development [Physiologic Function]
   804   C0678723:Development [Organism Function]
   804   C1527148:Development [Functional Concept]
   733 E C0458003:Developmental [Qualitative Concept]
   717   C0682638:Memory B Cell [Cell]

Phrase: "occurs at the early immune response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0301872:Immune response [Organ or Tissue Function]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1279919:Early [Temporal Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
   753   C2911692:Response [Mental Process]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of a GC environment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014406:Environment [Spatial Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "in normal mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "with anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at day 5 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "when"

Phrase: "GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "begins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]
Processing 00000000.tx.29: ICOS/AILIM is expressed on activated T cells within GCs (10); 

Phrase: "ICOS/AILIM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   829   C0024262:activation lymphocyte [Cell Function]
   818   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0024264:Lymphocyte [Cell]
   795   C0175727:Stimulator [Medical Device]
   795   C0205263:Inducible [Functional Concept]
   795   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "expressed on activated T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0039194:T-Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C1879547:Activated [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1515877:Activate [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "within GCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Centers [Tissue]
   861   C0205099:centers [Spatial Concept]

Phrase: "(10"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.30: therefore, we expected that the injection of anti-ICOS/AILIM antibody at the onset of GC formation would lead to the selective blockade of a GC-dependent pathway for memory B-cell generation. 

Phrase: "therefore,"

Phrase: "we"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "that"

Phrase: "the injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of anti-ICOS/AILIM antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   893   C0003369:Anti lymphocyte antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Lymphocyte Antibody
   891   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   791   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "would"

Phrase: "lead to the selective blockade of a GC-dependent pathway"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0282491:Germinal Center [Tissue]
   738   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   738   C0205099:Center [Spatial Concept]
   738   C0332206:Blockade [Functional Concept]
   738   C0851827:Dependent [Qualitative Concept]
   738   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   738   C1522538:Lead [Functional Concept]
   738   C1701901:Dependent [Qualitative Concept]
   738   C1704259:Pathway [Molecular Function]
   738   C1705987:Pathway [Conceptual Entity]
   738   C2348269:Lead [Element, Ion, or Isotope]
   738   C3244310:dependent [Functional Concept]
   738   C3275067:LEAD [Therapeutic or Preventive Procedure]
   738   C3540676:Blockade [Pharmacologic Substance]

Phrase: "for memory B-cell generation."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0682638:Memory B Cell [Cell]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]
   708   C0312737:Memory cell [Cell]
Processing 00000000.tx.31: We show here that the blockade of ICOS/AILIMICOS/AILIM ligand interaction within GCs impairs the recruitment of high-affinity B cells into the memory compartment, whereas low-affinity memory B cells are generated and maintained for a long period. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that"

Phrase: "the blockade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332206:Blockade [Functional Concept]
  1000   C3540676:Blockade [Pharmacologic Substance]

Phrase: "of ICOS/AILIMICOS/AILIM ligand interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "within GCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Centers [Tissue]
   861   C0205099:centers [Spatial Concept]

Phrase: "impairs"

Phrase: "the recruitment of high-affinity B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2949735:Recruitment [Activity]

Phrase: "into the memory compartment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "whereas"

Phrase: "low-affinity memory B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   933   C3554579:Low memory B cells [Finding]
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "maintained for a long period."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205166:Long [Qualitative Concept]
   760   C0439531:/period [Temporal Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C1948053:Period [Temporal Concept]
   726 E C0024501:Maintain [Activity]
Processing 00000000.tx.32: Taken together with previous findings, we propose that low-affinity memory B cells can be generated without GCs and maintained for a long period when higher affinity competitors are reduced.  

Phrase: "Taken together with previous findings,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0205156:Previous [Temporal Concept]
   760   C1552607:previous [Temporal Concept]
   760   C1883357:Together [Qualitative Concept]
   760   C1883727:Taken [Conceptual Entity]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C1515187:Take [Health Care Activity]
   726 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "propose"

Phrase: "that low-affinity memory B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   933   C3554579:Low memory B cells [Finding]
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "generated without GCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0282491:Germinal Centers [Tissue]
   770   C0205099:centers [Spatial Concept]
   770   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "maintained for a long period"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205166:Long [Qualitative Concept]
   760   C0439531:/period [Temporal Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C1948053:Period [Temporal Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "when"

Phrase: "higher affinity competitors"

Phrase: "are"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.33: Methods Top Abstract Introduction Methods Results Discussion References  Mice and immunization Female C57BL/6 mice and C57BL/6 mice with deficient recombination-activating gene (Rag-1/) were obtained from SLC Inc. 

Phrase: "Methods Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "immunization Female C57BL/6 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   873   C1521751:C57BL/6 Mouse [Mammal]
   853   C0025921:Mice, C57BL [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "C57BL/6 mice with deficient recombination-activating gene (Rag-1/)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   789   C1521751:C57BL/6 Mouse [Mammal]
   767   C0025921:Mice, C57BL [Mammal]
   767   C1417166:MICE gene [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "obtained from SLC Inc."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1301820:Obtained [Functional Concept]
   753   C1518071:Lymphoid [Qualitative Concept]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.34: (Hamamatsu, Japan) and the Jackson Laboratory (Bar Harbor, ME, USA), respectively. 

Phrase: "(Hamamatsu,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "the Jackson Laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "(Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.35: All mice were maintained in a specific pathogen-free condition. 

Phrase: "All mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "maintained in a specific pathogen-free condition."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   814   C0162470:Specific Pathogen Free [Organism]
   748   C0012634:condition [Disease or Syndrome]
   748   C0205369:Specific [Qualitative Concept]
   748   C0332296:free [Functional Concept]
   748   C0348080:Condition [Qualitative Concept]
   748   C0450254:Pathogen [Organism]
   748   C1314677:Maintained [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1705253:Condition [Conceptual Entity]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   714 E C0024501:Maintain [Activity]
Processing 00000000.tx.36: C57BL/6 mice were intra-peritoneally (i.p.) immunized with 100 g of (4-hydroxy-3-nitrophenyl) acetyl (NP) coupled on chicken gamma globulin (NP16-CG) in alum as previously described (21). 

Phrase: "C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "intra-peritoneally (i.p.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0347985:Intra [Temporal Concept]

Phrase: "immunized with 100 g of (4-hydroxy-3-nitrophenyl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439267:g% [Quantitative Concept]
   742   C0700307:Hydroxy [Inorganic Chemical]

Phrase: ")"

Phrase: "acetyl"

Phrase: "(NP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706141:NP [Gene or Genome]

Phrase: "coupled on chicken gamma globulin"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0017007:Gamma globulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0008051:Chicken [Bird]
   760   C0017011:Gamma [Natural Phenomenon or Process]
   760   C0017649:Globulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0677521:Chicken [Food]
   760   C1365945:CHICKEN [Food]
   760   C1552644:Gamma [Intellectual Product]
   760   C1948027:Coupled [Functional Concept]
   760   C2349976:Gamma [Quantitative Concept]
   726 E C0010222:couple [Family Group]

Phrase: "(NP16-CG) in alum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   770   C3540479:CG [Gene or Genome]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.37: At days 5, 6 and 7 post-immunization, the mice were intravenously injected with 100 g of anti-ICOS/AILIM mAb (B10.5; 36) or isotype-matched rat IgG2a mAb against phenyloxazolone (G18) as the control mAb. 

Phrase: "At days 5,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "6"

Phrase: "and"

Phrase: "7 post-immunization,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   827   C0042196:immunisation [Therapeutic or Preventive Procedure]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   827   C3244291:immunization [Functional Concept]
   755 E C1514253:Postal [Functional Concept]

Phrase: "the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "intravenously"

Phrase: "injected with 100 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439267:g% [Quantitative Concept]
   737   C1720154:Inject [Functional Concept]

Phrase: "of anti-ICOS/AILIM mAb (B10.5"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   809   C0024262:activation lymphocyte [Cell Function]
   801   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   788   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   788   C0024264:Lymphocyte [Cell]
   788   C0175727:Stimulator [Medical Device]
   788   C0205263:Inducible [Functional Concept]
   788   C0507110:B10 [Body Part, Organ, or Organ Component]
   788   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   788   C1414409:B10 [Gene or Genome]
   788   C1879547:Activation [Activity]

Phrase: "; 36"

Phrase: ")"

Phrase: "or"

Phrase: "isotype-matched rat IgG2a mAb against phenyloxazolone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(G18"

Phrase: ")"

Phrase: "as the control mAb."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.38: All mice were used in accordance with National Institute of Infectious Diseases Institutional Animal Care and Use Committee guidelines. 

Phrase: "All mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used in accordance with National Institute of Infectious Diseases Institutional Animal Care"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   753   C0009450:Infectious Diseases [Disease or Syndrome]
   753   C0178478:animal care [Occupation or Discipline]
   751   C0003047:Animal Diseases [Disease or Syndrome]
   751   C0868975:Institutional care [Health Care Activity]
   736   C0003062:Animal [Animal]
   736   C0012634:Diseases [Disease or Syndrome]
   736   C0021622:institute [Organization]
   736   C1272753:Institute [Idea or Concept]
   736   C1273517:used [Finding]
   736   C1947933:Care [Activity]
   736   C3245503:national [Intellectual Product]
   734   C1524063:Use of [Functional Concept]
   715   C0205721:institutional infection [Disease or Syndrome]
   703 E C0042153:use [Functional Concept]
   703 E C0457083:Use [Functional Concept]
   703 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "Use Committee guidelines."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0162791:Guidelines [Intellectual Product]
   827   C0220845:guidelines [Intellectual Product]
   827   C0282423:guidelines [Intellectual Product]
Processing 00000000.tx.39: Cell staining and sorting A single-cell suspension was prepared from spleens and bone marrows (BMs) as described previously (21). 

Phrase: "Cell staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "sorting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237886:Sorting [Mental Process]
  1000   C0700314:sorting [Cell Function]
  1000   C1947906:Sorting [Activity]

Phrase: "A single-cell suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038960:Suspension [Biomedical or Dental Material]
   827   C1382107:Suspension [Substance]
   827   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "prepared from spleens"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0037993:Spleens [Body Part, Organ, or Organ Component]
   756 E C0771377:SPLEEN [Tissue]
   756 E C1278932:Spleen [Body Part, Organ, or Organ Component]
   756   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "bone marrows (BMs)"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   983   C0005953:Bone Marrow [Tissue]
   861   C0330477:Marrows [Plant]
   827 E C0086590:Marrow [Food]
   827 E C0376152:Marrow [Body Part, Organ, or Organ Component]
   827 E C1546708:Marrow [Intellectual Product]
   789 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   789 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   789 E C1550278:Medullary [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.40: Cells were incubated with 10 g ml1 of anti-FcRII/III (2.4G2; BD Biosciences, San Jose, CA, USA) prior to staining with antibodies. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with 10 g ml1 of anti-FcRII/III"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C3501774:III-10 [Organic Chemical,Pharmacologic Substance]
   742   C0439070:III [Intellectual Product]
   742   C0439267:g% [Quantitative Concept]
   742   C1424252:ML1 [Gene or Genome]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1705160:III [Qualitative Concept]

Phrase: "(2.4G2"

Phrase: "; BD Biosciences,"

Phrase: "San Jose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "prior to staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.41: To track the generation of GC B cells, splenocytes were stained with PE-conjugated (4-hydroxy-5-iodo-3-nitrophenyl) acetyl (NIP)34-BSA (NIP-BSAPE), Texas red-coupled anti-B220 (B220TX), allophycocyanin (APC)-conjugated anti-CD38 (CS/2, CD38APC) and FITC-coupled peanut agglutinin (PNA) at 1 : 100 dilutions (PNAFITC; Biomeda Vector Laboratories, Burlingame, CA, USA). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "track"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040594:Track [Manufactured Object]

Phrase: "the generation of GC B cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519477:Splenocyte [Cell]

Phrase: "were"

Phrase: "stained with PE-conjugated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0522529:Conjugated [Spatial Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(4-hydroxy-5-iodo-3-nitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   895   C0048584:4-nitrophenyl [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "acetyl"

Phrase: "(NIP)34-BSA (NIP-BSAPE"

Phrase: ")"

Phrase: ","

Phrase: "Texas red-coupled anti-B220"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1335285:B220 [Gene or Genome]
   804   C1706240:B220 [Gene or Genome]

Phrase: "(B220TX"

Phrase: ")"

Phrase: ","

Phrase: "allophycocyanin (APC)-conjugated anti-CD38"

Phrase: "(CS/2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1413753:CS-2 [Gene or Genome]
  1000   C1422182:CS-2 [Gene or Genome]
   861   C3540510:cs [Quantitative Concept]

Phrase: "CD38APC"

Phrase: ")"

Phrase: "and"

Phrase: "FITC-coupled peanut agglutinin (PNA) at 1"

Phrase: ":"

Phrase: "100 dilutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0079240:dilutions [Laboratory Procedure]
   827 E C1948037:Dilution [Functional Concept]

Phrase: "(PNAFITC"

Phrase: "; Biomeda Vector Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Burlingame,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.42: As a control, cells were stained with BSAPE, instead of NIP-BSAPE. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with BSAPE,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "instead of NIP-BSAPE."
Processing 00000000.tx.43: To monitor the generation of memory B cells, cells were incubated with a mixture of biotinylated antibodies against IgM, IgD, CD90, CD5, CD43 and CD11b (BD Biosciences) to exclude naive B cells, B-1 cells, plasma cells and T cells from the analysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "the generation of memory B cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with a mixture of biotinylated antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0439962:Mixture [Substance]
   748   C1439852:Incubated [Laboratory Procedure]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against IgM,"

Phrase: "IgD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020843:IgD [Amino Acid, Peptide, or Protein]
  1000   C0577612:IGD [Laboratory Procedure]

Phrase: "CD90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348635:CD90 [Gene or Genome]
  1000   C2348783:CD90 [Amino Acid, Peptide, or Protein]

Phrase: "CD5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538992:CD5 [Laboratory Procedure]

Phrase: "CD43"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538777:CD43 [Gene or Genome]

Phrase: "and"

Phrase: "CD11b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541224:CD11B [Laboratory Procedure]

Phrase: "(BD Biosciences"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "naive B cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "B-1 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C2347469:/B [Quantitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "plasma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0032112:Plasma Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "T cells from the analysis."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0039194:T-Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.44: After washing, cells were stained for 30 min with a mixture of NIP-BSAPE, IgG1FITC, AlexaFluor 647-coupled anti-CD38 and AlexaFluor 594-coupled anti-B220 mAbs. 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained for 30 min"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with a mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "of NIP-BSAPE,"

Phrase: "IgG1FITC,"

Phrase: "AlexaFluor 647-coupled anti-CD38"

Phrase: "and"

Phrase: "AlexaFluor 594-coupled anti-B220 mAbs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.45: After washing, cells were incubated with Tricolor (TC)-conjugated streptavidine (streptavidineTC; Caltag Laboratories, Burlingame, CA, USA) and propidium iodide (Sigma, St Louis, MO, USA) to exclude dead cells from the analysis. 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with Tricolor (TC)-conjugated streptavidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0522529:Conjugated [Spatial Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(streptavidineTC"

Phrase: "; Caltag Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Burlingame,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "propidium iodide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "dead cells from the analysis."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.46: To purify GC and memory B cells, splenocytes were incubated with 10 g ml1 of anti-FcRII/III mAb for 20 min, followed by a 30-min incubation with biotinylated mAbs against IgM, IgD, CD90, CD5, CD43 and CD11b. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "GC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Center [Tissue]
   861   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "memory B cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519477:Splenocyte [Cell]

Phrase: "were"

Phrase: "incubated with 10 g ml1 of anti-FcRII/III mAb"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C3501774:III-10 [Organic Chemical,Pharmacologic Substance]
   739   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0439070:III [Intellectual Product]
   739   C0439267:g% [Quantitative Concept]
   739   C1424252:ML1 [Gene or Genome]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1705160:III [Qualitative Concept]

Phrase: "for 20 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by a 30-min incubation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332283:Followed by [Temporal Concept]
           followed
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "with biotinylated mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "against IgM,"

Phrase: "IgD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020843:IgD [Amino Acid, Peptide, or Protein]
  1000   C0577612:IGD [Laboratory Procedure]

Phrase: "CD90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348635:CD90 [Gene or Genome]
  1000   C2348783:CD90 [Amino Acid, Peptide, or Protein]

Phrase: "CD5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538992:CD5 [Laboratory Procedure]

Phrase: "CD43"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538777:CD43 [Gene or Genome]

Phrase: "and"

Phrase: "CD11b."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541224:CD11B [Laboratory Procedure]
Processing 00000000.tx.47: After washing, cells were incubated with streptavidine-coated microbeads (MiltenyiBiotec, Glad Bach, Germany) and IgM/IgD B cells were enriched by a MACS column (MiltenyiBiotec) according to the manufacturer's instructions. 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with streptavidine-coated microbeads"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0026032:Microbeads [Medical Device]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(MiltenyiBiotec,"

Phrase: "Glad Bach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1825831:BACH [Gene or Genome]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "IgM/IgD B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "enriched by a MACS column"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0359583:enriched [Food]
   760   C0599662:MACS [Laboratory Procedure]
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1416956:MACS [Gene or Genome]
   760   C1706132:Column [Idea or Concept]
   726 E C3538559:MAC [Cell Component]

Phrase: "(MiltenyiBiotec"

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.48: Enriched cells were provided for staining as described above. 

Phrase: "Enriched cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "provided for staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]
   790   C1999230:Provided [Activity]

Phrase: "as described above."
Processing 00000000.tx.49: After washing, dead cells were excluded from the population and NIP-binding (NIP-bdg) GC B cells (IgG1dull/CD38dull/B220+/IgM/IgD/CD43/CD5) and memory B cells (IgG1high/CD38+/B220+/IgM/IgD/CD43/CD5) were sorted by FACSVantage SE (Becton Dickinson, Mountain View, CA, USA), as described previously (21). 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "dead cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "excluded from the population"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]

Phrase: "and"

Phrase: "NIP-binding (NIP-bdg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1824986:NIP [Gene or Genome]
   861   C1825351:NIP [Gene or Genome]
   861   C2829592:Nip [Gene or Genome]

Phrase: "GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(IgG1dull/CD38dull/B220+/IgM/IgD/CD43/CD5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C3538992:CD5 [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(IgG1high/CD38+/B220+/IgM/IgD/CD43/CD5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C3538992:CD5 [Laboratory Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "sorted by FACSVantage SE (Becton Dickinson,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0331782:Becton Dickinson [Health Care Related Organization]
   753   C0237886:sorted [Mental Process]
   753   C0700314:sorted [Cell Function]
   753   C1947906:Sorted [Activity]

Phrase: "Mountain View,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.50: ELISPOT and ELISA assay NP-specific AFCs in BM were detected by enzyme-linked immunospot (ELISPOT) with the aid of HRP-conjugated goat antibodies against mouse IgM or IgG1 (Southern Biotechnology Associates, Birmingham, AL, USA) as developing reagents as previously described (36). 

Phrase: "ELISPOT"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   793   C1517892:Link [Intellectual Product]
   793   C1704666:Link [Intellectual Product]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "ELISA assay NP-specific AFCs in BM"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   764   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0007634:Cells [Cell]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0205431:Forming [Functional Concept]
   742   C1522492:Forming [Functional Concept]
   742   C3282337:Cells [Cell]
   708 E C0348078:Form [Qualitative Concept]
   708 E C0376315:Form [Manufactured Object]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "detected by enzyme-linked immunospot (ELISPOT)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "with the aid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018896:Aid [Social Behavior]
  1000   C0449435:Aid [Manufactured Object]
  1000   C3540469:AID [Gene or Genome]

Phrase: "of HRP-conjugated goat antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against mouse IgM"

Phrase: "or"

Phrase: "IgG1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020855:IgG1 [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Southern Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: ","

Phrase: "Birmingham,"

Phrase: "AL,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "as"

Phrase: "developing reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.51: The total number of anti-NP AFCs was measured by using NP18-BSA and high-affinity ones were measured by NP2-BSA as coating reagents (37). 

Phrase: "The total number of anti-NP AFCs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1441375:Cells.total [Cell]
   745   C0007584:Cell Number [Laboratory Procedure]
   742   C0237753:*Number [Quantitative Concept]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NP18-BSA"

Phrase: "and"

Phrase: "high-affinity ones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205447:One [Quantitative Concept]

Phrase: "were"

Phrase: "measured by NP2-BSA"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   819   C0365285:BSA Measured [Clinical Attribute]
   770   C0444706:Measured [Qualitative Concept]
   770   C1417813:NP2 [Gene or Genome]
   770   C2698422:NP2 [Gene or Genome]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "as coating reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.52: Immunohistochemistry Spleens were obtained from mice that had been injected with anti-AILIM/ICOS mAb or control mAb. 

Phrase: "Immunohistochemistry Spleens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037993:Spleens [Body Part, Organ, or Organ Component]
   827 E C0771377:SPLEEN [Tissue]
   827 E C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "obtained from mice"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "with anti-AILIM/ICOS mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "control mAb."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.53: Spleens were embedded in O.C.T. compound (Miles, Elkhart, IN, USA), frozen in liquid nitrogen for 30 s and stored at 80C. 

Phrase: "Spleens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0037993:Spleens [Body Part, Organ, or Organ Component]
   966 E C0771377:SPLEEN [Tissue]
   966 E C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "embedded in O.C.T. compound"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205198:Compound [Qualitative Concept]
   753   C1706082:Compound [Chemical]
   753   C1707903:Embedded [Laboratory Procedure]

Phrase: "(Miles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0331865:Miles [Quantitative Concept]
   966 E C2347127:mile [Quantitative Concept]
   966 E C2348616:mile [Quantitative Concept]

Phrase: "Elkhart,"

Phrase: "IN,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "frozen in liquid nitrogen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]

Phrase: "for 30 s"

Phrase: "and"

Phrase: "stored at 80C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.54: Frozen sections (5 m thick) were fixed in acetone on ice for 10 min. 

Phrase: "Frozen sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0016741:Frozen Sections [Tissue]
   966 E C0085188:Frozen Section [Laboratory Procedure]
   861   C0016701:Frozen [Natural Phenomenon or Process]
   861   C0677542:Frozen [Functional Concept]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "(5 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "thick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "fixed in acetone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.55: After washing with a staining buffer (0.1 M Tris, pH 8.0, 0.1 M NaCl, 0.1% Tween 20, 1% BSA, 30% heat-inactivated normal goat serum), the sections were pre-incubated with a staining buffer containing anti-FcRII/IIImAb (2.4G2) (100 g ml1) or purified MOPC21 (1 mg ml1) or both for 4 h at room temperature or overnight at 4C. 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "with a staining buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(0.1 M Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.1 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% Tween 20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "1% BSA,"

Phrase: "30% heat-inactivated normal goat serum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   799   C0018019:goat [Mammal]
   799   C0205307:Normal [Qualitative Concept]
   799   C0229671:Serum [Body Substance]
   799   C0439166:% normal [Quantitative Concept]
   799   C1265549:goat [Mammal]
   799   C1510458:Goat [Mammal]
   799   C1546774:Serum [Intellectual Product]
   799   C1550100:Serum [Body Substance]
   799   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "pre-incubated with a staining buffer"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0332152:Pre [Temporal Concept]
   753   C0487602:Staining [Laboratory Procedure]
   753   C0740175:Pre [Qualitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   753   C2257086:PRE [Genetic Function]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "anti-FcRII/IIImAb"

Phrase: "(2.4G2"

Phrase: ")"

Phrase: "(100 g ml1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424252:ML1 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "purified MOPC21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0909038:MOPC21 [Immunologic Factor]

Phrase: "(1 mg ml1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424252:ML1 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "both for 4 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0238767:Both [Spatial Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "or"

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.56: All reagents for staining were centrifuged at 15 000 revolutions per minute for 20 min before use. 

Phrase: "All reagents for staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "centrifuged at 15 000 revolutions per minute"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   814   C0582523:revolutions per minute [Quantitative Concept]
           revolution/minute
   748   C0439232:minute [Temporal Concept]
   748   C0441716:revolutions [Human-caused Phenomenon or Process]
   748   C0700321:minute [Quantitative Concept]
   748   C0702093:/minute [Temporal Concept]
   748   C1282918:Minute [Quantitative Concept]
   748   C2347166:Minute [Quantitative Concept]
   714 E C0035868:Revolution [Functional Concept]
   714   C0179834:centrifuge [Medical Device]
   714 E C2948499:Revolution [Pharmacologic Substance]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "before use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.57: To investigate the formation of small foci of NP-specific B cells in the spleen, the sections were stained with a mixture of NIP-BSAPE at 1 : 10 dilution and APC-conjugated anti-B220 (anti-B220APC; 2 g ml1, BD Biosciences) and PNAFITC at 1 : 100 dilution. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the formation of small foci of NP-specific B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "in the spleen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with a mixture of NIP-BSAPE at 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0439962:Mixture [Substance]
   742   C1824986:NIP [Gene or Genome]
   742   C1825351:NIP [Gene or Genome]
   742   C2829592:Nip [Gene or Genome]
   742   C2986582:Stained [Qualitative Concept]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ":"

Phrase: "10 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "and"

Phrase: "APC-conjugated anti-B220"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1335285:B220 [Gene or Genome]
   812   C1706240:B220 [Gene or Genome]

Phrase: "(anti-B220APC"

Phrase: "; 2 g ml1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424252:ML1 [Gene or Genome]

Phrase: "BD Biosciences"

Phrase: ")"

Phrase: "and"

Phrase: "PNAFITC at 1"

Phrase: ":"

Phrase: "100 dilution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.58: As a negative control, BSAPE was used for staining, instead of NIP-BSAPE. 

Phrase: "As a negative control,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "BSAPE"

Phrase: "was"

Phrase: "used for staining,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1273517:used [Finding]
   790   C1704680:Staining [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "instead of NIP-BSAPE."
Processing 00000000.tx.59: To investigate the expression of Bcl-6, the sections were stained with a mixture of biotinylated PNA (1 : 50, Biomeda Vector), anti-B220APC and purified rabbit anti-Bcl-6 (20 g ml1) at the first step, followed by PE-coupled ultra-avidin at 1 : 100 dilution (Leinco Technologies Inc. St Louis, MO, USA) and FITC-coupled affinity-purified (Fab')2 goat anti-rabbit IgG at 1 : 200 dilution (CAPPEL, West Chester, PA, USA), which was pre-absorbed with murine and rat Igs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the expression of Bcl-6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with a mixture of biotinylated PNA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0070198:Peanut Agglutinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   744   C0001804:Agglutinin [Immunologic Factor]
   744   C0030736:Peanut [Plant]
   744   C0439962:Mixture [Substance]
   744   C0949399:Peanut [Food]
   744   C2986582:Stained [Qualitative Concept]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50,"

Phrase: "Biomeda Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-B220APC"

Phrase: "and"

Phrase: "purified rabbit anti-Bcl-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0248007:BCL-6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(20 g ml1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424252:ML1 [Gene or Genome]

Phrase: ")"

Phrase: "at the first step,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1722730:First Step [Biomedical or Dental Material]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "followed by PE-coupled ultra-avidin at 1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0332283:Followed by [Temporal Concept]
           followed
   767   C0256645:PE-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0812270:PE-1 [Gene or Genome]
   767   C1705694:PE-1 [Gene or Genome]
   744   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0728475:ultra [Medical Device]
   744   C1948027:Coupled [Functional Concept]
   711 E C0010222:couple [Family Group]
   711 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "100 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "(Leinco Technologies Inc. St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3272372:ST [Intellectual Product]

Phrase: "MO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "FITC-coupled affinity-purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1998793:Purified [Functional Concept]
   719 E C1947930:Cleanse [Activity]

Phrase: "(Fab')2 goat anti-rabbit IgG at 1"

Phrase: ":"

Phrase: "200 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "(CAPPEL,"

Phrase: "West Chester,"

Phrase: "PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "pre-absorbed with murine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0026809:Murine [Mammal]
   770   C0332152:Pre [Temporal Concept]
   770   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   770   C0740175:Pre [Qualitative Concept]
   770   C2257086:PRE [Genetic Function]

Phrase: "and"

Phrase: "rat Igs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1306856:IGS [Disease or Syndrome]
Processing 00000000.tx.60: Anti-Bcl-6 antibody was affinity purified from the immune sera of rabbits that had been immunized with glutathione-S-transferase-murine Bcl-6 fusion protein (38). 

Phrase: "Anti-Bcl-6 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified from the immune sera of rabbits"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0020960:Immune Sera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]
   748   C0229671:Sera [Body Substance]
   748   C0439662:Immune [Functional Concept]
   748   C1151254:SerA [Molecular Function]
   748   C1998793:Purified [Functional Concept]
   714 E C1546774:Serum [Intellectual Product]
   714 E C1550100:Serum [Body Substance]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "immunized with glutathione-S-transferase-murine Bcl-6 fusion protein"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   782   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   760   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0248007:BCL-6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1418948:PROTEIN S [Gene or Genome]
   739   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026809:Murine [Mammal]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0332466:Fusion [Functional Concept]
   739   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   739   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.61: In some experiments, instead of NIP-BSAPE, anti-CD4PE (12 g ml1; BD Biosciences) was used for staining in combination with PNAFITC and anti-B220APC. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "instead of NIP-BSAPE,"

Phrase: "anti-CD4PE"

Phrase: "(12 g ml1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424252:ML1 [Gene or Genome]

Phrase: "; BD Biosciences"

Phrase: ")"

Phrase: "was"

Phrase: "used for staining"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1273517:used [Finding]
   790   C1704680:Staining [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with PNAFITC"

Phrase: "and"

Phrase: "anti-B220APC."
Processing 00000000.tx.62: The samples were examined by confocal laser microscopy (LSM510 Laser Scan Microscope; Carl Zeiss, Oberkochen, Germany) with the aid of dual Argon laser (488 nm)/Helium Neon laser (543 and 433 nm) systems. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "examined by confocal laser microscopy"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0600395:Laser Microscopy [Laboratory Procedure]
   797   C0242842:Microscopy, Confocal [Laboratory Procedure]
   760   C0023089:Laser [Manufactured Object]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0332128:Examined [Finding]
   760   C0458142:Laser [Phenomenon or Process]
   760   C1023865:Laser [Plant]
   760   C1706315:Laser [Medical Device]

Phrase: "(LSM510 Laser Scan Microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0181839:Microscope [Medical Device]
   812   C1706379:Microscope [Medical Device]

Phrase: "; Carl Zeiss,"

Phrase: "Oberkochen,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "with the aid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018896:Aid [Social Behavior]
  1000   C0449435:Aid [Manufactured Object]
  1000   C3540469:AID [Gene or Genome]

Phrase: "of dual Argon laser"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0392247:Argon laser [Medical Device]
   827   C0003781:Argon [Element, Ion, or Isotope]
   827   C0023089:Laser [Manufactured Object]
   827   C0458142:Laser [Phenomenon or Process]
   827   C1023865:Laser [Plant]
   827   C1706315:Laser [Medical Device]
   827   C1948015:Argon [Eukaryote]

Phrase: "(488 nm)/Helium Neon laser"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C1955848:Laser, Helium [Manufactured Object]
   804   C0018880:Helium [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0023089:Laser [Manufactured Object]
   804   C0027608:Neon [Element, Ion, or Isotope]
   804   C0458142:Laser [Phenomenon or Process]
   804   C1023865:Laser [Plant]
   804   C1091843:Neon [Eukaryote]
   804   C1706315:Laser [Medical Device]

Phrase: "(543"

Phrase: "and"

Phrase: "433 nm) systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.63: Sequence analysis of VH gene NIP-bdg GC and memory B cells were directly sorted into 400 l of proteinase K solution (500 g ml1 proteinase K in PBS) and incubated overnight at 37C. 

Phrase: "Sequence analysis of VH gene NIP-bdg"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0936012:Analysis [Research Activity]
   748   C1519249:Sequence [Functional Concept]
   748   C1524024:analysis [Functional Concept]

Phrase: " GC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Center [Tissue]
   861   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "sorted into 400 l of proteinase K solution"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0037633:Solution [Substance]
   744   C0237886:sorted [Mental Process]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0700314:sorted [Cell Function]
   744   C1622131:proteinase [Molecular Function]
   744   C1708601:K' [Quantitative Concept]
   744   C1947906:Sorted [Activity]
   744   C1947941:Proteinase [Enzyme]

Phrase: "(500 g ml1 proteinase K in PBS)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1622131:proteinase [Molecular Function]
   748   C1708601:K' [Quantitative Concept]
   748   C1947941:Proteinase [Enzyme]

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 37C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.64: The crude lysate was subjected to two rounds of nested PCR for amplifying the VH186.2 gene. 

Phrase: "The crude lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "subjected to two"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0205448:Two [Quantitative Concept]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "rounds of nested PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242574:Nested PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0332490:Round [Spatial Concept]
   770   C0677874:pCR [Finding]

Phrase: "for amplifying"

Phrase: "the VH186.2 gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.65: PCR products were size fractionated by agarose gel electrophoresis and the purified fragments were cloned into the PCR-ScriptTM Amp cloning vector (Stratagene, La Jolla, CA, USA). 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "fractionated by agarose gel electrophoresis"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1382104:Gel [Substance]
   760   C1979893:Fractionated [Qualitative Concept]

Phrase: "and"

Phrase: "the purified fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "cloned into the PCR-ScriptTM Amp cloning vector"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0086022:Cloning Vector [Nucleic Acid, Nucleoside, or Nucleotide]
           Vector
   744   C0009013:cloned [Cell]
   744   C0009015:Cloning [Research Activity]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0442335:Vector [Spatial Concept]
   744   C0677874:pCR [Finding]
   744   C1705099:Vector [Idea or Concept]
   711 E C1522642:Clone [Tissue]

Phrase: "(Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.66: The sequence of the variable (V), diversity (D) and joining (J) segment in a plasmid vector was determined by automated sequencing using an ABI PRISM 337 DNA sequencer (PE Biosystems, Foster City, CA, USA). 

Phrase: "The sequence of the variable (V),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "diversity (D)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diversity [Qualitative Concept]

Phrase: "and"

Phrase: "joining (J) segment in a plasmid vector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441635:Segment [Spatial Concept]

Phrase: "was"

Phrase: "determined by automated sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205554:Automated [Functional Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ABI PRISM 337 DNA sequencer"

Phrase: "(PE Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.67: Cell transfer C57BL/6 mice were immunized with NP-CG in alum, followed by injection with anti-AILIM/ICOS mAb or control Ig or immunized with CG (100 g per head) in alum. 

Phrase: "Cell transfer C57BL/6 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   873   C1521751:C57BL/6 Mouse [Mammal]
   853   C0025921:Mice, C57BL [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "immunized with NP-CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1706141:NP [Gene or Genome]
   770   C3540479:CG [Gene or Genome]

Phrase: "in alum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0330887:Alum [Plant]

Phrase: "followed by injection"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0021485:injection [Therapeutic or Preventive Procedure]
   790   C1272883:Injection [Biomedical or Dental Material]
   790   C1533685:Injection [Therapeutic or Preventive Procedure]
   790   C1828121:Injection [Functional Concept]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with anti-AILIM/ICOS mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "control Ig"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3541296:IG [Idea or Concept]

Phrase: "or"

Phrase: "immunized with CG (100 g"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]
   760   C3540479:CG [Gene or Genome]

Phrase: "per head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: ")"

Phrase: "in alum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0330887:Alum [Plant]
Processing 00000000.tx.68: Sixty to seventy days after immunization, a single-cell suspension was prepared from the pooled spleens of NP-primed and ICOS/AILIM-manipulated mice. 

Phrase: "Sixty to seventy days"

Phrase: "after immunization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "a single-cell suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038960:Suspension [Biomedical or Dental Material]
   827   C1382107:Suspension [Substance]
   827   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "prepared from the pooled spleens of NP-primed"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   744   C0037993:Spleens [Body Part, Organ, or Organ Component]
   744   C0871133:primed [Functional Concept]
   744   C1706141:NP [Gene or Genome]
   744   C1709595:Pooled [Conceptual Entity]
   744   C2349200:Pooled [Functional Concept]
   711 E C0337051:Pool [Geographic Area]
   711 E C0771377:SPLEEN [Tissue]
   711 E C1278932:Spleen [Body Part, Organ, or Organ Component]
   711 E C1509144:pool [Clinical Attribute]
   711   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "ICOS/AILIM-manipulated mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
Processing 00000000.tx.69: For B-cell purification, splenocytes were incubated with anti-FcRII/III antibody and with a mixture of biotinylated mAbs against CD3, CD8, CD11b, TER-119, Gr-1 and CD43. 

Phrase: "For B-cell purification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243114:purification [Functional Concept]
   827   C1998793:Purification [Functional Concept]
   734   C0004561:B-cell [Cell]

Phrase: "splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519477:Splenocyte [Cell]

Phrase: "were"

Phrase: "incubated with anti-FcRII/III antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0439070:III [Intellectual Product]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1705160:III [Qualitative Concept]

Phrase: "and with a mixture of biotinylated mAbs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439962:Mixture [Substance]
   748   C1515981:And [Idea or Concept]
   714   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "against CD3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3542405:CD3 [Laboratory Procedure]

Phrase: "CD8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538720:CD8 [Laboratory Procedure]
  1000   C3540595:CD8 [Gene or Genome]

Phrase: "CD11b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541224:CD11B [Laboratory Procedure]

Phrase: "TER-119,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1415273:TER [Gene or Genome]
   861   C3157085:TER [Cell Component]

Phrase: "Gr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "and"

Phrase: "CD43."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538777:CD43 [Gene or Genome]
Processing 00000000.tx.70: After washing, B cells were negatively enriched by a MACS system (>95% B220+). 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "negatively"

Phrase: "enriched by a MACS system"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0359583:enriched [Food]
   760   C0449913:System [Functional Concept]
   760   C0599662:MACS [Laboratory Procedure]
   760   C1416956:MACS [Gene or Genome]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   726 E C3538559:MAC [Cell Component]

Phrase: "("

Phrase: ">95% B220+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1335285:B220 [Gene or Genome]
   861   C1706240:B220 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.71: T cells were purified from the pooled spleens of CG-primed C57BL/6 mice (>90% CD3+) by a MACS system after incubation with mAb against B220, IgM, IgD, CD11b, TER-119 and Gr-1. 

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purified from the pooled spleens of CG-primed C57BL/6 mice"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   764   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   754   C0025921:Mice, C57BL [Mammal]
           C57BL
   754   C1413032:CG-6 [Gene or Genome]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0037993:Spleens [Body Part, Organ, or Organ Component]
   738   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0871133:primed [Functional Concept]
   738   C1709595:Pooled [Conceptual Entity]
   738   C1998793:Purified [Functional Concept]
   738   C2349200:Pooled [Functional Concept]
   738   C3540479:CG [Gene or Genome]
   721   C1519474:Mouse Spleen [Tissue]
   704 E C0337051:Pool [Geographic Area]
   704 E C0771377:SPLEEN [Tissue]
   704 E C1278932:Spleen [Body Part, Organ, or Organ Component]
   704 E C1509144:pool [Clinical Attribute]

Phrase: "("

Phrase: ">90% CD3+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3542405:CD3 [Laboratory Procedure]

Phrase: ")"

Phrase: "by a MACS system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "after incubation"

Phrase: "with mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "against B220,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335285:B220 [Gene or Genome]
  1000   C1706240:B220 [Gene or Genome]

Phrase: "IgM,"

Phrase: "IgD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020843:IgD [Amino Acid, Peptide, or Protein]
  1000   C0577612:IGD [Laboratory Procedure]

Phrase: "CD11b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541224:CD11B [Laboratory Procedure]

Phrase: "TER-119"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1415273:TER [Gene or Genome]
   861   C3157085:TER [Cell Component]

Phrase: "and"

Phrase: "Gr-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]
Processing 00000000.tx.72: Purified B cells (3 x 107) and T cells (1.5 x 107) were mixed and adoptively transferred into Rag-1/ mice by intravenous injection. 

Phrase: "Purified B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(3 x 107"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(1.5 x 107"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450316:1/5 [Quantitative Concept]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "adoptively"

Phrase: "transferred into Rag-1/ mice"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   783   C0678936:gene recombination [Genetic Function]
   783   C1417166:MICE gene [Gene or Genome]
   767   C1517499:Gene Transfer [Molecular Biology Research Technique]
   753   C0017337:Gene [Gene or Genome]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0034865:Recombination [Genetic Function]
   753   C0348011:transferred [Functional Concept]
   753   C1879547:activating [Activity]
   719 E C0040671:Transfer [Mental Process]
   719 E C1515877:Activate [Functional Concept]
   719 E C1705822:Transfer [Activity]

Phrase: "by intravenous injection."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021494:Intravenous injection [Functional Concept]
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0348016:Intravenous [Spatial Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]
Processing 00000000.tx.73: Twenty-four hours after the transfer, the recipient mice were i.p. challenged with 50 g of soluble NP-CG.  

Phrase: "Twenty-four hours after the transfer,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "the recipient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "i.p."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0347985:Intra [Temporal Concept]

Phrase: "challenged with 50 g of soluble NP-CG."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0439267:g% [Quantitative Concept]
   744   C1706141:NP [Gene or Genome]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   744   C3540479:CG [Gene or Genome]
   711   C0798503:Challenge [Clinical Attribute]
   711   C0805586:Challenge [Health Care Activity]
   711   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.74: Results Top Abstract Introduction Methods Results Discussion References  GC B cells were detected in the spleen at day 5 post-immunization Murine B cells express CD38 at a resting state, whereas the expression is down-regulated in GC B cells and plasma cells (39). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "detected in the spleen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037993:Spleen [Body Part, Organ, or Organ Component]
   770   C0442726:Detected [Finding]
   770   C0771377:SPLEEN [Tissue]
   770   C1278932:Spleen [Body Part, Organ, or Organ Component]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "at day 5 post-immunization Murine B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   818   C0004561:B-Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "CD38 at a resting state,"

Phrase: "whereas"

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "down-regulated in GC B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0004561:B-Cells [Cell]
   778   C0282491:Germinal Center [Tissue]
   748   C0007634:Cells [Cell]
   748   C0205099:Center [Spatial Concept]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "plasma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0032112:Plasma Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.75: To analyze the generation of GC B cells upon stimulation with T-cell-dependent antigen, we enumerated NP-specific CD38dull B cells in the spleen of C57BL/6 mice after immunization with alum-precipitated NP-CG. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the generation of GC B cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "upon stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with T-cell-dependent antigen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0487637:T-cell Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003320:Antigen [Immunologic Factor]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "we"

Phrase: "enumerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707927:Enumerated [Qualitative Concept]

Phrase: "NP-specific CD38dull B cells in the spleen of C57BL/6 mice"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0004561:B-Cells [Cell]
   736   C0007634:Cells [Cell]
   736   C3282337:Cells [Cell]
   734   C1522109:Mouse B Cell [Cell]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]

Phrase: "after immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "with alum-precipitated NP-CG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   812   C3540479:CG [Gene or Genome]
Processing 00000000.tx.76: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.77: 1(A), a small number of NIP-bdg/CD38dull B cells was detected in the spleen at day 5 post-immunization by FACS analysis, followed by a rapid expansion up to day 6 post-immunization. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "a small number of NIP-bdg"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0237753:*Number [Quantitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C0700321:Small [Quantitative Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1824986:NIP [Gene or Genome]
   753   C1825351:NIP [Gene or Genome]
   753   C2829592:Nip [Gene or Genome]

Phrase: "/CD38dull B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "detected in the spleen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037993:Spleen [Body Part, Organ, or Organ Component]
   770   C0442726:Detected [Finding]
   770   C0771377:SPLEEN [Tissue]
   770   C1278932:Spleen [Body Part, Organ, or Organ Component]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "at day 5 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "by FACS analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "followed by a rapid expansion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0439831:Rapid [Qualitative Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "up to day 6 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.78: NIP-bdg/CD38dull cells consisted of B220+ or B220dull B cells that bound high or low levels of PNA, respectively. 

Phrase: "NIP-bdg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1824986:NIP [Gene or Genome]
   861   C1825351:NIP [Gene or Genome]
   861   C2829592:Nip [Gene or Genome]

Phrase: "/CD38dull cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "consisted of B220+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1335285:B220 [Gene or Genome]
   790   C1706240:B220 [Gene or Genome]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "or"

Phrase: "B220dull B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "or"

Phrase: "low levels of PNA,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.79: NIP-bdg/CD38dull/PNAhigh B cells were of GC origin (40) and detected in the spleen at day 5 post-immunization at a low level but increased in number from 1 x 104 to 2 x 103 per splenocyte at day 6 post-immunization. 

Phrase: "NIP-bdg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1824986:NIP [Gene or Genome]
   861   C1825351:NIP [Gene or Genome]
   861   C2829592:Nip [Gene or Genome]

Phrase: "/CD38dull/PNAhigh B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were of GC origin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0282491:Germinal Center [Tissue]
   760   C0079946:origin [Classification]
   760   C0205099:Center [Spatial Concept]
   760   C0439659:Origin [Temporal Concept]
   760   C1550512:origin [Intellectual Product]
   756   C0085142:Center, Birth [Health Care Related Organization,Manufactured Object]
   704 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   704 E C0314603:Genetic [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "detected in the spleen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037993:Spleen [Body Part, Organ, or Organ Component]
   770   C0442726:Detected [Finding]
   770   C0771377:SPLEEN [Tissue]
   770   C1278932:Spleen [Body Part, Organ, or Organ Component]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "at day 5 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "at a low level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0205251:low [Qualitative Concept]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1299352:Low [Qualitative Concept]
   861   C1547707:Level [Geographic Area]
   861   C1550472:low [Idea or Concept]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "increased in number"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205217:Increased [Quantitative Concept]
   790   C0237753:*Number [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0449788:Number [Quantitative Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from 1 x 104"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "to 2 x 103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "per splenocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519477:Splenocyte [Cell]

Phrase: "at day 6 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.80: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.81: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.82: GC B cells are generated in the spleen from day 4 to day 6 post-immunization. 

Phrase: "GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "generated in the spleen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037993:Spleen [Body Part, Organ, or Organ Component]
   770   C0771377:SPLEEN [Tissue]
   770   C1278932:Spleen [Body Part, Organ, or Organ Component]
   770   C3146294:Generated [Activity]

Phrase: "from day 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "to day 6 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.83: Splenocytes were obtained from NP-CG-primed C57BL/6 mice at the indicated periods and incubated with anti-FcRII/III mAb, followed by APC-conjugated anti-CD38, B220TX, PNAFITC and NIP-BSAPE at the first step and propidium iodide at the second step. 

Phrase: "Splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519477:Splenocyte [Cell]

Phrase: "were"

Phrase: "obtained from NP-CG-primed C57BL/6 mice"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   789   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   767   C0025921:Mice, C57BL [Mammal]
           C57BL
   767   C1413032:CG-6 [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0871133:primed [Functional Concept]
   744   C1301820:Obtained [Functional Concept]
   744   C1706141:NP [Gene or Genome]
   744   C3540479:CG [Gene or Genome]
   711 E C1706701:Obtain [Activity]

Phrase: "at the indicated periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "and"

Phrase: "incubated with anti-FcRII/III mAb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439070:III [Intellectual Product]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1705160:III [Qualitative Concept]

Phrase: "followed by APC-conjugated anti-CD38,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0051214:allophycocyanin [Amino Acid, Peptide, or Protein]
   753   C0522529:Conjugated [Spatial Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "B220TX,"

Phrase: "PNAFITC"

Phrase: "and"

Phrase: "NIP-BSAPE at the first step"

Phrase: "and"

Phrase: "propidium iodide at the second step."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0021966:Iodide [Inorganic Chemical]
   753   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.84: (A) Viable NIP-bdg B cells were selected under a lymphocyte gate on forward and light scatter (data not shown). 

Phrase: "(A) Viable NIP-bdg B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   876   C1440044:A,B [Immunologic Factor]
   876   C1441322:Viable cells [Cell]
   827   C0004561:B-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "selected under a lymphocyte gate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0024264:Lymphocyte [Cell]
   726   C1707391:Select [Activity]

Phrase: "on forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "light scatter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0439742:scatter [Spatial Concept]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: Thereafter, CD38dull-negative cells were gated (top) and the number of PNA+/B220+ cells was determined (bottom, boxed). 

Phrase: "Thereafter,"

Phrase: "CD38dull-negative cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "gated"

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "the number of PNA+/B220+ cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "(bottom,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "boxed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]

Phrase: ")."
Processing 00000000.tx.86: (B) The mean number (open columns) of NIP-bdg/CD38dull-negative/PNA+/B220+ cells in individual mice (closed circle) is shown.  

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The mean number"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0237753:*Number [Quantitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]

Phrase: "(open columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: ")"

Phrase: "of NIP-bdg"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0243122:binding [Functional Concept]
   827   C0332285:Of [Spatial Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1824986:NIP [Gene or Genome]
   827   C1825351:NIP [Gene or Genome]
   827   C2829592:Nip [Gene or Genome]

Phrase: "/CD38dull-negative/PNA+/B220+ cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "in individual mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(closed circle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1282913:Circle [Spatial Concept]
   861   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.87: GC reaction starts at the T-cell and B-cell boundary from day 4 to day 6 post-immunization We analyzed the histological localization of NIP-bdg B cells in the spleen of C57BL/6 mice from day 4 to day 6 post-immunization with alum-precipitated NP-CG. 

Phrase: "GC reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0282491:Germinal Center [Tissue]

Phrase: "starts at the T-cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0039194:T-cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0439659:Start [Temporal Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "B-cell boundary from day 4"

Phrase: "to day 6 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "We"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the histological localization of NIP-bdg B cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   782   C1660153:localisation of cell [Biologic Function]
           cell localization
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "in the spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "of C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "from day 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "to day 6 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "with alum-precipitated NP-CG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   812   C3540479:CG [Gene or Genome]
Processing 00000000.tx.88: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.89: 2, microscopic examinations with low (x20) and high magnifications (x40) revealed that NIP-bdg B cells formed various sizes of clusters in the white pulp cord (Fig. 2A and C) as well as the red pulp (Fig. 2C) of the spleen at day 5.5 post-immunization. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "microscopic examinations with low"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0026018:Microscopic examination [Laboratory Procedure]
   770   C0031809:examinations [Health Care Activity]

Phrase: "(x20"

Phrase: ")"

Phrase: "and"

Phrase: "high magnifications"

Phrase: "(x40"

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that NIP-bdg B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "various sizes of clusters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456389:SIZES [Spatial Concept]

Phrase: "in the white pulp cord"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1550235:Cord [Body Part, Organ, or Organ Component]
   827   C1552938:cord [Quantitative Concept]
   827   C1706500:Cord [Manufactured Object]
   734   C0229686:White pulp [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "as well as"

Phrase: "the red pulp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0229687:Red pulp [Body Part, Organ, or Organ Component]
   861   C0011399:pulp [Body Part, Organ, or Organ Component]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "of the spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "at day 5.5 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   804   C0042196:immunisation [Therapeutic or Preventive Procedure]
   804   C0687676:Post [Temporal Concept]
   804   C1704687:Post [Manufactured Object]
   804   C3244291:immunization [Functional Concept]
   733 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.90: Clusters consisting of B220 cells with a high level of Ig in the red pulp (Fig. 2C) or in the T-cell area (Fig. 2D) may represent plasma blast foci, whereas NIP-bdg B cells with a low level of Ig formed small foci along the B-cell follicle in the vicinity of the T-cell-rich inner PALS at day 5.5 post-immunization (Fig. 2AD). 

Phrase: "Clusters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]

Phrase: "consisting of B220 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C1335285:B220 [Gene or Genome]
   770   C1706240:B220 [Gene or Genome]
   770   C3282337:Cells [Cell]
   737   C0332529:CONSIST [Qualitative Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with a high level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0205250:High [Qualitative Concept]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1299351:High [Qualitative Concept]
   861   C1547707:Level [Geographic Area]
   861   C2700149:HIGH [Intellectual Product]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "of Ig"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3541296:IG [Idea or Concept]

Phrase: "in the red pulp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0229687:Red pulp [Body Part, Organ, or Organ Component]
   861   C0011399:pulp [Body Part, Organ, or Organ Component]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "or in the T-cell area"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039194:T-cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0017446:Area [Geographic Area]
   753   C0205146:Area [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "plasma blast foci,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205234:Foci [Spatial Concept]
   793 E C1285542:focus [Functional Concept]

Phrase: "whereas"

Phrase: "NIP-bdg B cells with a low level of Ig"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0004561:B-Cells [Cell]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "small foci along the B-cell follicle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0205234:Foci [Spatial Concept]
   714 E C1285542:focus [Functional Concept]

Phrase: "in the vicinity"

Phrase: "of the T-cell-rich inner PALS"

Phrase: "at day 5.5 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   804   C0042196:immunisation [Therapeutic or Preventive Procedure]
   804   C0687676:Post [Temporal Concept]
   804   C1704687:Post [Manufactured Object]
   804   C3244291:immunization [Functional Concept]
   733 E C1514253:Postal [Functional Concept]

Phrase: "(Fig. 2AD"

Phrase: ")."
Processing 00000000.tx.91: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.92: 2(B and D), these cells bound to a high level of PNA and expressed cytoplasmic Bcl-6 (Fig. 2F), which indicated that they were GC B cells. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diversity [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "bound to a high level of PNA"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0070198:Peanut Agglutinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   744   C0001804:Agglutinin [Immunologic Factor]
   744   C0030736:Peanut [Plant]
   744   C0205250:High [Qualitative Concept]
   744   C0332297:bound [Spatial Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C0949399:Peanut [Food]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1299351:High [Qualitative Concept]
   744   C1547707:Level [Geographic Area]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]
   744   C2700149:HIGH [Intellectual Product]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "expressed cytoplasmic Bcl-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0248007:BCL-6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2F"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "they"

Phrase: "were"

Phrase: "GC B cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.93: The foci developed in size towards the B-cell area at day 6 post-immunization (Fig. 2E and G), which could be recognized as a typical GC structure. 

Phrase: "The foci"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205234:Foci [Spatial Concept]
   966 E C1285542:focus [Functional Concept]

Phrase: "developed in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456389:size [Spatial Concept]

Phrase: "towards the B-cell area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   734   C0004561:B-cell [Cell]

Phrase: "at day 6 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "(Fig. 2E"

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "could"

Phrase: "be"

Phrase: "recognized as a typical GC structure."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0282491:Germinal Center [Tissue]
   748   C0205099:Center [Spatial Concept]
   748   C0678594:Structure [Spatial Concept]
   748   C3538928:Typical [Qualitative Concept]
Processing 00000000.tx.94: In contrast, Bcl-6+/PNA+ cells were barely detected in the PALS or within the B-cell area of the spleen in non-immunized C57BL/6 mice and immunized and non-immunized CD40-deficient mice (data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Bcl-6+/PNA+ cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "barely"

Phrase: "detected in the PALS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0024264:Lymphocytic [Cell]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C2939172:Lymphocytic [Qualitative Concept]

Phrase: "or within the B-cell area of the spleen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0004561:B-cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0017446:Area [Geographic Area]
   742   C0037993:Spleen [Body Part, Organ, or Organ Component]
   742   C0205146:Area [Spatial Concept]
   742   C0771377:SPLEEN [Tissue]
   742   C1269647:Cell [Cell]
   742   C1278932:Spleen [Body Part, Organ, or Organ Component]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "in non-immunized C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   881   C1513853:NON Mouse [Mammal]
   873   C1521751:C57BL/6 Mouse [Mammal]
   853   C0025921:Mice, C57BL [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "immunized"

Phrase: "and"

Phrase: "non-immunized CD40-deficient mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C1513853:NON Mouse [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.95: Together, these results suggest that antigen-activated B cells may histologically develop into GC B cells from day 4 to day 6 post-immunization at the border of the B-cell follicle and T-cell area. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that antigen-activated B cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   875   C0368721:antigen b [Immunologic Factor]
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "histologically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205462:Histologically [Functional Concept]

Phrase: "develop into GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0004561:B-Cells [Cell]
   790   C0282491:Germinal Center [Tissue]
   753   C0007634:Cells [Cell]
   753   C0205099:Center [Spatial Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "from day 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "to day 6 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "at the border"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205284:Border [Spatial Concept]
  1000   C1522411:Border [Body Location or Region]
  1000   C2828371:Border [Classification]

Phrase: "of the B-cell follicle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   755 E C0439682:Follicular [Qualitative Concept]
   734   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "T-cell area."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   734   C0039194:T-cell [Cell]
Processing 00000000.tx.96: View larger version (73K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(73K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.97: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.98: NIP-bdg GC B cells form a small cluster in the spleen from day 5 to day 6 post-immunization. 

Phrase: "NIP-bdg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1824986:NIP [Gene or Genome]
   861   C1825351:NIP [Gene or Genome]
   861   C2829592:Nip [Gene or Genome]

Phrase: " GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a small cluster in the spleen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1555715:Cluster [Idea or Concept]
   753   C1704332:Cluster [Quantitative Concept]

Phrase: "from day 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "to day 6 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.99: Cryosections were prepared from spleens of C57BL/6 mice immunized with NP-CG/alum at day 5.5 (A, B, C, D and F) and day 6 (E and G) post-immunization. 

Phrase: "Cryosections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0085188:cryosection [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared from spleens of C57BL/6 mice"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   802   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   774   C0025921:Mice, C57BL [Mammal]
           C57BL
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0037993:Spleens [Body Part, Organ, or Organ Component]
   741   C1519474:Mouse Spleen [Tissue]
   714 E C0771377:SPLEEN [Tissue]
   714 E C1278932:Spleen [Body Part, Organ, or Organ Component]
   714   C1521827:Prepare [Functional Concept]

Phrase: "immunized with NP-CG/alum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
   760   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
   760   C0330887:Alum [Plant]
   760   C1706141:NP [Gene or Genome]
   760   C3540479:CG [Gene or Genome]

Phrase: "at day 5.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]

Phrase: "(A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "C,"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diversity [Qualitative Concept]

Phrase: "and"

Phrase: "F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "day 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(E"

Phrase: "and"

Phrase: "G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   861   C0042196:immunisation [Therapeutic or Preventive Procedure]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   861   C3244291:immunization [Functional Concept]
   789 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.100: In (AE), they were stained with NIP-BSAPE (green), anti-B220APC (blue) and PNAFITC (red). 

Phrase: "In (AE"

Phrase: ")"

Phrase: ","

Phrase: "they"

Phrase: "were"

Phrase: "stained with NIP-BSAPE"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C1824986:NIP [Gene or Genome]
   770   C1825351:NIP [Gene or Genome]
   770   C2829592:Nip [Gene or Genome]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-B220APC"

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PNAFITC"

Phrase: "(red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.101: Pink, yellow or white staining represents NIPB220+PNA+ cells, NIP+B220PNA+ cells or NIP+B220+PNA+ cells, respectively. 

Phrase: "Pink,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332585:Pink [Qualitative Concept]

Phrase: "yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: "or"

Phrase: "white staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "NIPB220+PNA+ cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "NIP+B220PNA+ cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "NIP+B220+PNA+ cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.102: In (F and G) sections were stained with biotinylated PNA, anti-B220APC (blue) and rabbit anti-Bcl-6 antibodies at the first step and developed by ultra-avidinPE (red) and anti-rabbit IgGFITC (green) at the second step. 

Phrase: "In (F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "G) sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with biotinylated PNA,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0070198:Peanut Agglutinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   760   C0001804:Agglutinin [Immunologic Factor]
   760   C0030736:Peanut [Plant]
   760   C0949399:Peanut [Food]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "anti-B220APC"

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "rabbit anti-Bcl-6 antibodies at the first step"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   762   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   745 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   745   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   708 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "developed by ultra-avidinPE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0728475:ultra [Medical Device]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "anti-rabbit IgGFITC"

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "at the second step."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]
Processing 00000000.tx.103: Pink or yellow staining represents B220+PNA+ cells or Bcl-6+B220PNA+ cells, respectively. 

Phrase: "Pink"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332585:Pink [Qualitative Concept]

Phrase: "or"

Phrase: "yellow staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "B220+PNA+ cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "Bcl-6+B220PNA+ cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.104: Co-localization of Bcl-6 and PNA was observed in a small number of cells for unknown reasons. 

Phrase: "Co-localization of Bcl-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "PNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0070198:Peanut Agglutinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   861   C0001804:Agglutinin [Immunologic Factor]
   861   C0030736:Peanut [Plant]
   861   C0949399:Peanut [Food]

Phrase: "was"

Phrase: "observed in a small number of cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0007634:Cells [Cell]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C0700321:Small [Quantitative Concept]
   748   C1441672:Observed [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "for unknown reasons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.105: The NIP-BSAPE-positive signals were diminished by pre-incubation with NIP-keyhole limpet hemocyanin (KLH) at a dose 10 times that of NIP-BSA, but neither with BSA nor KLH.  

Phrase: "The NIP-BSAPE-positive signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "diminished by pre-incubation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205216:Diminished [Quantitative Concept]
   770   C0332152:Pre [Temporal Concept]
   770   C0740175:Pre [Qualitative Concept]
   770   C2257086:PRE [Genetic Function]

Phrase: "with NIP-keyhole limpet hemocyanin (KLH)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0064332:keyhole-limpet haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018999:Haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0324030:Limpet [Eukaryote]
   812   C2350000:Limpet [Food]

Phrase: "at a dose 10 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "that of NIP-BSA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1824986:NIP [Gene or Genome]
   770   C1825351:NIP [Gene or Genome]
   770   C2829592:Nip [Gene or Genome]

Phrase: "but"

Phrase: "neither with BSA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3274651:Neither [Qualitative Concept]

Phrase: "nor"

Phrase: "KLH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0064332:keyhole-limpet haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018999:Haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0324030:Limpet [Eukaryote]
   827   C2350000:Limpet [Food]
Processing 00000000.tx.106: Memory B cells were generated independent of the formation of GCs The mice deficient for ICOS/AILIMICOS/AILIM ligand interaction show an impaired memory B-cell response (31, 32, 35), suggesting that this interaction is required for both GC-dependent and -independent pathways of memory B-cell generation. 

Phrase: "Memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "generated independent of the formation of GCs"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   782   C1817919:germinal center formation [Organism Function]
   770   C0282491:Germinal Centers [Tissue]
   770   C0332291:Independent of [Functional Concept]
   744   C0085862:Independent [Idea or Concept]
   744   C0205099:centers [Spatial Concept]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1299583:Independent [Finding]
   744   C1522492:Formation [Functional Concept]
   744   C3146294:Generated [Activity]

Phrase: "The mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "deficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011155:Deficient [Functional Concept]
  1000   C1636779:% deficient [Quantitative Concept]

Phrase: "for ICOS/AILIMICOS/AILIM ligand interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an impaired memory B-cell response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
   717   C0682638:Memory B Cell [Cell]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32,"

Phrase: "35"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "required for both GC-dependent"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282491:Germinal Center [Tissue]
   753   C0205099:Center [Spatial Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1514873:Required [Functional Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "and -"

Phrase: "independent pathways of memory B-cell generation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.107: To selectively inhibit memory B-cell generation through GCs, anti-ICOS/AILIM mAb was administered into mice at the onset of GC formation (at day 5 post-immunization). 

Phrase: "To selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "memory B-cell generation through GCs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "administered into mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1521801:Administered [Functional Concept]
   756 E C1621583:Administer [Functional Concept]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "("

Phrase: "at day 5 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: ")."
Processing 00000000.tx.108: C57BL/6 mice were immunized with alum-precipitated NP-CG and injected with either rat anti-ICOS/AILIM mAb or control rat IgG antibody at days 5, 6 and 7 post-immunization. 

Phrase: "C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "immunized with alum-precipitated NP-CG"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
   753   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
   753   C0330887:Alum [Plant]
   753   C1706141:NP [Gene or Genome]
   753   C3540479:CG [Gene or Genome]
   719   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "with either rat anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "control rat IgG antibody at days 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C2754943:IgG antibody [Cell Component]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "6"

Phrase: "and"

Phrase: "7 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   827   C0042196:immunisation [Therapeutic or Preventive Procedure]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   827   C3244291:immunization [Functional Concept]
   755 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.109: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.110: 3(A), administration of anti-ICOS/AILIM mAb reduced the size of each GC at day 10 post-immunization as has been observed in ICOS/AILIM- or ICOS/AILIM ligand-deficient mice (31, 32, 35). 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001554:Administration [Occupational Activity]
  1000   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the size of each GC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "at day 10 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "observed in ICOS/AILIM-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0024262:Lymphocyte Activation [Cell Function]
   742   C0024264:Lymphocyte [Cell]
   742   C0175727:Stimulator [Medical Device]
   742   C0205263:Inducible [Functional Concept]
   742   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1441672:Observed [Functional Concept]
   742   C1879547:Activation [Activity]

Phrase: "or"

Phrase: "ICOS/AILIM ligand-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.111: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.112: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.113: ICOS/AILIM-manipulated mice with a reduced number of GC B cells, but not memory B cells in their spleens. 

Phrase: "ICOS/AILIM-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "with a reduced number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of GC B cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not memory B cells in their spleens."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   804   C0682638:b cells memory [Cell]
   778   C0004561:B-Cells [Cell]
   774   C0312737:Memory cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.114: Mice were immunized with NP-CG in alum and treated with control antibody or anti-ICOS/AILIM mAb at days 5, 6 and 7 post-immunization. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "immunized with NP-CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1706141:NP [Gene or Genome]
   770   C3540479:CG [Gene or Genome]

Phrase: "in alum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0330887:Alum [Plant]

Phrase: "and"

Phrase: "treated with control antibody"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0243148:control [Qualitative Concept]
   770   C1522326:Treated [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at days 5,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "6"

Phrase: "and"

Phrase: "7 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   827   C0042196:immunisation [Therapeutic or Preventive Procedure]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   827   C3244291:immunization [Functional Concept]
   755 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.115: (A) Splenic cryosections were prepared from the mice at day 10 post-immunization and stained with PNAFITC (green), B220APC (blue) and CD4PE (red). 

Phrase: "(A) Splenic cryosections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0085188:cryosection [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared from the mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   737   C1521827:Prepare [Functional Concept]

Phrase: "at day 10 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "and"

Phrase: "stained with PNAFITC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "B220APC"

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "CD4PE"

Phrase: "(red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.116: The size of each GC per section was estimated by LSM510 software. 

Phrase: "The size of each GC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "per section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "estimated by LSM510 software."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037585:Software [Intellectual Product,Manufactured Object]
   770   C0750572:Estimated [Quantitative Concept]
Processing 00000000.tx.117: (B) Anti-ICOS mAb (closed circle) or control Ig (open circle) was administered into C57BL/6 mice (n > 5) at days 5, 6 and 7 post-immunization with NP-CG in alum. 

Phrase: "(B) Anti-ICOS mAb (closed circle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1282913:Circle [Spatial Concept]
   793   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "or"

Phrase: "control Ig (open circle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1282913:Circle [Spatial Concept]
   812   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "was"

Phrase: "administered into C57BL/6 mice"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   851   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   797   C0025921:Mice, C57BL [Mammal]
           C57BL
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1521801:Administered [Functional Concept]
   726 E C1621583:Administer [Functional Concept]

Phrase: "(n > 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "at days 5,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "6"

Phrase: "and"

Phrase: "7 post-immunization with NP-CG"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   753   C0042196:immunisation [Therapeutic or Preventive Procedure]
   753   C0687676:Post [Temporal Concept]
   753   C1704687:Post [Manufactured Object]
   753   C3244291:immunization [Functional Concept]

Phrase: "in alum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0330887:Alum [Plant]
Processing 00000000.tx.118: The number of GC B cells and memory B cells in the spleen of individual mice was analyzed by FACS at days 10, 30 and 70 post-immunization.  

Phrase: "The number of GC B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "memory B cells in the spleen of individual mice"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   784   C0682638:b cells memory [Cell]
   764   C0004561:B-Cells [Cell]
   762   C0312737:Memory cells [Cell]
   751   C1522109:Mouse B Cell [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "analyzed by FACS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "at days 10,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "30"

Phrase: "and"

Phrase: "70 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   827   C0042196:immunisation [Therapeutic or Preventive Procedure]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   827   C3244291:immunization [Functional Concept]
   755 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.119: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.120: 3(B), FACS analysis revealed that NP-specific IgG1+ memory B cells with phenotype IgG1high/CD38+/B220+/IgM/IgD/CD43/CD5 were detected in the spleens of ICOS/AILIM-manipulated mice at days 10, 30 and 70 post-immunization, comparable to the level found in control mice. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "FACS analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that NP-specific IgG1+ memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   844   C0682638:Memory B Cell [Cell]
   839   C0312737:Memory cells [Cell]
   827   C0004561:B-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "with phenotype IgG1high/CD38+/B220+/IgM/IgD/CD43/CD5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3538992:CD5 [Laboratory Procedure]

Phrase: "were"

Phrase: "detected in the spleens"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0037993:Spleens [Body Part, Organ, or Organ Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C0771377:SPLEEN [Tissue]
   737 E C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "of ICOS/AILIM-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "at days 10,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "30"

Phrase: "and"

Phrase: "70 post-immunization, comparable to the level"

Phrase: "found in control mice."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0150312:Found [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.121: In contrast, as expected from histological analysis, the number of NP-specific IgG1+ GC B cells with phenotype IgG1dull/CD38dull/B220+/IgM/IgD/CD43/CD5 was significantly reduced in anti-ICOS/AILIM-treated mice approximately five to six times below the level found in control mice at day 10 post-immunization (P = 0.0004), whereas the effect was marginal at day 30 post-immunization (P = 0.048), probably owing to the temporal effect of anti-ICOS/AILIM mAb. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "as"

Phrase: "expected from histological analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0205462:Histological [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1517001:Expected [Idea or Concept]
   770   C1524024:analysis [Functional Concept]

Phrase: "the number of NP-specific IgG1+ GC B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   741   C0007584:Cell Number [Laboratory Procedure]
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]

Phrase: "with phenotype IgG1dull/CD38dull/B220+/IgM/IgD/CD43/CD5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3538992:CD5 [Laboratory Procedure]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "in anti-ICOS/AILIM-treated mice approximately five"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   807   C0024262:activation lymphocyte [Cell Function]
   799   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   787   C0024264:Lymphocyte [Cell]
   787   C0025914:Mice [Mammal]
   787   C0025929:mice [Mammal]
   787   C0026809:Mice [Mammal]
   787   C0175727:Stimulator [Medical Device]
   787   C0205263:Inducible [Functional Concept]
   787   C0205451:Five [Quantitative Concept]
   787   C0332232:Approximately [Qualitative Concept]
   787   C0332293:treated [Therapeutic or Preventive Procedure]
   787   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   787   C1522326:Treated [Functional Concept]
   787   C1879547:Activation [Activity]
   754 E C1292734:TREAT [Functional Concept]

Phrase: "to six times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "below the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "found in control mice"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0150312:Found [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "at day 10 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "(P = 0.0004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "marginal at day 30 post-immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205284:Marginal [Spatial Concept]
   753   C1550517:marginal [Idea or Concept]
   753   C1947914:Marginal [Qualitative Concept]

Phrase: "(P = 0.048"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "probably owing to the temporal effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0442043:Temporal [Spatial Concept]
   753   C0750492:Probably [Idea or Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   753   C2362314:Temporal [Temporal Concept]

Phrase: "of anti-ICOS/AILIM mAb."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.122: These results suggest that anti-ICOS/AILIM antibody treatment at the onset of GC formation blocked the full maturation of GCs, but it did not affect the number of memory B cells retained over a long period. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that anti-ICOS/AILIM antibody treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   868   C0814472:co-treatment [Health Care Activity]
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   714   C0003369:Anti lymphocyte antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   713   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the full maturation of GCs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0678723:Maturation [Organism Function]
   753   C0870861:maturation [Phenomenon or Process]
   753   C1254042:Maturation [Physiologic Function]

Phrase: "but"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the number of memory B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "retained over a long period."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205166:Long [Qualitative Concept]
   760   C0333118:Retained [Functional Concept]
   760   C0439531:/period [Temporal Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C1948053:Period [Temporal Concept]
Processing 00000000.tx.123: Administration of anti-ICOS/AILIM mAb reduced the frequency of memory B cell accumulating mutations and impaired affinity maturation of IgG1 antibodies Within GCs, B cells accumulate somatic mutations and generate high-affinity variants, which are eventually selected as the precursors of either memory B cells or long-lived AFCs (41, 42). 

Phrase: "Administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001554:Administration [Occupational Activity]
  1000   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the frequency of memory B cell accumulating mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C3178846:Mutation Frequency [Qualitative Concept]
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "impaired affinity maturation of IgG1 antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0678723:Maturation [Organism Function]
   753   C0870861:maturation [Phenomenon or Process]
   753   C1254042:Maturation [Physiologic Function]

Phrase: "Within GCs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Centers [Tissue]
   861   C0205099:centers [Spatial Concept]

Phrase: "B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "accumulate"

Phrase: "somatic mutations"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C2986476:Somatic [Qualitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
   768 E C0599444:soma [Cell Component]
   768 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   755 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "generate"

Phrase: "high-affinity variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "eventually"

Phrase: "selected as the precursors of either memory B cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   784   C0682638:b cells memory [Cell]
   767   C0312738:Precursor B-Cells [Cell]
   764   C0004561:B-Cells [Cell]
   762   C0312737:Memory cells [Cell]
   745   C0018956:cells precursor [Cell]
   742   C0007634:Cells [Cell]
   742   C0025260:Memory [Mental Process]
   742   C0700327:memory [Finding]
   742   C1706377:Memory [Manufactured Object]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708   C1707391:Select [Activity]
   708   C1709634:Precursor [Idea or Concept]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "long-lived AFCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0007634:Cells [Cell]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0205431:Forming [Functional Concept]
   804   C1522492:Forming [Functional Concept]
   804   C3282337:Cells [Cell]
   771 E C0348078:Form [Qualitative Concept]
   771 E C0376315:Form [Manufactured Object]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.124: Thus, memory B cells generated through the GC-dependent pathway carry somatically mutated V genes with improved affinity, while those generated through the GC-independent pathway do not carry them. 

Phrase: "Thus,"

Phrase: "memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "generated through the GC-dependent pathway"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0282491:Germinal Center [Tissue]
   748   C0205099:Center [Spatial Concept]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
   748   C3146294:Generated [Activity]
   748   C3244310:dependent [Functional Concept]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "somatically"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "V genes with improved affinity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Genes [Gene or Genome]

Phrase: "while"

Phrase: "those"

Phrase: "generated through the GC-independent pathway"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0282491:Germinal Center [Tissue]
   748   C0085862:Independent [Idea or Concept]
   748   C0205099:Center [Spatial Concept]
   748   C1299583:Independent [Finding]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
   748   C3146294:Generated [Activity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "them."
Processing 00000000.tx.125: To gain an insight into the origin of memory B cells in anti-ICOS/AILIM antibody-treated mice, NIP-bdg GC and memory B cells were purified from mice that had been treated with anti-ICOS/AILIM mAb or control IgG (each group, n = 15). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "an insight into the origin of memory B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0233820:Insight [Mental Process]

Phrase: "in anti-ICOS/AILIM antibody-treated mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   788   C0025914:Mice [Mammal]
   788   C0025929:mice [Mammal]
   788   C0026809:Mice [Mammal]
   704   C0003369:Anti lymphocyte antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   703   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "NIP-bdg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1824986:NIP [Gene or Genome]
   861   C1825351:NIP [Gene or Genome]
   861   C2829592:Nip [Gene or Genome]

Phrase: " GC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Center [Tissue]
   861   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purified from mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1998793:Purified [Functional Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "with anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "control IgG ("

Phrase: "each group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "n = 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.126: The rearranged VH186.2 gene in purified B cells was amplified by PCR and sequenced as previously described (21). 

Phrase: "The rearranged VH186.2 gene in purified B cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C1861886:CELL Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.127: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.128: 4, NIP-bdg GC B cells accumulated both somatic mutations in the VH186.2 gene and a nucleotide substitution from tryptophan to leucine at amino acid position 33 (Leu 33) at days 10 and 30 post-immunization, as efficiently as did GC B cells in normal mice. 

Phrase: "4,"

Phrase: "NIP-bdg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1824986:NIP [Gene or Genome]
   861   C1825351:NIP [Gene or Genome]
   861   C2829592:Nip [Gene or Genome]

Phrase: " GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "accumulated"

Phrase: "both somatic mutations in the VH186.2 gene"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   744   C2986476:Somatic [Qualitative Concept]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "a nucleotide substitution from tryptophan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1555721:Substitution [Idea or Concept]
   760   C1706204:Substitution [Activity]

Phrase: "to leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "at amino acid position 33"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0733755:Position [Spatial Concept]
   741 E C0240795:POSITIONAL [Finding]

Phrase: "(Leu 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "at days 10"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "30 post-immunization,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   827   C0042196:immunisation [Therapeutic or Preventive Procedure]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   827   C3244291:immunization [Functional Concept]
   755 E C1514253:Postal [Functional Concept]

Phrase: "as"

Phrase: "efficiently"

Phrase: "as"

Phrase: "did"

Phrase: "GC B cells in normal mice."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0004561:B-Cells [Cell]
   778   C0282491:Germinal Center [Tissue]
   771   C1522109:Mouse B Cell [Cell]
   757   C0007634:Normal cell [Cell]
           Cells
   757   C1268443:Normal cell [Cell]
   748   C0205099:Center [Spatial Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.129: The Leu 33 substitution generally results in a 10-fold increase in affinity of the germ line gene product (43), supporting the notion that the anti-ICOS/AILIM antibody treatment does not affect the clonal selection for high-affinity B cells within GCs. 

Phrase: "The Leu 33 substitution generally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1555721:Substitution [Idea or Concept]
   812   C1706204:Substitution [Activity]

Phrase: "results in a 10-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1880834:FOLD [Phenomenon or Process]
   753   C2825142:Result [Finding]

Phrase: "in affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "of the germ line gene product"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017337:Gene [Gene or Genome]
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that"

Phrase: "the anti-ICOS/AILIM antibody treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   868   C0814472:co-treatment [Health Care Activity]
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   714   C0003369:Anti lymphocyte antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   713   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the clonal selection for high-affinity B cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   776   C1817719:B cell selection [Biologic Function]
   744   C0036576:selection [Genetic Function]

Phrase: "within GCs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Centers [Tissue]
   861   C0205099:centers [Spatial Concept]
Processing 00000000.tx.130: View larger version (29K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.131: 4. 

Phrase: "4."
Processing 00000000.tx.132: Manipulation by anti-ICOS/AILIM mAb reduced the frequency of memory B cell bearing affinity-enhancing mutation. 

Phrase: "Manipulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185111:Manipulation, NOS [Therapeutic or Preventive Procedure]
  1000   C0947647:Manipulation [Therapeutic or Preventive Procedure]

Phrase: "by anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the frequency of memory B cell bearing affinity-enhancing mutation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C3178846:Mutation Frequency [Qualitative Concept]
   739   C0376249:frequency [Quantitative Concept]
   739   C0439603:Frequency [Temporal Concept]
   739   C0871396:Frequency [Quantitative Concept]
   739   C1561548:Frequency [Qualitative Concept]
   739   C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.133: NIP-bdg GC B cells and memory B cells were purified from the pooled spleens of C57BL/6 mice (each group: n = 15), which had been treated with control antibody or anti-ICOS/AILIM antibody. 

Phrase: "NIP-bdg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1824986:NIP [Gene or Genome]
   861   C1825351:NIP [Gene or Genome]
   861   C2829592:Nip [Gene or Genome]

Phrase: " GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purified from the pooled spleens of C57BL/6 mice"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   779   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   762   C0025921:Mice, C57BL [Mammal]
           C57BL
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0037993:Spleens [Body Part, Organ, or Organ Component]
   742   C1709595:Pooled [Conceptual Entity]
   742   C1998793:Purified [Functional Concept]
   742   C2349200:Pooled [Functional Concept]
   728   C1519474:Mouse Spleen [Tissue]
   708 E C0337051:Pool [Geographic Area]
   708 E C0771377:SPLEEN [Tissue]
   708 E C1278932:Spleen [Body Part, Organ, or Organ Component]
   708 E C1509144:pool [Clinical Attribute]

Phrase: "("

Phrase: "each group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "n = 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "had"

Phrase: "been"

Phrase: "treated with control antibody"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0243148:control [Qualitative Concept]
   770   C1522326:Treated [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "anti-ICOS/AILIM antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   893   C0003369:Anti lymphocyte antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Lymphocyte Antibody
   891   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   791   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.134: The rearranged VH genes were amplified by two rounds of nested PCR. 

Phrase: "The rearranged VH genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "amplified by two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205448:Two [Quantitative Concept]

Phrase: "rounds of nested PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242574:Nested PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0332490:Round [Spatial Concept]
   770   C0677874:pCR [Finding]
Processing 00000000.tx.135: Genes encoded by VH186.2 were dominant among the recovered clones (>90%) and selected for further analysis. 

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoded by VH186.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]

Phrase: "were"

Phrase: "dominant among the recovered clones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1527180:Dominant [Functional Concept]

Phrase: "("

Phrase: ">90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "selected for further analysis."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1517331:Further [Spatial Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C0205108:far [Spatial Concept]
   737   C1707391:Select [Activity]
Processing 00000000.tx.136: Open circles represent the number of mutations in individual VH186.2 genes and closed circles indicate the number of mutations in individual genes carrying a Trp to Leu substitution at position 33 (Leu 33) together with Tyr at position 99 (Tyr99). 

Phrase: "Open circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the number of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in individual VH186.2 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: "indicate"

Phrase: "the number of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in individual genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a Trp to Leu substitution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1699992:Trp-Leu [Amino Acid, Peptide, or Protein]

Phrase: "at position 33"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "(Leu 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "together with Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1421250:TYR [Gene or Genome]

Phrase: "at position 99"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "(Tyr99"

Phrase: ")."
Processing 00000000.tx.137: Complete sequence data are available from DDBJ/EMBL/GenBank under accession numbers AB187273AB187380 (GC B cells) and AB187381AB187502 (memory B cells).  

Phrase: "Complete sequence data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "available from DDBJ/EMBL/GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]

Phrase: "under accession numbers AB187273AB187380"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C1510755:Accession Number [Intellectual Product]

Phrase: "(GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "AB187381AB187502"

Phrase: "(memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.138: In contrast, the frequency of mutations in NIP-bdg memory B cells was significantly reduced in anti-ICOS/AILIM-manipulated mice at days 30 and 70 post-immunization (P = 0.002 and P < 0.0001; Fig. 4C and D). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the frequency of mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C3178846:Mutation Frequency [Qualitative Concept]
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "in NIP-bdg memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "in anti-ICOS/AILIM-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "at days 30"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "70 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   827   C0042196:immunisation [Therapeutic or Preventive Procedure]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   827   C3244291:immunization [Functional Concept]
   755 E C1514253:Postal [Functional Concept]

Phrase: "(P = 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diversity [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.139: In particular, non-mutated cells were dominant in the memory compartment of ICOS/AILIM-manipulated mice at day 70 post-immunization, whereas the majority of the memory compartment of control mice consisted of mutated ones. 

Phrase: "In particular, non-mutated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "dominant in the memory compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1527180:Dominant [Functional Concept]

Phrase: "of ICOS/AILIM-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "at day 70 post-immunization,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "whereas"

Phrase: "the majority of the memory compartment of control mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0680220:majority [Social Behavior]

Phrase: "consisted of mutated ones."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1705285:Mutated [Cell or Molecular Dysfunction]
   737   C0205447:One [Quantitative Concept]
   737   C0332529:CONSIST [Qualitative Concept]
   737 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.140: These results suggest that the majority of memory B cells detected in ICOS/AILIM-manipulated mice is not of a GC origin. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the majority of memory B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in ICOS/AILIM-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "not of a GC origin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0282491:Germinal Center [Tissue]
   753   C0079946:origin [Classification]
   753   C0205099:Center [Spatial Concept]
   753   C0439659:Origin [Temporal Concept]
   753   C1518422:Not [Functional Concept]
   753   C1550512:origin [Intellectual Product]
   742   C0085142:Center, Birth [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.141: Administration of anti-ICOS/AILIM mAb impaired affinity maturation of IgG1 antibodies, but not the amount of antibodies Figure 5 shows that NP-specific IgG1 antibodies were comparable between ICOS-manipulated mice and control mice; 

Phrase: "Administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001554:Administration [Occupational Activity]
  1000   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "affinity maturation of IgG1 antibodies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the amount of antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "Figure"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that NP-specific IgG1 antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   858   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   844   C2754944:IgG1 antibody [Cell Component]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "comparable between ICOS-manipulated mice"

Phrase: "and"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.142: however, the level of high-affinity NP-specific IgG1 antibodies was reduced in anti-ICOS/AILIM-treated mice, three to four times below the level of the control mice at day 20 (P = 0.008), day 40 (P = 0.0018) and day 70 (P = 0.003) post-immunization (Fig. 5B). 

Phrase: "however,"

Phrase: "the level of high-affinity NP-specific IgG1 antibodies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1277793:Specific antibody level [Laboratory Procedure]
   770   C1287239:Specific antibody level [Laboratory or Test Result]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "in anti-ICOS/AILIM-treated mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "three to four times"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0040223:times [Temporal Concept]
   770   C0205449:Three [Quantitative Concept]
   770   C0205450:Four [Quantitative Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "below the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of the control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "at day 20"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(P = 0.008"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "day 40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
   861   C0439509:/40 [Temporal Concept]

Phrase: "(P = 0.0018"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "day 70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(P = 0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   861   C0042196:immunisation [Therapeutic or Preventive Procedure]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   861   C3244291:immunization [Functional Concept]
   789 E C1514253:Postal [Functional Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.143: This resulted in a significant reduction in the ratio of high-affinity to total IgG1 antibodies (NP2/NP18) in the anti-ICOS/AILIM-treated mice throughout the immune response (Fig. 5C). 

Phrase: "This"

Phrase: "resulted in a significant reduction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0237881:significant [Quantitative Concept]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "of high-affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "to total IgG1 antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2754944:IgG1 antibody [Cell Component]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(NP2/NP18"

Phrase: ")"

Phrase: "in the anti-ICOS/AILIM-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "throughout the immune response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.144: These results suggest that the injection of anti-ICOS/AILIM mAb at the onset of GC formation had a long-lasting effect on the affinity maturation of NP-specific IgG1 antibodies. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "had"

Phrase: "a long-lasting effect on the affinity maturation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "of NP-specific IgG1 antibodies."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   858   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   844   C2754944:IgG1 antibody [Cell Component]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.145: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.146: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.147: Affinity maturation in the anti-NP IgG1 antibody response was impaired by injection of anti-ICOS/AILIM mAb at day 5 post-immunization. 

Phrase: "Affinity maturation in the anti-NP IgG1 antibody response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0678723:Maturation [Organism Function]
   742   C0870861:maturation [Phenomenon or Process]
   742   C1254042:Maturation [Physiologic Function]

Phrase: "was"

Phrase: "impaired by injection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021485:injection [Therapeutic or Preventive Procedure]
   790   C0221099:Impaired [Functional Concept]
   790   C0684336:Impaired [Pathologic Function]
   790   C1272883:Injection [Biomedical or Dental Material]
   790   C1533685:Injection [Therapeutic or Preventive Procedure]
   790   C1828121:Injection [Functional Concept]

Phrase: "of anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at day 5 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.148: Mice were immunized with NP-CG in alum and injected intravenously with control rat Ig (open circle; n = 8) or rat anti-ICOS/AILIM mAb (closed circle; n = 8) at days 5, 6 and 7 post-immunization. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "immunized with NP-CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1706141:NP [Gene or Genome]
   770   C3540479:CG [Gene or Genome]

Phrase: "in alum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0330887:Alum [Plant]

Phrase: "and"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously with control rat Ig (open circle"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   748   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0175566:Open [Spatial Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1282913:Circle [Spatial Concept]
   748   C1550141:Control [Substance]
   748   C1551714:Circle [Population Group]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   748   C3541296:IG [Idea or Concept]

Phrase: "; n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "or rat anti-ICOS/AILIM mAb (closed circle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   786   C1282913:Circle [Spatial Concept]
   786   C1551714:Circle [Population Group]

Phrase: "; n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "at days 5,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "6"

Phrase: "and"

Phrase: "7 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   827   C0042196:immunisation [Therapeutic or Preventive Procedure]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   827   C3244291:immunization [Functional Concept]
   755 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.149: The level of NP-specific IgG1 antibody in individual serum was estimated at days 10, 20, 40 and 70 post-immunization by ELISA with the aid of NP18-BSA and NP2-BSA as coated antigens for estimation of the total (A) and high-affinity (B) NP-specific IgG1 antibodies. 

Phrase: "The level of NP-specific IgG1 antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1277793:Specific antibody level [Laboratory Procedure]
   800   C1287239:Specific antibody level [Laboratory or Test Result]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in individual serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "estimated at days 10,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   819   C1547061:10 days [Temporal Concept]
   770   C0439228:days [Temporal Concept]
   770   C0750572:Estimated [Quantitative Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "20,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "70 post-immunization by ELISA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   760   C0042196:immunisation [Therapeutic or Preventive Procedure]
   760   C0687676:Post [Temporal Concept]
   760   C1704687:Post [Manufactured Object]
   760   C3244291:immunization [Functional Concept]

Phrase: "with the aid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018896:Aid [Social Behavior]
  1000   C0449435:Aid [Manufactured Object]
  1000   C3540469:AID [Gene or Genome]

Phrase: "of NP18-BSA"

Phrase: "and"

Phrase: "NP2-BSA as coated antigens"

Phrase: "for estimation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0680844:estimation [Mental Process]
  1000   C0681916:Estimation [Quantitative Concept]
  1000   C0750572:Estimation [Quantitative Concept]

Phrase: "of the total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "high-affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "(B) NP-specific IgG1 antibodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   881   C0368720:B Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   836   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   823   C2754944:IgG1 antibody [Cell Component]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.150: (C) The ratios of total to high-affinity antibodies were calculated. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "The ratios of total"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0456603:Ratios [Quantitative Concept]
   770   C1610540:*Ratios [Quantitative Concept]
   737 E C1547037:Ratio [Intellectual Product]

Phrase: "to high-affinity antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "calculated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.151: The data were statistically evaluated by the MannWhitney non-parametric test (two-tailed). 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "statistically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038215:Statistically [Occupation or Discipline]

Phrase: "evaluated by the MannWhitney non-parametric test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C1709255:Non-Parametric Test [Intellectual Product]
   778   C1711157:Parametric Test [Intellectual Product]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0220825:Evaluated [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C1518422:Non [Functional Concept]

Phrase: "(two-tailed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039259:tailed [Body Part, Organ, or Organ Component]
   861   C0205448:Two [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.152: The data are representative of three independent experiments.  

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.153: Memory B cells in anti-ICOS/AILIM mAb-treated mice reduced the affinity of the secondary IgG1 response According to the VH gene sequence, it appeared that memory B cells in ICOS/AILIM-manipulated mice mostly consisted of low-affinity cells. 

Phrase: "Memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in anti-ICOS/AILIM mAb-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C0025914:Mice [Mammal]
   788   C0025929:mice [Mammal]
   788   C0026809:Mice [Mammal]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the affinity of the secondary IgG1 response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "According to the VH gene sequence,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0017337:Gene [Gene or Genome]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "it"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "that memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in ICOS/AILIM-manipulated mice mostly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "consisted of low-affinity cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0205251:low [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1550472:low [Idea or Concept]
   760   C3282337:Cells [Cell]
   726   C0332529:CONSIST [Qualitative Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.154: To evaluate the validity of this, NP-primed B cells were purified from the pooled spleens (n = 11) of ICOS-manipulated or control mice at day 70 post-immunization. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the validity of this,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2349101:Validity [Quantitative Concept]

Phrase: "NP-primed B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purified from the pooled spleens"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0037993:Spleens [Body Part, Organ, or Organ Component]
   760   C1709595:Pooled [Conceptual Entity]
   760   C1998793:Purified [Functional Concept]
   760   C2349200:Pooled [Functional Concept]
   726 E C0337051:Pool [Geographic Area]
   726 E C0771377:SPLEEN [Tissue]
   726 E C1278932:Spleen [Body Part, Organ, or Organ Component]
   726 E C1509144:pool [Clinical Attribute]

Phrase: "(n = 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "of ICOS-manipulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0947647:Manipulate [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "control mice at day 70 post-immunization."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.155: B cells were mixed with or without CG-primed T cells of normal mice and adoptively transferred into Rag-1/ mice, followed by challenge with soluble NP-CG 24 h after transfer. 

Phrase: "B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "mixed with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0205430:Mixed [Functional Concept]
   833   C3160715:Mixed [Finding]
   799 E C1421951:MIX [Gene or Genome]
   799 E C1720722:Mix [Qualitative Concept]

Phrase: "or without CG-primed T cells of normal mice"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   764   C0039194:T-Cells [Cell]
   751   C1522131:Mouse T Cell [Cell]
   745   C0007634:Normal cell [Cell]
           Cells
   745   C1268443:Normal cell [Cell]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0871133:primed [Functional Concept]
   742   C2347086:% Normal [Quantitative Concept]
   742   C3282337:Cells [Cell]
   742   C3540479:CG [Gene or Genome]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "adoptively"

Phrase: "transferred into Rag-1/ mice,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   783   C0678936:gene recombination [Genetic Function]
   783   C1417166:MICE gene [Gene or Genome]
   767   C1517499:Gene Transfer [Molecular Biology Research Technique]
   753   C0017337:Gene [Gene or Genome]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0034865:Recombination [Genetic Function]
   753   C0348011:transferred [Functional Concept]
   753   C1879547:activating [Activity]
   719 E C0040671:Transfer [Mental Process]
   719 E C1515877:Activate [Functional Concept]
   719 E C1705822:Transfer [Activity]

Phrase: "followed by challenge"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0798503:Challenge [Clinical Attribute]
   790   C0805586:Challenge [Health Care Activity]
   790   C3274764:Challenge [Conceptual Entity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with soluble NP-CG 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0033727:H+ [Element, Ion, or Isotope]
   804   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441932:H+ [Classification]
   804   C0564385:/h [Quantitative Concept]

Phrase: "after transfer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]
Processing 00000000.tx.156: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.157: 6, NP-primed B cells of ICOS/AILIM-manipulated mice and control mice efficiently reconstituted an anti-NP IgG secondary response in adoptive recipients at similar levels; 

Phrase: "6,"

Phrase: "NP-primed B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "of ICOS/AILIM-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "control mice efficiently"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "reconstituted"

Phrase: "an anti-NP IgG secondary response in adoptive recipients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "at similar levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.158: however, the affinity of serum antibodies was low in the hosts repopulated with NP-primed B cells of ICOS/AILIM-manipulated mice compared with the serum antibody affinity of the control mice (data not shown). 

Phrase: "however,"

Phrase: "the affinity of serum antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0003255:Antibody Affinity [Molecular Function]
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "low in the hosts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]

Phrase: "repopulated with NP-primed B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0004561:B-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0871133:primed [Functional Concept]
   753   C1706141:NP [Gene or Genome]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "of ICOS/AILIM-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "compared with the serum antibody affinity of the control mice"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   760   C0003255:Antibody Affinity [Molecular Function]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0229671:Serum [Body Substance]
   739   C0243148:control [Qualitative Concept]
   739   C1510827:Affinity [Natural Phenomenon or Process]
   739   C1546774:Serum [Intellectual Product]
   739   C1550100:Serum [Body Substance]
   739   C1550141:Control [Substance]
   739   C1707455:Compared [Activity]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.159: Likewise, the frequency of NP-specific IgG1 AFCs was comparable between the control and ICOS/AILIM-manipulated mice (Fig. 6A), but the ratios of high-affinity NP-specific IgG AFCs were significantly reduced in ICOS/AILIM-manipulated mice (Fig. 6B; P = 0.0032). 

Phrase: "Likewise,"

Phrase: "the frequency of NP-specific IgG1 AFCs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0376249:frequency [Quantitative Concept]
   742   C0439603:Frequency [Temporal Concept]
   742   C0871396:Frequency [Quantitative Concept]
   742   C1561548:Frequency [Qualitative Concept]
   742   C1705502:Frequency [Quantitative Concept]

Phrase: "was"

Phrase: "comparable between the control"

Phrase: "and"

Phrase: "ICOS/AILIM-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the ratios of high-affinity NP-specific IgG AFCs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C0456603:Ratios [Quantitative Concept]
   738   C1610540:*Ratios [Quantitative Concept]
   704 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "in ICOS/AILIM-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "(Fig. 6B"

Phrase: "; P = 0.0032"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.160: Taken together, these results suggest that the blockade of ICOS/AILIMICOS/AILIM ligand interaction at the onset of GC formation severely impaired the recruitment of high-affinity B cells into the memory compartment. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the blockade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332206:Blockade [Functional Concept]
  1000   C3540676:Blockade [Pharmacologic Substance]

Phrase: "of ICOS/AILIMICOS/AILIM ligand interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation severely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1817919:germinal center formation [Organism Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "the recruitment of high-affinity B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2949735:Recruitment [Activity]

Phrase: "into the memory compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.161: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.162: 6. 

Phrase: "6."
Processing 00000000.tx.163: Anti-NP secondary response in Rag-1/ mice reconstituted with B cells from anti-ICOS/AILIM mAb-treated mice. 

Phrase: "Anti-NP secondary response in Rag-1/ mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "reconstituted with B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0004561:B-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "from anti-ICOS/AILIM mAb-treated mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C0025914:Mice [Mammal]
   788   C0025929:mice [Mammal]
   788   C0026809:Mice [Mammal]
Processing 00000000.tx.164: B cells were purified from the pooled spleens (n = 11) of mice that had been immunized with NP-CG in alum 70 days before or non-immunized mice (naive). 

Phrase: "B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purified from the pooled spleens"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0037993:Spleens [Body Part, Organ, or Organ Component]
   760   C1709595:Pooled [Conceptual Entity]
   760   C1998793:Purified [Functional Concept]
   760   C2349200:Pooled [Functional Concept]
   726 E C0337051:Pool [Geographic Area]
   726 E C0771377:SPLEEN [Tissue]
   726 E C1278932:Spleen [Body Part, Organ, or Organ Component]
   726 E C1509144:pool [Clinical Attribute]

Phrase: "(n = 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "immunized with NP-CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1706141:NP [Gene or Genome]
   770   C3540479:CG [Gene or Genome]

Phrase: "in alum 70 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "before"

Phrase: "or"

Phrase: "non-immunized mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C1513853:NON Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(naive"

Phrase: ")."
Processing 00000000.tx.165: These mice were treated with either control antibody or anti-ICOS/AILIM mAb at days 5, 6 and 7 post-immunization. 

Phrase: "These mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "treated with either control antibody"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0243148:control [Qualitative Concept]
   760   C1522326:Treated [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at days 5,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "6"

Phrase: "and"

Phrase: "7 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   827   C0042196:immunisation [Therapeutic or Preventive Procedure]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   827   C3244291:immunization [Functional Concept]
   755 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.166: Purified B cells were mixed with T cells purified from the pooled spleens of CG-immunized mice and transferred into RAG-1-deficient mice. 

Phrase: "Purified B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "mixed with T cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0039194:T-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0205430:Mixed [Functional Concept]
   770   C3160715:Mixed [Finding]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1704653:Cell [Medical Device]
   737 E C1720722:Mix [Qualitative Concept]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "purified from the pooled spleens of CG-immunized mice"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0037993:Spleens [Body Part, Organ, or Organ Component]
   742   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1709595:Pooled [Conceptual Entity]
   742   C1998793:Purified [Functional Concept]
   742   C2349200:Pooled [Functional Concept]
   742   C3540479:CG [Gene or Genome]
   728   C1519474:Mouse Spleen [Tissue]
   708 E C0337051:Pool [Geographic Area]
   708 E C0771377:SPLEEN [Tissue]
   708 E C1278932:Spleen [Body Part, Organ, or Organ Component]
   708 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "transferred into RAG-1-deficient mice."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0085218:RAG-1 [Gene or Genome]
   753   C0011155:Deficient [Functional Concept]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0348011:transferred [Functional Concept]
   753   C1636779:% deficient [Quantitative Concept]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]
Processing 00000000.tx.167: Recipient mice were challenged with (+) or without () 50 g of NP-CG 1 day after transfer. 

Phrase: "Recipient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "challenged with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0798503:Challenge [Clinical Attribute]
   799   C0805586:Challenge [Health Care Activity]
   799   C3274764:Challenge [Conceptual Entity]

Phrase: "(+"

Phrase: ")"

Phrase: "or without"

Phrase: "("

Phrase: ")"

Phrase: "50 g of NP-CG 1 day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0439417:g/day [Quantitative Concept]
   774   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   748   C0439267:g% [Quantitative Concept]

Phrase: "after transfer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]
Processing 00000000.tx.168: Anti-NP AFCs in the BM were estimated at day 10 post-immunization by ELISPOT with the use of NP2-BSA or NP18-BSA as a coating antigen. 

Phrase: "Anti-NP AFCs in the BM"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0007634:Cells [Cell]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0205431:Forming [Functional Concept]
   744   C1522492:Forming [Functional Concept]
   744   C3282337:Cells [Cell]
   711 E C0348078:Form [Qualitative Concept]
   711 E C0376315:Form [Manufactured Object]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "estimated at day 10 post-immunization"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   753   C0042196:immunisation [Therapeutic or Preventive Procedure]
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   753   C0687676:Post [Temporal Concept]
   753   C0750572:Estimated [Quantitative Concept]
   753   C1704687:Post [Manufactured Object]
   753   C3244291:immunization [Functional Concept]

Phrase: "by ELISPOT"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   793   C1517892:Link [Intellectual Product]
   793   C1704666:Link [Intellectual Product]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "with the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of NP2-BSA"

Phrase: "or"

Phrase: "NP18-BSA as a coating antigen."
Processing 00000000.tx.169: (A) Circles represent the number of NP18-specific IgG1 AFCs in individual mice (open circle, control Ig; closed circle, anti-ICOS/AILIM). 

Phrase: "(A) Circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the number of NP18-specific IgG1 AFCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C0007584:Cell Number [Laboratory Procedure]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]

Phrase: "in individual mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(open circle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1282913:Circle [Spatial Concept]
   861   C1551714:Circle [Population Group]

Phrase: "control Ig"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3541296:IG [Idea or Concept]

Phrase: "; closed circle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1282913:Circle [Spatial Concept]
   861   C1551714:Circle [Population Group]

Phrase: "anti-ICOS/AILIM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   822   C0024262:activation lymphocyte [Cell Function]
   812   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0024264:Lymphocyte [Cell]
   793   C0175727:Stimulator [Medical Device]
   793   C0205263:Inducible [Functional Concept]
   793   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1879547:Activation [Activity]

Phrase: ")."
Processing 00000000.tx.170: (B) The ratios of NP2/NP18-specific IgG1 AFCs were plotted. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The ratios of NP2/NP18-specific IgG1 AFCs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0456603:Ratios [Quantitative Concept]
   739   C1610540:*Ratios [Quantitative Concept]
   706 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "plotted."
Processing 00000000.tx.171: The data were statistically evaluated by the MannWhitney non-parametric test (two-tailed). 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "statistically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038215:Statistically [Occupation or Discipline]

Phrase: "evaluated by the MannWhitney non-parametric test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C1709255:Non-Parametric Test [Intellectual Product]
   778   C1711157:Parametric Test [Intellectual Product]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0220825:Evaluated [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C1518422:Non [Functional Concept]

Phrase: "(two-tailed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039259:tailed [Body Part, Organ, or Organ Component]
   861   C0205448:Two [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.172: The data are representative of three independent experiments.   

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.173: Discussion Top Abstract Introduction Methods Results Discussion References  B cells and T cells interact at the border of the B-cell follicle and T-cell area from day 2 to day 3 post-immunization (11). 

Phrase: "Discussion Top Abstract Introduction Methods Results Discussion"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "interact at the border of the B-cell follicle"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0004561:B-cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0018120:Follicle [Body Part, Organ, or Organ Component]
   742   C0205284:Border [Spatial Concept]
   742   C1269647:Cell [Cell]
   742   C1522411:Border [Body Location or Region]
   742   C1571705:Follicle [Body Part, Organ, or Organ Component]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2828371:Border [Classification]

Phrase: "and"

Phrase: "T-cell area from day 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0805132:Area 2 [Spatial Concept]
   753   C0017446:Area [Geographic Area]
   753   C0205146:Area [Spatial Concept]

Phrase: "to day 3 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.174: The present results raise the possibility that activated B cells progress to GC B cells and start to form small foci at the boundary of the B-cell follicle and T-cell area in the spleen at day 5 post-immunization. 

Phrase: "The present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that activated B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "progress to GC B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0004561:B-Cells [Cell]
   790   C0282491:Germinal Center [Tissue]
   753   C0007634:Cells [Cell]
   753   C0205099:Center [Spatial Concept]
   753   C1272688:progress [Functional Concept]
   753   C1280477:Progress [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "start"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "small foci at the boundary of the B-cell follicle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0205234:Foci [Spatial Concept]
   706 E C1285542:focus [Functional Concept]

Phrase: "and"

Phrase: "T-cell area in the spleen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Area [Geographic Area]
   753   C0205146:Area [Spatial Concept]

Phrase: "at day 5 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.175: These foci developed in size vigorously from day 5.5 towards the B-cell area; 

Phrase: "These foci"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205234:Foci [Spatial Concept]
   966 E C1285542:focus [Functional Concept]

Phrase: "developed in size vigorously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456389:size [Spatial Concept]
   770   C1690553:Vigorously [Qualitative Concept]

Phrase: "from day 5.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]

Phrase: "towards the B-cell area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   734   C0004561:B-cell [Cell]

Phrase: ";"
Processing 00000000.tx.176: however, the development was inhibited by anti-ICOS/AILIM mAbs given at day 5 post-immunization, suggesting that the ICOS/AILIMICOS/AILIM ligand interaction is required for either the generation (3032) or full maturation of GCs, although they are not mutually exclusive. 

Phrase: "however,"

Phrase: "the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "was"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "by anti-ICOS/AILIM mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   758   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "given at day 5 post-immunization,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   753   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   753   C0042196:immunisation [Therapeutic or Preventive Procedure]
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   753   C0687676:Post [Temporal Concept]
   753   C1442162:GIVEN [Conceptual Entity]
   753   C1550718:given [Idea or Concept]
   753   C1704687:Post [Manufactured Object]
   753   C3244291:immunization [Functional Concept]
   753   C3244317:given [Intellectual Product]
   719 E C1947971:Give [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ICOS/AILIMICOS/AILIM ligand interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "required for either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "(3032"

Phrase: ")"

Phrase: "or"

Phrase: "full maturation of GCs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]

Phrase: "although"

Phrase: "they"

Phrase: "are"

Phrase: "not mutually exclusive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1548966:Exclusive [Idea or Concept]
Processing 00000000.tx.177: It has been widely believed that memory B cells are generated after the affinity maturation of BCR within GCs (41); 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "widely"

Phrase: "believed"

Phrase: "that memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "generated after the affinity maturation of BCR"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   807   C1817724:B cell affinity maturation [Biologic Function]
   790   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   764   C0004561:B-cell [Cell]
   762   C1514760:Receptor Cell [Cell]
   762   C1516349:Cell Maturation [Cell Function]
   742   C0007634:Cell [Cell]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0678723:Maturation [Organism Function]
   742   C0870861:maturation [Phenomenon or Process]
   742   C1254042:Maturation [Physiologic Function]
   742   C1269647:Cell [Cell]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C3146294:Generated [Activity]

Phrase: "within GCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Centers [Tissue]
   861   C0205099:centers [Spatial Concept]

Phrase: "(41"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.178: however, recent studies using Bcl-6-deficient mice and transgenic mice expressing low-affinity BCR revealed that memory B cells can be generated independent of GCs and affinity maturation of BCR (22, 24). 

Phrase: "however,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Bcl-6-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "low-affinity BCR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   840   C0004561:B-cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "generated independent of GCs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0282491:Germinal Centers [Tissue]
   806   C0332291:Independent of [Functional Concept]
   760   C0085862:Independent [Idea or Concept]
   760   C0205099:centers [Spatial Concept]
   760   C1299583:Independent [Finding]
   760   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "affinity maturation of BCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C1817724:B cell affinity maturation [Biologic Function]
   783   C1516349:Cell Maturation [Cell Function]
   753   C0678723:Maturation [Organism Function]
   753   C0870861:maturation [Phenomenon or Process]
   753   C1254042:Maturation [Physiologic Function]

Phrase: "(22,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.179: To exclude the secondary effect of gene modification, we produced GC-deficient mice by injecting anti-ICOS mAb into normal mice at the onset of GC formation and monitored the kinetics of GC and memory B cells in response to NP-CG in alum. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the secondary effect of gene modification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "produced"

Phrase: "GC-deficient mice by injecting anti-ICOS mAb"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]

Phrase: "into normal mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "and"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "the kinetics of GC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022702:Kinetics [Natural Phenomenon or Process]
   760   C0220865:kinetics [Functional Concept]
   760   C2825046:Kinetics [Occupation or Discipline]

Phrase: "and"

Phrase: "memory B cells in response"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   845   C0682638:Memory B Cell [Cell]
   806   C0004561:B-Cells [Cell]
   797   C0312737:Memory cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "to NP-CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "in alum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0330887:Alum [Plant]
Processing 00000000.tx.180: We observed that the number of memory B cells in the primary immune response in the ICOS-manipulated mice is comparable to that of control immunized mice. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the number of memory B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in the primary immune response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0301875:Primary immune response [Organism Function]
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "in the ICOS-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "comparable to that of control immunized mice."
Processing 00000000.tx.181: The majority of memory B cells in the ICOS-manipulated mice did not accumulate somatic mutations and these cells reconstituted the secondary response in adoptive hosts by low-affinity IgG1 antibodies, suggesting that in the normal primary response non-mutated and low-affinity memory B cells are generated without GC formation. 

Phrase: "The majority of memory B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "in the ICOS-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accumulate"

Phrase: "somatic mutations"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C2986476:Somatic [Qualitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
   768 E C0599444:soma [Cell Component]
   768 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   755 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "reconstituted"

Phrase: "the secondary response in adoptive hosts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0301872:Host response [Organ or Tissue Function]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "by low-affinity IgG1 antibodies,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C2754944:IgG1 antibody [Cell Component]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that in the normal primary response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205225:Primary [Qualitative Concept]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2911692:Response [Mental Process]

Phrase: "non-mutated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1518422:Non [Functional Concept]
   861   C1705285:Mutated [Cell or Molecular Dysfunction]
   827 E C1513776:Mutate [Genetic Function]

Phrase: "and"

Phrase: "low-affinity memory B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   933   C3554579:Low memory B cells [Finding]
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "generated without GC formation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1817919:germinal center formation [Organism Function]
   806   C0282491:Germinal Center [Tissue]
   760   C0205099:Center [Spatial Concept]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
   760   C3146294:Generated [Activity]
Processing 00000000.tx.182: The origin of GC-independent and GC-dependent memory B cells is unknown, but it is conceivable that the majority of memory B cells generated at the early immune response may enter into the GC and convert into high-affinity ones by the accumulation of somatic mutations at later time points. 

Phrase: "The origin of GC-independent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0079946:origin [Classification]
   753   C0439659:Origin [Temporal Concept]
   753   C1550512:origin [Intellectual Product]
   742   C0085142:Center, Birth [Health Care Related Organization,Manufactured Object]

Phrase: "and"

Phrase: "GC-dependent memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   844   C0682638:Memory B Cell [Cell]
   839   C0312737:Memory cells [Cell]
   827   C0004561:B-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that"

Phrase: "the majority of memory B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "generated at the early immune response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0301872:Immune response [Organ or Tissue Function]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1279919:Early [Temporal Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
   753   C3146294:Generated [Activity]

Phrase: "may"

Phrase: "enter into the GC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0282491:Germinal Center [Tissue]
   760   C0205099:Center [Spatial Concept]
   760   C1522196:ENTER [Functional Concept]

Phrase: "and"

Phrase: "convert into high-affinity ones"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C2700149:HIGH [Intellectual Product]
   726   C0205447:One [Quantitative Concept]

Phrase: "by the accumulation"

Phrase: "of somatic mutations"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C2986476:Somatic [Qualitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
   768 E C0599444:soma [Cell Component]
   768 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   755 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "at later time points."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.183: Alternatively, non-mutated memory B cells are generated from naive B cells at the initial immune response, whereas mutated ones are differentiated from GC B cells upon antigen-driven selection. 

Phrase: "Alternatively,"

Phrase: "non-mutated memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "generated from naive B cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0004561:B-Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3146294:Generated [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "at the initial immune response,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "whereas"

Phrase: "mutated ones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "are"

Phrase: "differentiated from GC B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0004561:B-Cells [Cell]
   790   C0282491:Germinal Center [Tissue]
   753   C0007589:Differentiated [Cell Function]
   753   C0007634:Cells [Cell]
   753   C0205099:Center [Spatial Concept]
   753   C0205615:Differentiated [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "upon antigen-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "selection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036576:selection [Genetic Function]
Processing 00000000.tx.184: In addition, considering that marginal zone B cells promptly respond to T-cell-dependent antigens (44), we could not exclude another possibility that marginal zone and follicular B cells generate memory cells with different kinetics after immunization. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "that marginal zone B cells promptly"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "respond to T-cell-dependent antigens"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C0487637:T-cell Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0039194:T-cell [Cell]
   753   C0003320:Antigens [Immunologic Factor]
   753   C0007634:Cell [Cell]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "that marginal zone"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1711368:Marginal Zone [Tissue]
   861   C0205284:Marginal [Spatial Concept]
   861   C1550517:marginal [Idea or Concept]
   861   C1710706:Zone [Spatial Concept]
   861   C1947914:Marginal [Qualitative Concept]
   789 E C0229985:margin [Body Part, Organ, or Organ Component]
   789 E C1269830:Margin [Finding]
   789 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "follicular B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "generate"

Phrase: "memory cells with different kinetics"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0312737:Memory cells [Cell]
   781   C1516333:Cell Kinetics [Occupation or Discipline]
   760   C0007634:Cells [Cell]
   760   C0025260:Memory [Mental Process]
   760   C0700327:memory [Finding]
   760   C1706377:Memory [Manufactured Object]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0679055:mnemonic [Mental Process]

Phrase: "after immunization."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]
Processing 00000000.tx.185: The number of memory B cells in the ICOS-manipulated mice was retained at a level similar to that of normal mice until day 70 post-immunization, suggesting that low-affinity memory B cells are maintained as long as those generated in GCs, regardless of their reduced BCR affinity. 

Phrase: "The number of memory B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in the ICOS-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "retained at a level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0333118:Retained [Functional Concept]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "similar to that of normal mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "until day 70 post-immunization,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that low-affinity memory B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   933   C3554579:Low memory B cells [Finding]
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "maintained as long"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205166:Long [Qualitative Concept]
   790   C1314677:Maintained [Functional Concept]
   790   C1706317:Long [Qualitative Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "as those"

Phrase: "generated in GCs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0282491:Germinal Centers [Tissue]
   770   C0205099:centers [Spatial Concept]
   770   C3146294:Generated [Activity]

Phrase: "regardless of their reduced BCR affinity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1510827:Affinity [Natural Phenomenon or Process]
   717   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.186: The memory compartment mostly consisted of non-mutated cells in the ICOS-manipulated mice, whereas non-mutated ones only exist at a level of 1020% in normal memory B cells (21, 37). 

Phrase: "The memory compartment mostly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "consisted of non-mutated cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C1518422:Non [Functional Concept]
   760   C1705285:Mutated [Cell or Molecular Dysfunction]
   760   C3282337:Cells [Cell]
   726   C0332529:CONSIST [Qualitative Concept]
   726 E C1269647:Cell [Cell]
   726 E C1513776:Mutate [Genetic Function]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in the ICOS-manipulated mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "whereas"

Phrase: "non-mutated ones only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0205447:One [Quantitative Concept]

Phrase: "exist at a level of 1020%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
   753   C2987476:Exist [Conceptual Entity]

Phrase: "in normal memory B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   906   C0682638:Memory B Cell [Cell]
   886   C0007634:Normal cell [Cell]
           Cells
   886   C1268443:Normal cell [Cell]
   875   C0312737:Memory cells [Cell]
   861   C0004561:B-Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(21,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.187: Despite the different cellular component, both the ICOS-manipulated mice and normal mice retained a comparable number of memory cells in the spleen over a long period after immunization, suggesting that the size of the memory compartment in the immune response is limited. 

Phrase: "Despite the different cellular component,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1166607:cellular component [Cell Component]
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "both"

Phrase: "the ICOS-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "normal mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "a comparable number of memory cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in the spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "over a long period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "after immunization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the size of the memory compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "in the immune response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "limited."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.188: Memory B cells migrate into the marginal zone in the spleen after selection (45, 46), which may provide the limiting space for their persistence. 

Phrase: "Memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "migrate into the marginal zone"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1711368:Marginal Zone [Tissue]
   760   C0205284:Marginal [Spatial Concept]
   760   C0232902:migrate [Functional Concept]
   760   C1550517:marginal [Idea or Concept]
   760   C1710706:Zone [Spatial Concept]
   760   C1947914:Marginal [Qualitative Concept]

Phrase: "in the spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "after selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036576:selection [Genetic Function]

Phrase: "(45,"

Phrase: "46"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the limiting space for their persistence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883067:Space [Spatial Concept]
Processing 00000000.tx.189: Therefore, a reduction in the frequency of non-mutated cells in the normal memory compartment, in parallel to the generation of mutated and high-affinity memory cells, could be attributable to the competition between low- and high-affinity memory B cells in the resident place, if an antigen is involved in the efficient persistence of memory cells (45, 46). 

Phrase: "Therefore,"

Phrase: "a reduction in the frequency of non-mutated cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the normal memory compartment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "in parallel to the generation of mutated"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0150312:In [Quantitative Concept]
   748   C0332285:In [Spatial Concept]
   748   C2348042:Parallel [Qualitative Concept]
   748   C2826345:PARALLEL [Research Activity]

Phrase: "and"

Phrase: "high-affinity memory cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   861   C0312737:Memory cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0025260:Memory [Mental Process]
   812   C0700327:memory [Finding]
   812   C1706377:Memory [Manufactured Object]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C0679055:mnemonic [Mental Process]

Phrase: "could"

Phrase: "be"

Phrase: "attributable to the competition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596130:Attributable [Mental Process]

Phrase: "between low-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "high-affinity memory B cells in the resident place,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   784   C0682638:b cells memory [Cell]
   764   C0004561:B-Cells [Cell]
   762   C0312737:Memory cells [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "if"

Phrase: "an antigen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "is"

Phrase: "involved in the efficient persistence of memory cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0312737:Memory cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0025260:Memory [Mental Process]
   744   C0442799:Efficient [Qualitative Concept]
   744   C0546816:Persistence [Mental Process]
   744   C0700327:memory [Finding]
   744   C1314939:Involved [Functional Concept]
   744   C1706377:Memory [Manufactured Object]
   744   C3282337:Cells [Cell]
   731   C1882350:Persistent Memory [Manufactured Object]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.190: Alternatively, as discussed above, involvement of non-mutated memory B cells in the GC reaction could be associated with a reduction in the frequency of non-mutated cells in the normal memory compartment. 

Phrase: "Alternatively,"

Phrase: "as"

Phrase: "discussed above,"

Phrase: "involvement of non-mutated memory B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in the GC reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0282491:Germinal Center [Tissue]

Phrase: "could"

Phrase: "be"

Phrase: "associated with a reduction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "of non-mutated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in the normal memory compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.191: Further analysis is needed to clarify this issue. 

Phrase: "Further analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "this issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.192: Previous reports suggest that the memory B-cell response is impaired in mice deficient in ICOS or ICOS-L, probably owing to the malfunction of T and B cells in the primary response (31, 32, 35). 

Phrase: "Previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the memory B-cell response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C0682638:Memory B Cell [Cell]
   708   C0312737:Memory cell [Cell]

Phrase: "is"

Phrase: "impaired in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0221099:Impaired [Functional Concept]
   790   C0684336:Impaired [Pathologic Function]

Phrase: "deficient in ICOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011155:Deficient [Functional Concept]
   760   C1636779:% deficient [Quantitative Concept]

Phrase: "or"

Phrase: "ICOS-L,"

Phrase: "probably owing to the malfunction of T"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0231174:Malfunction [Functional Concept]
   748   C0277785:Malfunction, NOS [Qualitative Concept]
   748   C0750492:Probably [Idea or Concept]
   748   C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "B cells in the primary response"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0004561:B-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.193: Consistently, affinity maturation in serum IgG1 antibodies was impaired in tertiary immunized ICOS-L/ mice (35). 

Phrase: "Consistently,"

Phrase: "affinity maturation in serum IgG1 antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0678723:Maturation [Organism Function]
   753   C0870861:maturation [Phenomenon or Process]
   753   C1254042:Maturation [Physiologic Function]

Phrase: "was"

Phrase: "impaired in tertiary immunized ICOS-L/ mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0175727:Stimulator [Medical Device]
   742   C0205263:Inducible [Functional Concept]
   742   C0205372:Tertiary [Quantitative Concept]
   742   C0221099:Impaired [Functional Concept]
   742   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0684336:Impaired [Pathologic Function]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.194: ICOS-L is constitutively expressed in naive B cells at a low level, whereas T cells express ICOS upon T-cell antigen receptor stimulation (47), thereby raising the possibility that ICOS-ICOS-L co-stimulation is involved in the early phase of B- and T-cell interaction upon antigen stimulation. 

Phrase: "ICOS-L"

Phrase: "is"

Phrase: "constitutively"

Phrase: "expressed in naive B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0004561:B-Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "at a low level,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0205251:low [Qualitative Concept]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1299352:Low [Qualitative Concept]
   861   C1547707:Level [Geographic Area]
   861   C1550472:low [Idea or Concept]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "whereas"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "ICOS upon T-cell antigen receptor stimulation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C1415846:inducible T-cell co-stimulator [Gene or Genome]
   827   C3203085:Inducible T-Cell Co-Stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C1622572:T-cell co-stimulation [Cell Function]
   764   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0175727:Stimulator [Medical Device]
   742   C0205263:Inducible [Functional Concept]
   742   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that ICOS-ICOS-L co-stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   791   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "involved in the early phase of B-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205390:Phase [Temporal Concept]
   748   C1279919:Early [Temporal Concept]
   748   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "T-cell interaction upon antigen stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007582:Cell Interaction [Cell Function]
   753   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.195: It has been reported that B cells in the spleen of normal mice that had been immunized with NP-ovalbumin peptide (OVA) in CFA 10 days before reconstitute the secondary response in adoptive hosts upon stimulation with NP-OVA in incomplete Freund's adjuvant (IFA), whereas B cells of ICOS-L-deficient mice do not (35). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that B cells in the spleen of normal mice"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0004561:B-Cells [Cell]
   751   C1522109:Mouse B Cell [Cell]
   745   C0007634:Normal cell [Cell]
           Cells
   745   C1268443:Normal cell [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "immunized with NP-ovalbumin peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C1706141:NP [Gene or Genome]

Phrase: "(OVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029974:Ova [Cell]

Phrase: ")"

Phrase: "in CFA 10 days before"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1547061:10 days [Temporal Concept]
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]

Phrase: "reconstitute"

Phrase: "the secondary response in adoptive hosts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0301872:Host response [Organ or Tissue Function]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "upon stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with NP-OVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029974:Ova [Cell]

Phrase: "in incomplete Freund's adjuvant"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0281643:incomplete Freund's adjuvant [Carbohydrate,Pharmacologic Substance]
   913   C0301976:Incomplete adjuvant [Immunologic Factor]
   901   C0016712:Freund's Adjuvant [Immunologic Factor,Pharmacologic Substance]
   827   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   827   C0001552:Adjuvant [Chemical Viewed Functionally]
   827   C0205257:Incomplete [Quantitative Concept]
   827   C0728938:incomplete [Quantitative Concept]
   827   C1522673:Adjuvant [Functional Concept]
   827   C1548386:incomplete [Idea or Concept]

Phrase: "(IFA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0281643:IFA [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "B cells of ICOS-L-deficient mice"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   764   C0004561:B-Cells [Cell]
   762   C0347983:cells/L [Quantitative Concept]
   751   C1522109:Mouse B Cell [Cell]
   745 E C0022827:cell l [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "do"

Phrase: "not (35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: ")."
Processing 00000000.tx.196: The present view is that ICOSICOS-L co-stimulation may play a role in GC-independent memory B-cell generation at the early immune response as well as a GC-dependent one at the later immune response. 

Phrase: "The present view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "is"

Phrase: "that ICOSICOS-L co-stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in GC-independent memory B-cell generation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "at the early immune response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "as well as"

Phrase: "a GC-dependent one at the later immune response."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205447:One [Quantitative Concept]
Processing 00000000.tx.197: Together, the present results suggest that memory B cells are generated by two different pathways, independent of and dependent on GC formation and affinity maturation, whereas both pathways may require ICOSICOS-L co-stimulation. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "generated by two different pathways,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205448:Two [Quantitative Concept]
   760   C1704259:Pathways [Molecular Function]
   760   C1705242:Different [Qualitative Concept]
   760   C1705987:Pathways [Conceptual Entity]
   760   C3146294:Generated [Activity]

Phrase: "independent of"

Phrase: "and"

Phrase: "dependent on GC formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "affinity maturation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "whereas"

Phrase: "both pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "may"

Phrase: "require"

Phrase: "ICOSICOS-L co-stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.198: Expansion of GC B cells peaks at day 7 to day 10 post-immunization (21, 23). 

Phrase: "Expansion of GC B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C0007595:cell expansion [Cell Function]

Phrase: "peaks at day 7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C0444505:Peak [Quantitative Concept]

Phrase: "to day 10 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "(21,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.199: The frequency of GC B cells rapidly declined at day 20 and finally reached a level 10 times above the level of non-immunized mice, although GC B cells continuously accumulated somatic mutations in the rearranged VH genes over long periods following immunization (21). 

Phrase: "The frequency of GC B cells rapidly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]

Phrase: "declined at day 20"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "finally"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a level 10 times above the level of non-immunized mice,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C0040223:times [Temporal Concept]
   738   C1632851:Times [Quantitative Concept]
   704 E C3541383:Time [Temporal Concept]

Phrase: "although"

Phrase: "GC B cells continuously"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0007634:Cells [Cell]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "accumulated"

Phrase: "somatic mutations in the rearranged VH genes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   757   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   748   C2986476:Somatic [Qualitative Concept]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "over long periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.200: As expected from the results of the ICOS-deficient mice (31, 32, 35), administration of anti-ICOS mAb at the onset of GC formation (at day 5 post-immunization) caused a five- to six-time reduction in GC response at day 10 post-immunization, compared with the level of the control mice (P = 0.0004), whereas it did not affect the accumulation of somatic mutations and subsequent affinity maturation in GC B cells. 

Phrase: "As"

Phrase: "expected from the results of the ICOS-deficient mice"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   756   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0011155:Deficient [Functional Concept]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0175727:Stimulator [Medical Device]
   738   C0205263:Inducible [Functional Concept]
   738   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1517001:Expected [Idea or Concept]
   738   C1636779:% deficient [Quantitative Concept]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32,"

Phrase: "35"

Phrase: ")"

Phrase: ","

Phrase: "administration of anti-ICOS mAb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "("

Phrase: "at day 5 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: ")"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a five-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "to six-time reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0301630:Reduction [Natural Phenomenon or Process]
   827   C0392756:Reduction [Qualitative Concept]
   827   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in GC response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C0282491:Germinal Center [Tissue]

Phrase: "at day 10 post-immunization,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "compared with the level of the control mice"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0243148:control [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C1550141:Control [Substance]
   744   C1707455:Compared [Activity]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2946261:Level [Pharmacologic Substance]
   744   C3274648:Control [Qualitative Concept]

Phrase: "(P = 0.0004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the accumulation of somatic mutations"

Phrase: "and"

Phrase: "subsequent affinity maturation in GC B cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   808   C1817724:B cell affinity maturation [Biologic Function]
   750   C1516349:Cell Maturation [Cell Function]
   744   C0678723:Maturation [Organism Function]
   744   C0870861:maturation [Phenomenon or Process]
   744   C1254042:Maturation [Physiologic Function]
Processing 00000000.tx.201: ICOS manipulation caused a 2-fold reduction in the number of GC B cells relative to that of control mice at day 30 post-immunization (P = 0.048), in which the remaining GC B cells increased the number of mutations per VH genes and underwent affinity maturation, as efficiently as did control GC B cells. 

Phrase: "ICOS manipulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185111:Manipulation, NOS [Therapeutic or Preventive Procedure]
   812   C0947647:Manipulation [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 2-fold reduction in the number of GC B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0301630:Reduction [Natural Phenomenon or Process]
   736   C0392756:Reduction [Qualitative Concept]
   736   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "relative to that of control mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "at day 30 post-immunization"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]

Phrase: "(P = 0.048"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "the remaining GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0007634:Cells [Cell]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the number of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "per VH genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "underwent"

Phrase: "affinity maturation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "as"

Phrase: "efficiently"

Phrase: "as"

Phrase: "did"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "GC B cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.202: Given that GC B cells accumulate somatic mutations with proliferation (48), the results may imply that GC B cells may proliferate in ICOS-manipulated mice as efficiently as do GC B cells in control mice but give rise to fewer survivor cells at each round of proliferation. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "accumulate"

Phrase: "somatic mutations with proliferation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   770   C0026882:Mutations [Genetic Function]
   770   C2986476:Somatic [Qualitative Concept]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(48"

Phrase: ")"

Phrase: ","

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "may"

Phrase: "imply"

Phrase: "that GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "proliferate in ICOS-manipulated mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0175727:Stimulator [Medical Device]
   748   C0205263:Inducible [Functional Concept]
   748   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   714   C0947647:Manipulate [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "efficiently"

Phrase: "as"

Phrase: "do"

Phrase: "GC B cells in control mice"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0004561:B-Cells [Cell]
   778   C0282491:Germinal Center [Tissue]
   771   C1522109:Mouse B Cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0205099:Center [Spatial Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to fewer survivor cells"

Phrase: "at each round"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Round [Spatial Concept]

Phrase: "of proliferation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.203: ICOSICOS-L signaling causes T-cell proliferation and Th2 cytokine production, including IL-4, which may support GC B-cell development and survival (49, 50). 

Phrase: "ICOSICOS-L signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "T-cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155046:T-Cell Proliferation [Cell Function]
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C0039194:T-cell [Cell]

Phrase: "and"

Phrase: "Th2 cytokine production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1327413:cytokine production [Organism Function]
   827   C0033268:production [Occupational Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "IL-4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "which"

Phrase: "may"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "GC B-cell development"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C3155098:germinal center B cell development [Cell Function]
   884   C1511002:B-Cell Development [Cell Function]
   884   C3158362:B cell development [Cell Function]
   840   C0815089:cell development [Cell Function]
   804   C0243107:development [Physiologic Function]
   804   C0678723:Development [Organism Function]
   804   C1527148:Development [Functional Concept]
   733 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "(49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.204: Further analysis is needed to clarify this issue. 

Phrase: "Further analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "this issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.205: A high-affinity IgG response persists over a long period of post-immunization, as a result of the generation of long-lived IgG plasma cells by antigen-driven selection in GCs (51, 52). 

Phrase: "A high-affinity IgG response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "persists over a long period of post-immunization,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   744   C0042196:immunisation [Therapeutic or Preventive Procedure]
   744   C0205166:Long [Qualitative Concept]
   744   C0439531:/period [Temporal Concept]
   744   C0687676:Post [Temporal Concept]
   744   C1704687:Post [Manufactured Object]
   744   C1706317:Long [Qualitative Concept]
   744   C1948053:Period [Temporal Concept]
   744   C3244291:immunization [Functional Concept]

Phrase: "as"

Phrase: "a result of the generation of long-lived IgG plasma cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C2825142:Result [Finding]

Phrase: "by antigen-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "selection in GCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036576:selection [Genetic Function]

Phrase: "(51,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.206: In ICOS/ or ICOS-L/ mice, the IgG1 antibody response is diminished, although the level of the reduction varied depending on the antigens and adjuvants used for the immunization (31, 32). 

Phrase: "In ICOS/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0175727:Stimulator [Medical Device]
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "ICOS-L/ mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "the IgG1 antibody response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0003261:Antibody Response [Biologic Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C2754944:IgG1 antibody [Cell Component]

Phrase: "is"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: ","

Phrase: "although"

Phrase: "the level of the reduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "varied"

Phrase: "depending on the antigens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003320:Antigens [Immunologic Factor]
   737   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "adjuvants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   966   C0001552:Adjuvant [Chemical Viewed Functionally]
   966   C1522673:Adjuvant [Functional Concept]

Phrase: "used for the immunization"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   770   C0042196:immunisation [Therapeutic or Preventive Procedure]
   770   C1273517:used [Finding]
   770   C3244291:immunization [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.207: For example, immunization with NP-OVA in CFA caused only a marginal reduction in IgG1 antibody response in ICOS/ mice, whereas the response to keyhole limpet hemocyanin in IFA was profoundly reduced in the mutant animals (31). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "immunization with NP-OVA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   770   C0042196:immunisation [Therapeutic or Preventive Procedure]
   770   C3244291:immunization [Functional Concept]

Phrase: "in CFA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1003714:CFA [Virus]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a marginal reduction in IgG1 antibody response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in ICOS/ mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "whereas"

Phrase: "the response to keyhole limpet hemocyanin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "in IFA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0281643:IFA [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "profoundly"

Phrase: "reduced in the mutant animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003062:Animals [Animal]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.208: In this context, we observed that the administration of anti-ICOS mAb at the onset of GC formation had little effect, if any, on IgG antibody response in serum to NP-CG in alum, although it impaired the production of high-affinity antibodies by day 70 post-immunization. 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the administration of anti-ICOS mAb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0001554:Administration [Occupational Activity]
   744   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of GC formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "had"

Phrase: "little effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "if"

Phrase: "any,"

Phrase: "on IgG antibody response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0003261:Antibody Response [Biologic Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C2754943:IgG antibody [Cell Component]

Phrase: "in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "to NP-CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "in alum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051522:alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0137988:Alum [Inorganic Chemical,Pharmacologic Substance]
  1000   C0330887:Alum [Plant]

Phrase: "although"

Phrase: "it"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "the production of high-affinity antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0003261:antibodies production [Biologic Function]
   753   C0033268:production [Occupational Activity]

Phrase: "by day 70 post-immunization."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   812   C0042196:immunisation [Therapeutic or Preventive Procedure]
   812   C0687676:Post [Temporal Concept]
   812   C1704687:Post [Manufactured Object]
   812   C3244291:immunization [Functional Concept]
   741 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.209: High-affinity long-lived AFCs may arise early in the GC reaction (51). 

Phrase: "High-affinity long-lived AFCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0007634:Cells [Cell]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   795   C0205431:Forming [Functional Concept]
   795   C1522492:Forming [Functional Concept]
   795   C3282337:Cells [Cell]
   762 E C0348078:Form [Qualitative Concept]
   762 E C0376315:Form [Manufactured Object]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "arise"

Phrase: "early in the GC reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282491:Germinal Center [Tissue]
   783   C2755839:reaction center [Cell Component]
   753   C0205099:Center [Spatial Concept]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1279919:Early [Temporal Concept]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.210: Therefore, the reduced level of high-affinity IgG antibodies in the ICOS-manipulated mice may reflect a loss of precursors early in the response, as reflected by impairment of the GC reaction. 

Phrase: "Therefore,"

Phrase: "the reduced level of high-affinity IgG antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in the ICOS-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a loss of precursors early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "in the response,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "as"

Phrase: "reflected by impairment of the GC reaction."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0282491:Germinal Center [Tissue]
   767   C2755839:reaction center [Cell Component]
   744   C0205099:Center [Spatial Concept]
   744   C0443286:Reaction [Functional Concept]
   744   C0558058:reflected [Mental Process]
   744   C0684336:Impairment [Pathologic Function]
   744   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.211: If so, what is the origin of the long-lasting IgG antibodies in the sera of the ICOS-manipulated mice? 

Phrase: "If"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "what"

Phrase: "is"

Phrase: "the origin of the long-lasting IgG antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0079946:origin [Classification]
   744   C0439659:Origin [Temporal Concept]
   744   C1550512:origin [Intellectual Product]

Phrase: "in the sera"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0229671:Sera [Body Substance]
  1000   C1151254:SerA [Molecular Function]
   966 E C1546774:Serum [Intellectual Product]
   966 E C1550100:Serum [Body Substance]

Phrase: "of the ICOS-manipulated mice?"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.212: Considering the recent observation that high-affinity memory B cells may give rise to long-term AFCs (53), we propose that low-affinity memory B cells also give rise to long-lasting AFCs in the immune response. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the recent observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that high-affinity memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to long-term AFCs"

Phrase: "(53"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "propose"

Phrase: "that low-affinity memory B cells also"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C3554579:Low memory B cells [Finding]
   844   C0682638:Memory B Cell [Cell]
   839   C0312737:Memory cells [Cell]
   827   C0004561:B-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to long-lasting AFCs"

Phrase: "in the immune response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]
Processing 00000000.tx.213: Like ICOS-manipulated mice, Rag-1/ mice reconstituted with BM cells of Bcl-6-deficient mice (Bcl-6/ RM mice) produce serum IgG1 antibodies with low affinity in the primary response at a comparable level to that of littermate controls (22). 

Phrase: "Like ICOS-manipulated mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "Rag-1/ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "reconstituted with BM cells of Bcl-6-deficient mice"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C0248007:BCL-6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cells [Cell]
   742   C0011155:Deficient [Functional Concept]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C1636779:% deficient [Quantitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(Bcl-6/ RM mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: ")"

Phrase: "produce"

Phrase: "serum IgG1 antibodies with low affinity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C2754944:IgG1 antibody [Cell Component]
   767   C0003255:Antibody Affinity [Molecular Function]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in the primary response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "at a comparable level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "to that"

Phrase: "of littermate controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.214: Although the response in Bcl-6/ RM mice terminates by unknown reasons at day 70 post-immunization, earlier than in control mice or ICOS-manipulated mice, Bcl-6/ RM mice and ICOS-manipulated mice have a common feature in the generation and persistence of low-affinity IgG1 memory cells and antibodies in the primary response. 

Phrase: "Although"

Phrase: "the response in Bcl-6/ RM mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "terminates by unknown reasons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392360:reasons [Idea or Concept]
   770   C0439673:Unknown [Qualitative Concept]
   715   C0011065:Expired [Organism Function]
   715   C0231800:Expired [Organ or Tissue Function]
   715   C1704631:Expire [Idea or Concept]

Phrase: "at day 70 post-immunization, earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1279919:Early [Temporal Concept]

Phrase: "than"

Phrase: "in control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "ICOS-manipulated mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "Bcl-6/ RM mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "ICOS-manipulated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "a common feature in the generation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "persistence of low-affinity IgG1 memory cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0546816:Persistence [Mental Process]
   738   C1882350:Persistent Memory [Manufactured Object]

Phrase: "and"

Phrase: "antibodies in the primary response."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0003261:antibodies response [Biologic Function]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.215: Therefore, it is worthwhile to analyze whether or not low-affinity memory cells progress to long-lasting low-affinity AFCs in the immune response. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "worthwhile to"

Phrase: "analyze"

Phrase: "whether"

Phrase: "or"

Phrase: "not low-affinity memory cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   840   C0312737:Memory cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0025260:Memory [Mental Process]
   804   C0700327:memory [Finding]
   804   C1706377:Memory [Manufactured Object]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C0679055:mnemonic [Mental Process]

Phrase: "progress to long-lasting low-affinity AFCs"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   762   C0003255:Antibody Affinity [Molecular Function]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0007634:Cells [Cell]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0205166:Long [Qualitative Concept]
   742   C0205251:low [Qualitative Concept]
   742   C0205431:Forming [Functional Concept]
   742   C1272688:progress [Functional Concept]
   742   C1280477:Progress [Functional Concept]
   742   C1299352:Low [Qualitative Concept]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C1522492:Forming [Functional Concept]
   742   C1550472:low [Idea or Concept]
   742   C1706317:Long [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C0348078:Form [Qualitative Concept]
   708 E C0376315:Form [Manufactured Object]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "in the immune response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]
Processing 00000000.tx.216: In summary, our studies shed light on the cellular dynamics of the memory B-cell response emphasizing that there are two waves of memory B-cell generation within a limited period in the primary immune response, associated with or without a GC reaction, resulting in the construction of the memory compartment by low- and high-affinity cells. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "shed"

Phrase: "light on the cellular dynamics of the memory B-cell response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C1517881:Light Cell [Cell]
   754   C2945741:light response [Organism Function]
   738   C0023693:Light [Natural Phenomenon or Process]
   738   C1306462:Light [Functional Concept]
   738   C1881376:Light [Qualitative Concept]

Phrase: "emphasizing"

Phrase: "that there"

Phrase: "are"

Phrase: "two waves of memory B-cell generation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0678544:waves [Natural Phenomenon or Process]
   714 E C1421479:WAVE [Gene or Genome]

Phrase: "within a limited period"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0332186:Limited period [Temporal Concept]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "in the primary immune response,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0301875:Primary immune response [Organism Function]
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "associated with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C0750490:Associate [Idea or Concept]
   799 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or without a GC reaction,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0282491:Germinal Center [Tissue]
   783   C2755839:reaction center [Cell Component]
   753   C0205099:Center [Spatial Concept]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]

Phrase: "resulting in the construction of the memory compartment"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0332294:Resulting in [Functional Concept]
   744   C0025260:Memory [Mental Process]
   744   C0441513:Construction [Therapeutic or Preventive Procedure]
   744   C0678226:resulting [Functional Concept]
   744   C0700327:memory [Finding]
   744   C1185625:Compartment [Body Space or Junction]
   744   C1706377:Memory [Manufactured Object]
   744   C2986730:Compartment [Spatial Concept]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "by low-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "high-affinity cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.217: They are functionally intact, retain longevity and give rise to a prompt secondary immune response. 

Phrase: "They"

Phrase: "are"

Phrase: "functionally intact,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205266:Intact [Qualitative Concept]
   861   C1554187:Intact [Idea or Concept]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "longevity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023980:Longevity [Temporal Concept]

Phrase: "and"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to a prompt secondary immune response."
Processing 00000000.tx.218: Whether these two waves of memory B-cell generation reflect the different developmental pathways of low- and high-affinity memory B cells or the conversion from low- to high-affinity memory B cells remains to be elucidated.  

Phrase: "Whether"

Phrase: "these two waves of memory B-cell generation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0678544:waves [Natural Phenomenon or Process]
   711 E C1421479:WAVE [Gene or Genome]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the different developmental pathways of low-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "high-affinity memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "the conversion from low-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439836:Conversion [Functional Concept]

Phrase: "to high-affinity memory B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.219: Acknowledgements  We thank JT Pharmaceutical Frontier Research Laboratories, Inc. 

Phrase: "Acknowledgements"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "JT Pharmaceutical Frontier Research Laboratories,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0022886:research laboratory [Research Activity]
   804   C0022877:Laboratories [Manufactured Object,Organization]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1619828:Laboratories [Intellectual Product]
   771 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."
Processing 00000000.tx.220: (Kanagawa, Japan) for kindly providing anti-ICOS/AILIM mAb and Hideo Yagita at Juntendo University for discussion. 

Phrase: "(Kanagawa,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "for kindly"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "anti-ICOS/AILIM mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Hideo Yagita at Juntendo University"

Phrase: "for discussion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.221: We also thank Miyashita, Y. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Miyashita,"

Phrase: "Y."
Processing 00000000.tx.222: Nakano and E. 

Phrase: "Nakano"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.223: Watanabe at National Institute of Infectious Diseases for their technical help. 

Phrase: "Watanabe at National Institute of Infectious Diseases"

Phrase: "for their technical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449851:Technical [Functional Concept]

Phrase: "help."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]
Processing 00000000.tx.224: This work was supported by a Special Coordination Fund for Promoting Science and Technology and by the Ministry of Education, Culture, Sports, Science and Technology, Japan.  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a Special Coordination Fund"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0016820:Fund [Quantitative Concept]
   753   C0205555:Special [Qualitative Concept]
   753   C0242414:Coordination [Physiologic Function]
   753   C0700114:Coordination [Functional Concept]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]

Phrase: "for Promoting Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "and by the Ministry of Education,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0013621:Education [Educational Activity]
   753   C0013622:education [Classification]
   753   C0013658:Education, NOS [Finding]
   753   C0039401:Education [Educational Activity]
   753   C1515981:And [Idea or Concept]

Phrase: "Culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.225: Abbreviations  AFC antibody-forming cell AILIM activation-inducible lymphocyte immunomodulatory anti-B220APC APC-conjugated anti-B220 APC allophycocyania BCR B cell receptor BLC B Lymphocyte chemoattractant BMs bone marrows CG chicken gamma globulin ELISPOT enzyme-linked immunospot GC germinal center ICOS inducible co-stimulator IFA incomplete Freund's adjuvant i.p. intra-peritoneally NIP (4-hydroxy-5-iodo-3-nitrophenyl) acetyl NIP-bdg NIP-binding NIP-BSAPE PE-conjugated NIP-BSA NP (4-hydroxy-3-nitrophenyl) acetyl OVA ovalbumin PALS periarteriolar lymphocytic sheath PNA peanut agglutinin PNAFITC FITC-coupled peanut agglutinin SLC/ELC secondary lymphoid chemokine/EBV-induced molecule 1 ligand chemokine TC Tricolor WT wild type  Notes  Transmitting editor: T. 

Phrase: "Abbreviations  AFC antibody-forming cell AILIM activation-inducible lymphocyte immunomodulatory anti-B220APC APC-conjugated anti-B220 APC allophycocyania BCR B cell receptor BLC B Lymphocyte chemoattractant BMs bone marrows CG chicken gamma globulin ELISPOT enzyme-linked immunospot GC germinal center ICOS inducible co-stimulator IFA incomplete Freund's adjuvant i.p. intra-peritoneally NIP (4-hydroxy-5-iodo-3-nitrophenyl"

Phrase: ")"

Phrase: "acetyl NIP-bdg NIP-binding NIP-BSAPE PE-conjugated NIP-BSA NP (4-hydroxy-3-nitrophenyl"

Phrase: ")"

Phrase: "acetyl OVA ovalbumin PALS periarteriolar lymphocytic sheath PNA peanut agglutinin PNAFITC FITC-coupled peanut agglutinin SLC/ELC secondary lymphoid chemokine/EBV-induced molecule 1 ligand chemokine TC Tricolor WT wild type"

Phrase: "Notes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Transmitting editor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707883:Editor [Occupation or Discipline]

Phrase: ":"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.226: Watanabe Received 10 September 2004, accepted 15 February 2005.  

Phrase: "Watanabe"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "10 September 2004,"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "15 February 2005."
Processing 00000000.tx.227: References Top Abstract Introduction Methods Results Discussion References  Cyster, J. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cyster,"

Phrase: "J."
Processing 00000000.tx.228: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.229: 1999. 

Phrase: "1999."
Processing 00000000.tx.230: Chemokines and cell migration in secondary lymphoid organs. 

Phrase: "Chemokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "cell migration in secondary lymphoid organs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1622501:Migration, Cell [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.231: Science 286:2098.[Abstract/Free FullText] Legler, D. 

Phrase: "Science 286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "2098."

Phrase: "[Abstract/Free FullText"

Phrase: "] Legler,"

Phrase: "D."
Processing 00000000.tx.232: F., Loetscher, M., Roos, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Loetscher,"

Phrase: "M."

Phrase: ","

Phrase: "Roos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.233: S. et al. 

Phrase: "S. et al."
Processing 00000000.tx.234: 1998. 

Phrase: "1998."
Processing 00000000.tx.235: B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. 

Phrase: "B cell-attracting chemokine 1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963811:B Cell-Attracting Chemokine 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366572:B CELL-ATTRACTING CHEMOKINE 1 [Gene or Genome]
   840   C0004561:B-cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "a human CXC chemokine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0282553:CxC chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "expressed in lymphoid tissues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0024296:Tissues, Lymphoid [Tissue]
   770   C0040300:Tissues [Tissue]
   770   C1518071:Lymphoid [Qualitative Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "selectively"

Phrase: "attracts"

Phrase: "B lymphocytes via BLR1/CXCR5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0004561:B-Lymphocytes [Cell]
   760   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.236: J. 

Phrase: "J."
Processing 00000000.tx.237: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.238: Med. 

Phrase: "Med."
Processing 00000000.tx.239: 187:655.[Abstract/Free FullText] Gunn, M. 

Phrase: "187"

Phrase: ":"

Phrase: "655."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gunn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.240: D., Ngo, V. 

Phrase: "D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diversity [Qualitative Concept]

Phrase: "Ngo,"

Phrase: "V."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]
Processing 00000000.tx.241: N., Ansel, K. 

Phrase: "N., Ansel,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.242: M. et al. 

Phrase: "M. et al."
Processing 00000000.tx.243: 1998. 

Phrase: "1998."
Processing 00000000.tx.244: A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. 

Phrase: "A B-cell-homing chemokine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963811:B-Cell-Homing Chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "made in lymphoid follicles"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   816   C0229654:Lymphoid follicle [Body Part, Organ, or Organ Component]
   770   C0018120:Follicles [Body Part, Organ, or Organ Component]
   770   C0221971:Follicles [Body Part, Organ, or Organ Component]
   770   C1518071:Lymphoid [Qualitative Concept]
   737 E C1571705:Follicle [Body Part, Organ, or Organ Component]
   737   C1881534:Make [Functional Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Burkitt's lymphoma receptor-1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1332421:BURKITT LYMPHOMA RECEPTOR 1 [Gene or Genome]
  1000   C2756976:Burkitt Lymphoma Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
   861   C0006413:Burkitt Lymphoma [Neoplastic Process]
   812   C0024299:Lymphoma [Neoplastic Process]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.245: Nature 391:799.[CrossRef][ISI][Medline] Luther, S. 

Phrase: "Nature 391"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "799."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Luther,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.246: A., Lopez, T., Bai, W., Hanahan, D. and Cyster, J. 

Phrase: "A.,"

Phrase: "Lopez,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234880:bai [Individual Behavior]

Phrase: "W.,"

Phrase: "Hanahan,"

Phrase: "D."

Phrase: "and"

Phrase: "Cyster,"

Phrase: "J."
Processing 00000000.tx.247: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.248: 2000. 

Phrase: "2000."
Processing 00000000.tx.249: BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. 

Phrase: "BLC expression in pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "B cell recruitment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2949735:Recruitment [Activity]
   734   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "lymphotoxin-dependent lymphoid neogenesis."
Processing 00000000.tx.250: Immunity 12:471.[CrossRef][ISI][Medline] Reif, K., Ekland, E. 

Phrase: "Immunity 12"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "471."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reif,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ekland,"

Phrase: "E."
Processing 00000000.tx.251: H., Ohl, L. et al. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ohl,"

Phrase: "L. et al."
Processing 00000000.tx.252: 2002. 

Phrase: "2002."
Processing 00000000.tx.253: Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. 

Phrase: "Balanced responsiveness to chemoattractants"

Phrase: "from adjacent zones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1710706:Zone [Spatial Concept]
   777 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]

Phrase: "determines"

Phrase: "B-cell position."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0733755:Position [Spatial Concept]
   755 E C0240795:POSITIONAL [Finding]
   734   C0004561:B-cell [Cell]
Processing 00000000.tx.254: Nature 416:94.[CrossRef][ISI][Medline] Ngo, V. 

Phrase: "Nature 416"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "94."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ngo,"

Phrase: "V."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]
Processing 00000000.tx.255: N., Tang, H. 

Phrase: "N., Tang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.256: L. and Cyster, J. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Cyster,"

Phrase: "J."
Processing 00000000.tx.257: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.258: 1998. 

Phrase: "1998."
Processing 00000000.tx.259: Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. 

Phrase: "Epstein-Barr virus-induced molecule 1 ligand chemokine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0539791:Epstein-Barr Virus-Induced Molecule 1 Ligand Chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "expressed by dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0011306:Dendritic Cells [Cell]
   799 E C0003315:Dendritic cell [Cell]
   799 E C1511762:Dendritic Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0011305:Dendritic [Cell Component]
   770   C0439640:Dendritic [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in lymphoid tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0024296:Tissues, Lymphoid [Tissue]
   861   C0040300:Tissues [Tissue]
   861   C1518071:Lymphoid [Qualitative Concept]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "strongly"

Phrase: "attracts"

Phrase: "naive T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C3641721:Naive T Cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "activated B cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.260: J. 

Phrase: "J."
Processing 00000000.tx.261: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.262: Med. 

Phrase: "Med."
Processing 00000000.tx.263: 188:181.[Abstract/Free FullText] Yoshida, R., Nagira, M., Kitaura, M. et al. 

Phrase: "188"

Phrase: ":"

Phrase: "181."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yoshida,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Nagira,"

Phrase: "M."

Phrase: ","

Phrase: "Kitaura,"

Phrase: "M. et al."
Processing 00000000.tx.264: 1998. 

Phrase: "1998."
Processing 00000000.tx.265: Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. 

Phrase: "Secondary lymphoid-tissue chemokine"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0670509:Secondary Lymphoid-Tissue Chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332684:SECONDARY LYMPHOID TISSUE CHEMOKINE [Gene or Genome]
  1000   C1523979:Secondary Lymphoid-Tissue Chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   923   C0282491:Secondary lymphoid tissue [Tissue]
   861   C0024296:Lymphoid Tissue [Tissue]
   812   C0027627:secondary [Neoplastic Process]
   812   C0040300:Tissue [Tissue]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1518071:Lymphoid [Qualitative Concept]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "a functional ligand for the CC chemokine receptor CCR7."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1751414:CCR7 chemokine receptor ligand [Molecular Function]
   784   C1149464:chemokine receptor ligand [Molecular Function]
   762   C1621296:receptor ligand [Molecular Function]
   742   C0023688:Ligand [Chemical]
Processing 00000000.tx.266: J. 

Phrase: "J."
Processing 00000000.tx.267: Biol. 

Phrase: "Biol."
Processing 00000000.tx.268: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.269: 273:7118.[Abstract/Free FullText] Baekkevold, E. 

Phrase: "273"

Phrase: ":"

Phrase: "7118."

Phrase: "[Abstract/Free FullText"

Phrase: "] Baekkevold,"

Phrase: "E."
Processing 00000000.tx.270: S., Yamanaka, T., Palframan, R. 

Phrase: "S."

Phrase: ","

Phrase: "Yamanaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Palframan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.271: T. et al. 

Phrase: "T. et al."
Processing 00000000.tx.272: 2001. 

Phrase: "2001."
Processing 00000000.tx.273: The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. 

Phrase: "The CCR7 ligand elc"

Phrase: "(CCL19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0539791:CCL19 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332682:CCL19 [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "transcytosed in high endothelial venules"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   828   C0596700:High Endothelial Venule [Body Part, Organ, or Organ Component]
   760   C0014257:Endothelial [Tissue]
   760   C0042520:Venules [Body Part, Organ, or Organ Component]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   745   C1179026:Venule endothelium [Tissue]
   726 E C1282854:Venule [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "T cell recruitment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2949735:Recruitment [Activity]
   734   C0039194:T-cell [Cell]
Processing 00000000.tx.274: J. 

Phrase: "J."
Processing 00000000.tx.275: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.276: Med. 

Phrase: "Med."
Processing 00000000.tx.277: 193:1105.[Abstract/Free FullText] Breitfeld, D., Ohl, L., Kremmer, E. et al. 

Phrase: "193"

Phrase: ":"

Phrase: "1105."

Phrase: "[Abstract/Free FullText"

Phrase: "] Breitfeld,"

Phrase: "D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diversity [Qualitative Concept]

Phrase: "Ohl,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kremmer,"

Phrase: "E. et al."
Processing 00000000.tx.278: 2000. 

Phrase: "2000."
Processing 00000000.tx.279: Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. 

Phrase: "Follicular B helper T cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   884   C0018894:Helper T-Cells [Cell]
           Helper Cells
   840   C0039194:T-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "CXC chemokine receptor 5,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2756976:CXC Chemokine Receptor 5 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1955904:CXC Chemokine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0282553:CxC chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0524914:chemokine receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "localize to B cell follicles,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0004561:B-cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0018120:Follicles [Body Part, Organ, or Organ Component]
   760   C0221971:Follicles [Body Part, Organ, or Organ Component]
   760   C0392752:localize [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1571705:Follicle [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "support immunoglobulin production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003261:immunoglobulin production [Biologic Function]
   827   C0033268:production [Occupational Activity]
Processing 00000000.tx.280: J. 

Phrase: "J."
Processing 00000000.tx.281: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.282: Med. 

Phrase: "Med."
Processing 00000000.tx.283: 192:1545.[Abstract/Free FullText] Schaerli, P., Willimann, K., Lang, A. 

Phrase: "192"

Phrase: ":"

Phrase: "1545."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schaerli,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Willimann,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lang,"

Phrase: "A."
Processing 00000000.tx.284: B. et al. 

Phrase: "B. et al."
Processing 00000000.tx.285: 2000. 

Phrase: "2000."
Processing 00000000.tx.286: CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. 

Phrase: "CXC chemokine receptor 5 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0597360:receptor expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C2756976:CXC Chemokine Receptor 5 [Amino Acid, Peptide, or Protein,Receptor]
   717   C1955904:CXC Chemokine Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "defines"

Phrase: "follicular homing T cells with B cell helper function."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C3656689:B cell+T cell [Cell]
   784   C0018894:Helper T-Cells [Cell]
           Helper Cells
   764   C0039194:T-Cells [Cell]
   762   C0007613:cells function [Cell Function]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.287: J. 

Phrase: "J."
Processing 00000000.tx.288: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.289: Med. 

Phrase: "Med."
Processing 00000000.tx.290: 192:1553.[Abstract/Free FullText] Garside, P., Ingulli, E., Merica, R. 

Phrase: "192"

Phrase: ":"

Phrase: "1553."

Phrase: "[Abstract/Free FullText"

Phrase: "] Garside,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ingulli,"

Phrase: "E.,"

Phrase: "Merica,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3085819:Merica [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.291: R. et al. 

Phrase: "R. et al."
Processing 00000000.tx.292: 1998. 

Phrase: "1998."
Processing 00000000.tx.293: Visualization of specific B and T lymphocyte interactions in the lymph node. 

Phrase: "Visualization of specific B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0175631:Visualization [Mental Process]
   770   C2827662:Visualization [Occupation or Discipline]

Phrase: "and"

Phrase: "T lymphocyte interactions in the lymph node."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.294: Science 281:96.[Abstract/Free FullText] June, C. 

Phrase: "Science 281"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "96."

Phrase: "[Abstract/Free FullText"

Phrase: "] June,"

Phrase: "C."
Processing 00000000.tx.295: H., Ledbetter, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ledbetter,"

Phrase: "J."
Processing 00000000.tx.296: A., Linsley, P. 

Phrase: "A.,"

Phrase: "Linsley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.297: S. and Thompson, C. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Thompson,"

Phrase: "C."
Processing 00000000.tx.298: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.299: 1990. 

Phrase: "1990."
Processing 00000000.tx.300: Role of the CD28 receptor in T-cell activation. 

Phrase: "Role of the CD28 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in T-cell activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1155065:T-Cell Activation [Cell Function]
   901   C1326120:cell activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0039194:T-cell [Cell]
Processing 00000000.tx.301: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.302: Today 11:211.[CrossRef][ISI][Medline] June, C. 

Phrase: "Today 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0310367:Today [Antibiotic,Organic Chemical]
   861   C0750526:Today [Temporal Concept]

Phrase: ":"

Phrase: "211."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] June,"

Phrase: "C."
Processing 00000000.tx.303: H., Bluestone, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bluestone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0056301:Bluestone [Inorganic Chemical,Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.304: A., Nadler, L. 

Phrase: "A.,"

Phrase: "Nadler,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.305: M. and Thompson, C. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Thompson,"

Phrase: "C."
Processing 00000000.tx.306: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.307: 1994. 

Phrase: "1994."
Processing 00000000.tx.308: The B7 and CD28 receptor families. 

Phrase: "The B7"

Phrase: "and"

Phrase: "CD28 receptor families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.309: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.310: Today 15:321.[CrossRef][ISI][Medline] Yoshinaga, S. 

Phrase: "Today 15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0310367:Today [Antibiotic,Organic Chemical]
   861   C0750526:Today [Temporal Concept]

Phrase: ":"

Phrase: "321."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yoshinaga,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.311: K., Whoriskey, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Whoriskey,"

Phrase: "J."
Processing 00000000.tx.312: S., Khare, S. 

Phrase: "S."

Phrase: ","

Phrase: "Khare,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.313: D. et al. 

Phrase: "D. et al."
Processing 00000000.tx.314: 1999. 

Phrase: "1999."
Processing 00000000.tx.315: T-cell co-stimulation through B7RP-1 and ICOS. 

Phrase: "T-cell co-stimulation through B7RP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1622572:T-cell co-stimulation [Cell Function]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "ICOS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0175727:Stimulator [Medical Device]
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.316: Nature 402:827.[CrossRef][ISI][Medline] Brodie, D., Collins, A. 

Phrase: "Nature 402"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "827."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brodie,"

Phrase: "D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diversity [Qualitative Concept]

Phrase: "Collins,"

Phrase: "A."
Processing 00000000.tx.317: V., Iaboni, A. et al. 

Phrase: "V.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]

Phrase: "Iaboni,"

Phrase: "A. et al."
Processing 00000000.tx.318: 2000. 

Phrase: "2000."
Processing 00000000.tx.319: LICOS, a primordial costimulatory ligand? 

Phrase: "LICOS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424734:LICOS [Gene or Genome]

Phrase: "a primordial costimulatory ligand?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligand [Chemical]
Processing 00000000.tx.320: Curr. 

Phrase: "Curr."
Processing 00000000.tx.321: Biol. 

Phrase: "Biol."
Processing 00000000.tx.322: 10:333.[CrossRef][ISI][Medline] Hutloff, A., Dittrich, A. 

Phrase: "10"

Phrase: ":"

Phrase: "333."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hutloff,"

Phrase: "A.,"

Phrase: "Dittrich,"

Phrase: "A."
Processing 00000000.tx.323: M., Beier, K. 

Phrase: "M."

Phrase: ","

Phrase: "Beier,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.324: C. et al. 

Phrase: "C. et al."
Processing 00000000.tx.325: 1999. 

Phrase: "1999."
Processing 00000000.tx.326: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. 

Phrase: "ICOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0175727:Stimulator [Medical Device]
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an inducible T-cell co-stimulator structurally"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   947   C1415846:inducible T-cell co-stimulator [Gene or Genome]
   947   C3203085:Inducible T-Cell Co-Stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0175727:Stimulator [Medical Device]

Phrase: "and"

Phrase: "functionally"

Phrase: "related to CD28."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.327: Nature 397:263.[CrossRef][ISI][Medline] Banchereau, J., Bazan, F., Blanchard, D. et al. 

Phrase: "Nature 397"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "263."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Banchereau,"

Phrase: "J.,"

Phrase: "Bazan,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Blanchard,"

Phrase: "D. et al."
Processing 00000000.tx.328: 1994. 

Phrase: "1994."
Processing 00000000.tx.329: The CD40 antigen and its ligand. 

Phrase: "The CD40 antigen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0054959:CD40 Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1539081:CD40 ANTIGEN [Gene or Genome]
   861   C0003320:Antigen [Immunologic Factor]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "and"

Phrase: "its ligand."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]
Processing 00000000.tx.330: Annu. 

Phrase: "Annu."
Processing 00000000.tx.331: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.332: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.333: 12:881.[CrossRef][ISI][Medline] Le Hir, M. and Eugster, H. 

Phrase: "12"

Phrase: ":"

Phrase: "881."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Le Hir,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416586:HIR [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Eugster,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.334: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.335: 1997. 

Phrase: "1997."
Processing 00000000.tx.336: Absence of follicular dendritic cells (FDC) in mutant mice with deficient TNF/lymphotoxin (LT) signaling. 

Phrase: "Absence of follicular dendritic cells (FDC)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "with deficient TNF/lymphotoxin (LT) signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]
Processing 00000000.tx.337: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.338: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.339: Med. 

Phrase: "Med."
Processing 00000000.tx.340: Biol. 

Phrase: "Biol."
Processing 00000000.tx.341: 417:487.[ISI][Medline] Matsumoto, M., Fu, Y. 

Phrase: "417"

Phrase: ":"

Phrase: "487."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matsumoto,"

Phrase: "M."

Phrase: ","

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.342: X., Molina, H. and Chaplin, D. 

Phrase: "X.,"

Phrase: "Molina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1915092:Molina [Eukaryote]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Chaplin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0684011:chaplin [Professional or Occupational Group]

Phrase: "D."
Processing 00000000.tx.343: D. 

Phrase: "D."
Processing 00000000.tx.344: 1997. 

Phrase: "1997."
Processing 00000000.tx.345: Lymphotoxin-alpha-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. 

Phrase: "Lymphotoxin-alpha-deficient"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0011155:Deficient [Functional Concept]
   827   C1636779:% deficient [Quantitative Concept]
   734   C0024320:Lymphotoxin-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C0812308:LYMPHOTOXIN-ALPHA [Gene or Genome]
   734   C1527150:Lymphotoxin-Alpha [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "TNF receptor-I-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "define"

Phrase: "developmental"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0458003:Developmental [Qualitative Concept]
  1000   C0678723:Developmental [Organism Function]
   928 E C0243107:development [Physiologic Function]
   928 E C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "functional characteristics of germinal centers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.346: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.347: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.348: 156:137.[ISI][Medline] Muramatsu, M., Kinoshita, K., Fagarasan, S. et al. 

Phrase: "156"

Phrase: ":"

Phrase: "137."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Muramatsu,"

Phrase: "M."

Phrase: ","

Phrase: "Kinoshita,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fagarasan,"

Phrase: "S. et al."
Processing 00000000.tx.349: 2000. 

Phrase: "2000."
Processing 00000000.tx.350: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. 

Phrase: "Class switch recombination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206071:class switch recombination [Genetic Function]
   901   C1512667:Switch Recombination [Genetic Function]
   827   C0034865:Recombination [Genetic Function]

Phrase: "and"

Phrase: "hypermutation"

Phrase: "require"

Phrase: "activation-induced cytidine deaminase (AID),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1421876:ACTIVATION-INDUCED CYTIDINE DEAMINASE [Gene or Genome]
  1000   C3538973:Activation-Induced Cytidine Deaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010723:Cytidine Deaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1413247:CYTIDINE DEAMINASE [Gene or Genome]
   812   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a potential RNA editing enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.351: Cell 102:553.[CrossRef][ISI][Medline] Takahashi, Y., Ohta, H. and Takemori. 

Phrase: "Cell 102"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "553."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Takahashi,"

Phrase: "Y.,"

Phrase: "Ohta,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Takemori."
Processing 00000000.tx.352: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.353: 2001. 

Phrase: "2001."
Processing 00000000.tx.354: Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. 

Phrase: "Fas"

Phrase: "is"

Phrase: "required for clonal selection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0036576:selection [Genetic Function]
   770   C1514873:Required [Functional Concept]
   770   C1522642:Clonal [Tissue]
   770   C1704387:Clonal [Qualitative Concept]

Phrase: "in germinal centers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Centers [Tissue]
   861   C0205099:centers [Spatial Concept]

Phrase: "and"

Phrase: "the subsequent establishment of the memory B cell repertoire."
Processing 00000000.tx.355: Immunity 14:181.[ISI][Medline] Toyama, H., Okada, S., Hatano, M. et al. 

Phrase: "Immunity 14"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "181."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Toyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Okada,"

Phrase: "S."

Phrase: ","

Phrase: "Hatano,"

Phrase: "M. et al."
Processing 00000000.tx.356: 2002. 

Phrase: "2002."
Processing 00000000.tx.357: Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells. 

Phrase: "Memory B cells without somatic hypermutation"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   820   C0682638:b cells memory [Cell]
   790   C0004561:B-Cells [Cell]
   783   C0312737:Memory cells [Cell]
   783   C1257909:Somatic cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   720 E C0599444:Cell soma [Cell Component]
   720 E C2752549:cell soma [Cell Component]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "generated from Bcl6-deficient B cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0004561:B-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0011155:Deficient [Functional Concept]
   753   C0248007:BCL-6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1636779:% deficient [Quantitative Concept]
   753   C3146294:Generated [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.358: Immunity 17:329.[CrossRef][ISI][Medline] Driver, D. 

Phrase: "Immunity 17"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "329."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Driver,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684312:driver [Population Group]
  1000   C1556026:Driver [Professional or Occupational Group]
  1000   C1705366:Driver [Medical Device]

Phrase: "D."
Processing 00000000.tx.359: J., McHeyzer-Williams, L. 

Phrase: "J.,"

Phrase: "McHeyzer-Williams,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.360: J., Cool, M., Stetson, D. 

Phrase: "J.,"

Phrase: "Cool,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548792:Cool [Qualitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Stetson,"

Phrase: "D."
Processing 00000000.tx.361: B. and McHeyzer-Williams, M. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "McHeyzer-Williams,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.362: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.363: 2001. 

Phrase: "2001."
Processing 00000000.tx.364: Development and maintenance of a B220-memory B cell compartment. 

Phrase: "Development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "maintenance of a B220-memory B cell compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1516348:Cell Maintenance [Cell Function]
   744   C0024501:Maintenance [Activity]
Processing 00000000.tx.365: J. 

Phrase: "J."
Processing 00000000.tx.366: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.367: 167:1393.2 Dal Porto, J. 

Phrase: "167"

Phrase: ":"

Phrase: "1393.2 Dal Porto,"

Phrase: "J."
Processing 00000000.tx.368: M., Haberman, A. 

Phrase: "M."

Phrase: ","

Phrase: "Haberman,"

Phrase: "A."
Processing 00000000.tx.369: M., Kelsoe, G. and Shlomchik, M. 

Phrase: "M."

Phrase: ","

Phrase: "Kelsoe,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Shlomchik,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.370: J. 

Phrase: "J."
Processing 00000000.tx.371: 2002. 

Phrase: "2002."
Processing 00000000.tx.372: Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced. 

Phrase: "Very low affinity B cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   924   C1863714:Very low B cells [Finding]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "germinal centers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Centers [Tissue]
   861   C0205099:centers [Spatial Concept]

Phrase: "become"

Phrase: "memory B cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "participate in secondary immune responses"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   828   C0021055:Secondary immune response [Organ or Tissue Function]
   806   C0301872:immune responses [Organ or Tissue Function]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C0439662:Immune [Functional Concept]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "when"

Phrase: "higher affinity competition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679932:competition [Social Behavior]

Phrase: "is"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.373: J. 

Phrase: "J."
Processing 00000000.tx.374: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.375: Med. 

Phrase: "Med."
Processing 00000000.tx.376: 195:1215.[Abstract/Free FullText] Kawabe, T., Naka, T., Yoshida, K. et al. 

Phrase: "195"

Phrase: ":"

Phrase: "1215."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kawabe,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Naka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yoshida,"

Phrase: "K. et al."
Processing 00000000.tx.377: 1994. 

Phrase: "1994."
Processing 00000000.tx.378: The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. 

Phrase: "The immune responses in CD40-deficient mice"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   778   C0301872:immune responses [Organ or Tissue Function]
   748   C0439662:Immune [Functional Concept]
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: ":"

Phrase: "impaired immunoglobulin class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456387:Class [Intellectual Product]
   827   C1705943:Class [Classification]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "and"

Phrase: "germinal center formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]
Processing 00000000.tx.379: Immunity 1:167.[CrossRef][ISI][Medline] Xu, J., Foy, T. 

Phrase: "Immunity 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "167."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xu,"

Phrase: "J.,"

Phrase: "Foy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086325:Foy [Organic Chemical,Pharmacologic Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.380: M., Laman, J. 

Phrase: "M."

Phrase: ","

Phrase: "Laman,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0283775:LAMAN [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1416997:LAMAN [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.381: D. et al. 

Phrase: "D. et al."
Processing 00000000.tx.382: 1994. 

Phrase: "1994."
Processing 00000000.tx.383: Mice deficient for the CD40 ligand. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "deficient for the CD40 ligand."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011155:Deficient [Functional Concept]
   760   C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.384: Immunity 1:423.[CrossRef][ISI][Medline] Allen, R. 

Phrase: "Immunity 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "423."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Allen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.385: C., Armitage, R. 

Phrase: "C., Armitage,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.386: J., Conley, M. 

Phrase: "J.,"

Phrase: "Conley,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.387: E. et al. 

Phrase: "E. et al."
Processing 00000000.tx.388: 1993. 

Phrase: "1993."
Processing 00000000.tx.389: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. 

Phrase: "CD40 ligand gene defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0243067:defects [Functional Concept]
   779 E C1457869:Defect [Functional Concept]
   779 E C1861101:DEFECT [Disease or Syndrome]
   708   C1539081:CD40 gene [Gene or Genome]

Phrase: "responsible for X-linked hyper-IgM syndrome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1273518:Responsible [Finding]
   731   C0398689:X-Linked Hyper IgM Syndrome [Disease or Syndrome]
Processing 00000000.tx.390: Science 259:990.[ISI][Medline] Linsley, P. 

Phrase: "Science 259"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "990."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Linsley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.391: S. and Ledbetter, J. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Ledbetter,"

Phrase: "J."
Processing 00000000.tx.392: A. 

Phrase: "A."
Processing 00000000.tx.393: 1993. 

Phrase: "1993."
Processing 00000000.tx.394: The role of the CD28 receptor during T cell responses to antigen. 

Phrase: "The role of the CD28 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "during T cell responses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]
   734   C0039194:T-cell [Cell]

Phrase: "to antigen."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.395: Annu. 

Phrase: "Annu."
Processing 00000000.tx.396: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.397: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.398: 11:191.[CrossRef][ISI][Medline] Borriello, F., Sethna, M. 

Phrase: "11"

Phrase: ":"

Phrase: "191."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Borriello,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sethna,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.399: P., Boyd, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Boyd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347048:Boyd [Intellectual Product]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.400: D. et al. 

Phrase: "D. et al."
Processing 00000000.tx.401: 1997. 

Phrase: "1997."
Processing 00000000.tx.402: B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. 

Phrase: "B7-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366561:B7-1 [Gene or Genome]
  1000   C1705431:B7-1 [Gene or Genome]

Phrase: "and"

Phrase: "B7-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413243:B7-2 [Gene or Genome]
  1000   C2698599:B7-2 [Gene or Genome]

Phrase: "have"

Phrase: "overlapping, critical roles in immunoglobulin class"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "and"

Phrase: "germinal center formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817919:germinal center formation [Organism Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0282491:Germinal Center [Tissue]
Processing 00000000.tx.403: Immunity 6:303.[CrossRef][ISI][Medline] Dong, C., Temann, U. 

Phrase: "Immunity 6"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "303."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dong,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Temann,"

Phrase: "U."
Processing 00000000.tx.404: A. and Flavell, R. 

Phrase: "A."

Phrase: "and"

Phrase: "Flavell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.405: A. 

Phrase: "A."
Processing 00000000.tx.406: 2001. 

Phrase: "2001."
Processing 00000000.tx.407: Critical role of inducible costimulator in germinal center reactions. 

Phrase: "Critical role of inducible costimulator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in germinal center reactions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]
   734   C0282491:Germinal Center [Tissue]
Processing 00000000.tx.408: J. 

Phrase: "J."
Processing 00000000.tx.409: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.410: 166:3659.[Abstract/Free FullText] McAdam, A. 

Phrase: "166"

Phrase: ":"

Phrase: "3659."

Phrase: "[Abstract/Free FullText"

Phrase: "] McAdam,"

Phrase: "A."
Processing 00000000.tx.411: J., Greenwald, R. 

Phrase: "J.,"

Phrase: "Greenwald,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.412: A., Levin, M. 

Phrase: "A.,"

Phrase: "Levin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.413: A. et al. 

Phrase: "A. et al."
Processing 00000000.tx.414: 2001. 

Phrase: "2001."
Processing 00000000.tx.415: ICOS is critical for CD40-mediated antibody class switching. 

Phrase: "ICOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0175727:Stimulator [Medical Device]
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "critical for CD40-mediated antibody class"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511545:Critical [Qualitative Concept]

Phrase: "switching."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]
Processing 00000000.tx.416: Nature 409:102.[CrossRef][ISI][Medline] Tafuri, A., Shahinian, A., Bladt, F. et al. 

Phrase: "Nature 409"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "102."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tafuri,"

Phrase: "A.,"

Phrase: "Shahinian,"

Phrase: "A.,"

Phrase: "Bladt,"

Phrase: "F. et al."
Processing 00000000.tx.417: 2001. 

Phrase: "2001."
Processing 00000000.tx.418: ICOS is essential for effective T-helper-cell responses. 

Phrase: "ICOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0175727:Stimulator [Medical Device]
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "essential for effective T-helper-cell responses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.419: Nature 409:105.[CrossRef][ISI][Medline] Han, S., Hathcock, K., Zheng, B. et al. 

Phrase: "Nature 409"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "105."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S."

Phrase: ","

Phrase: "Hathcock,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "B. et al."
Processing 00000000.tx.420: 1995. 

Phrase: "1995."
Processing 00000000.tx.421: Cellular interaction in germinal centers. 

Phrase: "Cellular interaction in germinal centers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.422: Roles of CD40 ligand and B7-2 in established germinal centers. 

Phrase: "Roles of CD40 ligand"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "B7-2 in established germinal centers."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282491:Germinal Centers [Tissue]
   790   C1413243:B7-2 [Gene or Genome]
   790   C2698599:B7-2 [Gene or Genome]
   753   C0205099:centers [Spatial Concept]
   753   C0443211:Established [Qualitative Concept]
   753   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.423: J. 

Phrase: "J."
Processing 00000000.tx.424: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.425: 155:556.[Abstract] Coyle, A. 

Phrase: "155"

Phrase: ":"

Phrase: "556."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Coyle,"

Phrase: "A."
Processing 00000000.tx.426: J., Lehar, S., Lloyd, C. et al. 

Phrase: "J.,"

Phrase: "Lehar,"

Phrase: "S."

Phrase: ","

Phrase: "Lloyd,"

Phrase: "C. et al."
Processing 00000000.tx.427: 2000. 

Phrase: "2000."
Processing 00000000.tx.428: The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. 

Phrase: "The CD28-related molecule ICOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0175727:Stimulator [Medical Device]
   799   C0205263:Inducible [Functional Concept]
   799   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "required for effective T cell-dependent immune responses."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   770   C0039194:T-cell [Cell]
   770   C0301872:immune responses [Organ or Tissue Function]
   750   C2985857:Required Response [Idea or Concept]
   744   C0007634:Cell [Cell]
   744   C0439662:Immune [Functional Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C0871261:responses [Organism Attribute]
   744   C1269647:Cell [Cell]
   744   C1280519:effective [Qualitative Concept]
   744   C1514873:Required [Functional Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1704419:Effective [Qualitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C3244310:dependent [Functional Concept]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]
Processing 00000000.tx.429: Immunity 13:95.[CrossRef][ISI][Medline] Ogawa, S., Nagamatsu, G., Watanabe, M. et al. 

Phrase: "Immunity 13"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "95."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "S."

Phrase: ","

Phrase: "Nagamatsu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Watanabe,"

Phrase: "M. et al."
Processing 00000000.tx.430: 2001. 

Phrase: "2001."
Processing 00000000.tx.431: Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease. 

Phrase: "Opposing effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   893   C0003369:Anti lymphocyte antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Lymphocyte Antibody
   891   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   791   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "on the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of acute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205178:acute [Temporal Concept]

Phrase: "versus"

Phrase: "chronic graft-versus-host disease."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0867389:Chronic graft-versus-host disease [Disease or Syndrome]
   937   C0018133:Graft-Versus-Host Disease [Disease or Syndrome]
   937   C2984293:Graft-versus-host disease [Functional Concept]
   897   C0008679:Chronic disease [Disease or Syndrome]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0181074:{Graft} [Biomedical or Dental Material]
   804   C0332835:Graft [Tissue]
   804   C1167395:Host [Organism]
   804   C1961139:Graft, NOS [Therapeutic or Preventive Procedure]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.432: J. 

Phrase: "J."
Processing 00000000.tx.433: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.434: 167:5741.[Abstract/Free FullText] Mak, T. 

Phrase: "167"

Phrase: ":"

Phrase: "5741."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mak,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416988:MAK [Gene or Genome]
  1000   C1538267:MAK [Gene or Genome]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.435: W., Shahinian, A., Yoshinaga, S. 

Phrase: "W., Shahinian,"

Phrase: "A.,"

Phrase: "Yoshinaga,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.436: K. et al. 

Phrase: "K. et al."
Processing 00000000.tx.437: 2003. 

Phrase: "2003."
Processing 00000000.tx.438: Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. 

Phrase: "Costimulation through the inducible costimulator ligand"

Phrase: "is"

Phrase: "essential for both T helper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "B cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004561:B-cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "functions in T cell-dependent B cell responses."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   819   C3656689:B cell+T cell [Cell]
   770   C0004561:B-cell [Cell]
   770   C0039194:T-cell [Cell]
   767   C0007613:Cell Function [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C0851827:Dependent [Qualitative Concept]
   744   C0871261:responses [Organism Attribute]
   744   C1269647:Cell [Cell]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1705273:Function [Intellectual Product]
   744   C1948049:Cell [Spatial Concept]
   744   C3244310:dependent [Functional Concept]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]
Processing 00000000.tx.439: Nat. 

Phrase: "Nat."
Processing 00000000.tx.440: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.441: 4:765.[CrossRef][ISI][Medline] Shimoda, M., Nakamura, T., Takahashi, Y. et al. 

Phrase: "4"

Phrase: ":"

Phrase: "765."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimoda,"

Phrase: "M."

Phrase: ","

Phrase: "Nakamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takahashi,"

Phrase: "Y. et al."
Processing 00000000.tx.442: 2001. 

Phrase: "2001."
Processing 00000000.tx.443: Isotype-specific selection of high affinity memory B cells in nasal-associated lymphoid tissue. 

Phrase: "Isotype-specific selection of high affinity memory B cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1817719:B cell selection [Biologic Function]
   742   C0036576:selection [Genetic Function]

Phrase: "in nasal-associated lymphoid tissue."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C2698431:Nasal-Associated Lymphoid Tissue [Tissue]
   861   C0024296:Lymphoid Tissue [Tissue]
   812   C0028429:Nasal [Body Part, Organ, or Organ Component]
   812   C0040300:Tissue [Tissue]
   812   C0332281:Associated [Qualitative Concept]
   812   C1518071:Lymphoid [Qualitative Concept]
   812   C1547928:Tissue [Intellectual Product]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.444: J. 

Phrase: "J."
Processing 00000000.tx.445: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.446: Med. 

Phrase: "Med."
Processing 00000000.tx.447: 194:1597.[Abstract/Free FullText] Fukuda, T., Yoshida, T., Okada, S. et al. 

Phrase: "194"

Phrase: ":"

Phrase: "1597."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fukuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yoshida,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okada,"

Phrase: "S. et al."
Processing 00000000.tx.448: 1997. 

Phrase: "1997."
Processing 00000000.tx.449: Disruption of the Bcl6 gene results in an impaired germinal center formation. 

Phrase: "Disruption of the Bcl6 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "results in an impaired germinal center formation."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C1817919:germinal center formation [Organism Function]
   778   C0282491:Germinal Center [Tissue]
   748   C0205099:Center [Spatial Concept]
   748   C0220781:formation [Biologic Function]
   748   C0221099:Impaired [Functional Concept]
   748   C0439634:formation [Spatial Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C1274040:Result [Functional Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
Processing 00000000.tx.450: J. 

Phrase: "J."
Processing 00000000.tx.451: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.452: Med. 

Phrase: "Med."
Processing 00000000.tx.453: 186:439.[Abstract/Free FullText] Oliver, A. 

Phrase: "186"

Phrase: ":"

Phrase: "439."

Phrase: "[Abstract/Free FullText"

Phrase: "] Oliver,"

Phrase: "A."
Processing 00000000.tx.454: M., Martin, F. and Kearney, J. 

Phrase: "M."

Phrase: ","

Phrase: "Martin,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Kearney,"

Phrase: "J."
Processing 00000000.tx.455: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.456: 1997. 

Phrase: "1997."
Processing 00000000.tx.457: Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. 

Phrase: "Mouse CD38"

Phrase: "is"

Phrase: "down-regulated on germinal center B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0004561:B-Cells [Cell]
   778   C0282491:Germinal Center [Tissue]
   748   C0007634:Cells [Cell]
   748   C0205099:Center [Spatial Concept]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "mature plasma cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C2698029:Mature Plasma Cells [Laboratory Procedure]
   901   C0032112:Plasma Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.458: J. 

Phrase: "J."
Processing 00000000.tx.459: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.460: 158:1108.[Abstract] Ridderstad, A. and Tarlinton, D. 

Phrase: "158"

Phrase: ":"

Phrase: "1108."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ridderstad,"

Phrase: "A."

Phrase: "and"

Phrase: "Tarlinton,"

Phrase: "D."
Processing 00000000.tx.461: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.462: 1998. 

Phrase: "1998."
Processing 00000000.tx.463: Kinetics of establishing the memory B cell population as revealed by CD38 expression. 

Phrase: "Kinetics of establishing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0022702:Kinetics [Natural Phenomenon or Process]
   790   C0220865:kinetics [Functional Concept]
   790   C2825046:Kinetics [Occupation or Discipline]

Phrase: "the memory B cell population"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]
   756   C0682638:Memory B Cell [Cell]
   708   C0312737:Memory cell [Cell]

Phrase: "as"

Phrase: "revealed by CD38 expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0443289:Revealed [Qualitative Concept]
Processing 00000000.tx.464: J. 

Phrase: "J."
Processing 00000000.tx.465: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.466: 160:4688.[Abstract/Free FullText] McHeyzer-Williams, M. 

Phrase: "160"

Phrase: ":"

Phrase: "4688."

Phrase: "[Abstract/Free FullText"

Phrase: "] McHeyzer-Williams,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.467: G. and Ahmed, R. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Ahmed,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.468: 1999. 

Phrase: "1999."
Processing 00000000.tx.469: B cell memory and the long-lived plasma cell. 

Phrase: "B cell memory"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0312737:cell memory [Cell]
   827   C0025260:Memory [Mental Process]
   827   C0700327:memory [Finding]
   827   C1706377:Memory [Manufactured Object]
   771 E C0679055:mnemonic [Mental Process]
   734   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "the long-lived plasma cell."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032112:Plasma cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0032105:Plasma [Body Substance]
   812   C1269647:Cell [Cell]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.470: Curr. 

Phrase: "Curr."
Processing 00000000.tx.471: Opin. 

Phrase: "Opin."
Processing 00000000.tx.472: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.473: 11:172.[CrossRef][ISI][Medline] Tarlinton, D. 

Phrase: "11"

Phrase: ":"

Phrase: "172."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tarlinton,"

Phrase: "D."
Processing 00000000.tx.474: M. and Smith, K. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.475: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.476: 2000. 

Phrase: "2000."
Processing 00000000.tx.477: Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal centre. 

Phrase: "Dissecting affinity maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678723:Maturation [Organism Function]
   827   C0870861:maturation [Phenomenon or Process]
   827   C1254042:Maturation [Physiologic Function]

Phrase: ":"

Phrase: "a model explaining selection of antibody-forming cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0036576:selection [Genetic Function]

Phrase: "and"

Phrase: "memory B cells in the germinal centre."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   804   C0682638:b cells memory [Cell]
   778   C0004561:B-Cells [Cell]
   774   C0312737:Memory cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.478: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.479: Today 21:436.[CrossRef][ISI][Medline] Allen, D., Simon, T., Sablitzky, F., Rajewsky, K. and Cumano, K. 

Phrase: "Today 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0310367:Today [Antibiotic,Organic Chemical]
   861   C0750526:Today [Temporal Concept]

Phrase: ":"

Phrase: "436."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Allen,"

Phrase: "D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diversity [Qualitative Concept]

Phrase: "Simon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:Simon [Intellectual Product]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sablitzky,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rajewsky,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Cumano,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.480: 1988. 

Phrase: "1988."
Processing 00000000.tx.481: Antibody engineering for the analysis of affinity maturation of an anti-hapten response. 

Phrase: "Antibody engineering for the analysis of affinity maturation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014279:Engineering [Occupation or Discipline]

Phrase: "of an anti-hapten response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.482: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.483: 7:1995.[Abstract] Song, H. and Cerny, J. 

Phrase: "7"

Phrase: ":"

Phrase: "1995."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Cerny,"

Phrase: "J."
Processing 00000000.tx.484: 2003. 

Phrase: "2003."
Processing 00000000.tx.485: Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. 

Phrase: "Functional heterogeneity of marginal zone B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "revealed by their ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C0443289:Revealed [Qualitative Concept]

Phrase: "generate"

Phrase: "both early antibody-forming cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0007634:Cells [Cell]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0205431:Forming [Functional Concept]
   812   C1522492:Forming [Functional Concept]
   812   C3282337:Cells [Cell]
   779 E C0348078:Form [Qualitative Concept]
   779 E C0376315:Form [Manufactured Object]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "germinal centers with hypermutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0282491:Germinal Centers [Tissue]
   770   C0205099:centers [Spatial Concept]

Phrase: "and"

Phrase: "memory in response"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025260:Memory [Mental Process]
   790   C0700327:memory [Finding]
   790   C1706377:Memory [Manufactured Object]
   734 E C0679055:mnemonic [Mental Process]

Phrase: "to a T-dependent antigen."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   902   C0348042:A antigen [Immunologic Factor]
   812   C0003320:Antigen [Immunologic Factor]
   712 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.486: J. 

Phrase: "J."
Processing 00000000.tx.487: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.488: Med. 

Phrase: "Med."
Processing 00000000.tx.489: 198:1923.[Abstract/Free FullText] Liu, Y.-J., Oldfield, S. and MacLennan, I. 

Phrase: "198"

Phrase: ":"

Phrase: "1923."

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu,"

Phrase: "Y.-J.,"

Phrase: "Oldfield,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "MacLennan,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.490: C. 

Phrase: "C."
Processing 00000000.tx.491: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.492: 1988. 

Phrase: "1988."
Processing 00000000.tx.493: Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. 

Phrase: "Memory B cells in T cell-dependent antibody responses"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C3656689:B cell+T cell [Cell]
   784   C0682638:b cells memory [Cell]
   781   C0682639:Memory T Cells [Cell]
   767   C0301850:B cell antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C0004561:B-Cells [Cell]
   762   C0312737:Memory cells [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "colonize"

Phrase: "the splenic marginal zones."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   983   C1710158:Splenic Marginal Zone [Tissue]
   896   C2332734:Splenic zone [Body Location or Region]
   867   C1711368:Marginal Zone [Tissue]
   827   C0205284:Marginal [Spatial Concept]
   827   C1550517:marginal [Idea or Concept]
   827   C1947914:Marginal [Qualitative Concept]
   793   C1710706:Zone [Spatial Concept]
   755 E C0229985:margin [Body Part, Organ, or Organ Component]
   755 E C1269830:Margin [Finding]
   743 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.494: Eur. 

Phrase: "Eur."
Processing 00000000.tx.495: J. 

Phrase: "J."
Processing 00000000.tx.496: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.497: 18:355.[ISI][Medline] Dunn-Walters, D. 

Phrase: "18"

Phrase: ":"

Phrase: "355."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dunn-Walters,"

Phrase: "D."
Processing 00000000.tx.498: K., Isaacson, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Isaacson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.499: G. and Spencer, J. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Spencer,"

Phrase: "J."
Processing 00000000.tx.500: 1995. 

Phrase: "1995."
Processing 00000000.tx.501: Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. 

Phrase: "Analysis of mutations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C0796357:mutation analysis [Laboratory Procedure]
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "in immunoglobulin heavy chain variable region genes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   919   C0017351:Genes, Immunoglobulin Heavy Chain [Gene or Genome]
           Immunoglobulin Heavy Gene
   895   C0017350:Genes, Immunoglobulin [Gene or Genome]
   844   C0598666:variable region gene [Gene or Genome]
   799   C0017337:Genes [Gene or Genome]
   719   C0877857:Immunoglobulin Variable Region [Amino Acid, Peptide, or Protein,Immunologic Factor]
   709   C1302678:Immunoglobulin region [Amino Acid, Peptide, or Protein]

Phrase: "of microdissected marginal zone (MGZ) B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the MGZ of human spleen"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C0734905:Marginal zone of spleen [Body Location or Region]
   804   C1710158:Spleen Marginal Zone [Tissue]
   804   C2332734:Zone of spleen [Body Location or Region]
   778   C1711368:Marginal Zone [Tissue]
   776   C1283696:Margin of spleen [Body Location or Region]
   748   C0205284:Marginal [Spatial Concept]
   748   C1550517:marginal [Idea or Concept]
   748   C1710706:Zone [Spatial Concept]
   748   C1947914:Marginal [Qualitative Concept]

Phrase: "is"

Phrase: "a reservoir of memory B cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0442537:Reservoir [Geographic Area]
   753   C1705182:Reservoir [Medical Device]
Processing 00000000.tx.502: J. 

Phrase: "J."
Processing 00000000.tx.503: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.504: Med. 

Phrase: "Med."
Processing 00000000.tx.505: 182:559.[Abstract/Free FullText] Liang, L., Porter, E. 

Phrase: "182"

Phrase: ":"

Phrase: "559."

Phrase: "[Abstract/Free FullText"

Phrase: "] Liang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Porter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0402671:Porter [Professional or Occupational Group]
  1000   C2244327:porter [Molecular Function]

Phrase: "E."
Processing 00000000.tx.506: M. and Sha, W. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Sha,"

Phrase: "W."
Processing 00000000.tx.507: C. 

Phrase: "C."
Processing 00000000.tx.508: 2002. 

Phrase: "2002."
Processing 00000000.tx.509: Constitutive expression of the B7h ligand for inducible costimulator on nave B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. 

Phrase: "Constitutive expression of the B7h ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for inducible costimulator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1415846:INDUCIBLE COSTIMULATOR [Gene or Genome]
   861   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205263:Inducible [Functional Concept]
   861   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "on nave B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "extinguished after activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "by distinct B cell receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0004561:B-cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "interleukin 4 receptor-mediated pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   717   C0123771:Interleukin 4 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C1334118:INTERLEUKIN 4 RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "rescued by CD40 signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037083:Signaling [Cell Function]
   770   C3537152:signaling [Biologic Function]
Processing 00000000.tx.510: J. 

Phrase: "J."
Processing 00000000.tx.511: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.512: Med. 

Phrase: "Med."
Processing 00000000.tx.513: 196:97.[Abstract/Free FullText] Kimoto, H., Nagaoka, H., Adachi Y. et al. 

Phrase: "196"

Phrase: ":"

Phrase: "97."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nagaoka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Adachi Y. et al."
Processing 00000000.tx.514: 1997. 

Phrase: "1997."
Processing 00000000.tx.515: Accumulation of somatic hypermutation and antigen-driven selection in rapidly cycling surface Ig+ germinal center (GC)B cells which occupy GC at a high frequency during the primary anti-hapten response in mice. 

Phrase: "Accumulation of somatic hypermutation"

Phrase: "and"

Phrase: "antigen-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "selection in rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036576:selection [Genetic Function]

Phrase: "cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1511572:Cycle [Temporal Concept]

Phrase: "surface Ig+ germinal center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282491:Germinal Center [Tissue]
   812   C0205099:Center [Spatial Concept]

Phrase: "(GC)B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "occupy"

Phrase: "GC at a high frequency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0282491:Germinal Center [Tissue]
   753   C0205099:Center [Spatial Concept]

Phrase: "during the primary anti-hapten response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.516: Eur. 

Phrase: "Eur."
Processing 00000000.tx.517: J. 

Phrase: "J."
Processing 00000000.tx.518: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.519: 27:268.[ISI][Medline] Galibert, L., Burdin, N., Barthelemy, C. et al. 

Phrase: "27"

Phrase: ":"

Phrase: "268."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Galibert,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Burdin,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Barthelemy,"

Phrase: "C. et al."
Processing 00000000.tx.520: 1996. 

Phrase: "1996."
Processing 00000000.tx.521: Negative selection of human germinal center B cells by prolonged BCR cross-linking. 

Phrase: "Negative selection of human germinal center B cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   802   C1817732:B cell negative selection [Biologic Function]
   776   C1817719:B cell selection [Biologic Function]
   770   C2347338:Negative Selection [Laboratory Procedure]
   744   C0036576:selection [Genetic Function]
   744   C0205160:Negative [Qualitative Concept]
   744   C1513916:Negative [Finding]
   744   C2825415:Negative [Conceptual Entity]
   744   C2825491:Negative [Qualitative Concept]

Phrase: "by prolonged BCR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0004561:B-cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "cross-linking."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]
Processing 00000000.tx.522: J. 

Phrase: "J."
Processing 00000000.tx.523: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.524: Med. 

Phrase: "Med."
Processing 00000000.tx.525: 183:2075.[Abstract/Free FullText] Choe, J., Kim, H. 

Phrase: "183"

Phrase: ":"

Phrase: "2075."

Phrase: "[Abstract/Free FullText"

Phrase: "] Choe,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.526: S., Armitage, R. 

Phrase: "S."

Phrase: ","

Phrase: "Armitage,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.527: J. and Choi, Y. 

Phrase: "J."

Phrase: "and"

Phrase: "Choi,"

Phrase: "Y."
Processing 00000000.tx.528: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.529: 1997. 

Phrase: "1997."
Processing 00000000.tx.530: The functional role of B cell antigen receptor stimulation and IL-4 in the generation of human memory B cells from germinal center B cells. 

Phrase: "The functional role of B cell antigen receptor stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1705810:Functional Role [Conceptual Entity]
           Role
   742   C0035820:Role [Social Behavior]

Phrase: "and"

Phrase: "IL-4 in the generation of human memory B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0020898:IL [Geographic Area]
   739   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0022271:IL [Geographic Area]

Phrase: "from germinal center B cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.531: J. 

Phrase: "J."
Processing 00000000.tx.532: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.533: 159:3757.[Abstract] Smith, K. 

Phrase: "159"

Phrase: ":"

Phrase: "3757."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.534: G., Light, A., Nossal, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Light,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "A.,"

Phrase: "Nossal,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.535: J. and Tarlinton, D. 

Phrase: "J."

Phrase: "and"

Phrase: "Tarlinton,"

Phrase: "D."
Processing 00000000.tx.536: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.537: 1997. 

Phrase: "1997."
Processing 00000000.tx.538: The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. 

Phrase: "The extent of affinity maturation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "differs between the memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025260:Memory [Mental Process]
   770   C0700327:memory [Finding]
   770   C1706377:Memory [Manufactured Object]
   715 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "antibody-forming cell compartments in the primary immune response."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C1948049:Cell (compartment) [Spatial Concept]
   748   C2349967:Cell compartment [Anatomical Structure]
   742   C1185625:Compartments [Body Space or Junction]
   742   C1382196:Compartments [Natural Phenomenon or Process]
   708 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.539: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.540: 16:2996.[Abstract/Free FullText] Takahashi, Y., Dutta, P. 

Phrase: "16"

Phrase: ":"

Phrase: "2996."

Phrase: "[Abstract/Free FullText"

Phrase: "] Takahashi,"

Phrase: "Y.,"

Phrase: "Dutta,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.541: R., Cerasoli, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cerasoli,"

Phrase: "D."
Processing 00000000.tx.542: M. and Kelsoe, G. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Kelsoe,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.543: 1998. 

Phrase: "1998."
Processing 00000000.tx.544: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. 

Phrase: "In situ studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0444498:In situ [Spatial Concept]

Phrase: "of the primary immune response to (4-hydroxy-3-nitrophenyl"

Phrase: ")"

Phrase: "acetyl."
Processing 00000000.tx.545: V. 

Phrase: "V."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]
Processing 00000000.tx.546: Affinity maturation develops in two stages of clonal selection. 

Phrase: "Affinity maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "develops in two stages of clonal selection."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0036576:selection [Genetic Function]
   748   C0205448:Two [Quantitative Concept]
   748   C1306673:Stages [Qualitative Concept]
   748   C1522642:Clonal [Tissue]
   748   C1704387:Clonal [Qualitative Concept]
   714 E C0205390:Stage [Temporal Concept]
   714 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.547: J. 

Phrase: "J."
Processing 00000000.tx.548: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.549: Med. 

Phrase: "Med."
Processing 00000000.tx.550: 187:885.[Abstract/Free FullText] Shapiro-Shelef, M., Lin, K. 

Phrase: "187"

Phrase: ":"

Phrase: "885."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shapiro-Shelef,"

Phrase: "M."

Phrase: ","

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.551: I., McHeyzer-Williams, L. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "McHeyzer-Williams,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.552: J. et al. 

Phrase: "J. et al."
Processing 00000000.tx.553: 2003. 

Phrase: "2003."
Processing 00000000.tx.554: Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. 

Phrase: "Blimp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0254341:BLIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "required for the formation of immunoglobulin secreting plasma cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   784   C0085820:Immunoglobulin-Secreting Cells [Cell]
   764   C0032112:Plasma Cells [Cell]
   742   C0007634:Cells [Cell]
   742   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0032105:Plasma [Body Substance]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1327616:Secreting [Cell Function]
   742   C1514873:Required [Functional Concept]
   742   C1522492:Formation [Functional Concept]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1621846:immunoglobulin [Molecular Function]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "pre-plasma memory B cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   911   C0312738:Pre-B-Cells [Cell]
   875   C0032112:Plasma Cells [Cell]
   875   C1292769:pre-b [Neoplastic Process]
   867   C0682638:Memory B Cell [Cell]
   853   C0312737:Memory cells [Cell]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.555: Immunity 19:607.[CrossRef][ISI][Medline]

Phrase: "Immunity 19"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "607."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

